LayerRx Mapping ID
537
Slot System
Featured Buckets
Featured Buckets Admin
Reverse Chronological Sort
Allow Teaser Image

A Novel Technique for the Treatment of Jersey Fingers

Article Type
Changed
Thu, 09/19/2019 - 13:18
Display Headline
A Novel Technique for the Treatment of Jersey Fingers

ABSTRACT

The avulsion of the flexor digitorum profundus from its insertion, or “jersey finger,” is a relatively common injury. Numerous modifications have been made to the classification and treatment of this injury since its initial description. We describe a novel variation of the surgical management of jersey finger.

The avulsion-type injury of the flexor digitorum profundus (FDP) from its insertion on the distal phalanx is relatively common. FDP avulsions are seen in athletes and nonathletes, and are the result of the sudden hyperextension of the distal interphalangeal joint during active flexion. These injuries usually occur while grasping the jersey of an opposing player and are thus commonly referred to as “jersey finger.” Initially described in 1977 by Leddy and Packer1, FDP avulsions are classified on the basis of the proximal extent of the retraction of the FDP and the presence or absence of a bony avulsion fracture fragment. Type I injuries are defined by tendon retraction to the level of the palm, where it is tethered by the lumbricals. At this level, the vinculum longus profundus (VLP) and vinculum brevis profundus (VBP) are ruptured, resulting in the substantial loss of intrinsic and extrinsic vascular supply to the tendon. In type II injuries, which are the most common type of FDP avulsions, the FDP tendon retracts to the level of the proximal interphalangeal (PIP) joint. Although the VBP is disrupted in this scenario, the VLP remains preserved because it arises at the level of the volar plate of the PIP joint.  Type III lesions involve tendon avulsions with an associated bony fragment that is typically sufficiently large to not pass through the flexor sheath, thus limiting retraction to the level of the A4 pulley. Both vincula remain intact, given that the VBP originates at the distal portion of the middle phalanx. The Leddy and Packer classification was later expanded to include type IV and V injury patterns, which are less common than other injury patterns. Similar to type III injuries, type IV injuries involve a bony avulsion; however, the FDP subsequently ruptures from this fragment and the tendon subsequently retracts into the finger or palm.2,3 Type V injuries are more complex than other injury types because they involve a concomitant distal phalanx fracture with the FDP avulsion.4 Al-Qattan5 subclassified type V injuries into extra-articular (type Va) and intra-articular (type Vb) distal phalanx fractures on the basis of the distinct management of these 2 entities.

Numerous techniques have been proposed and described for the repair of FDP avulsion injuries. The pullout suture-dorsal button combination is the most widely described technique and was initially described by Bunnell.6 Unfortunately, this technique is accompanied by numerous potential postoperative complications.6 Nail plate deformity is the most commonly described complication. Other complications include local wound irritation, pain, button snagging, and repair failure. Additionally, the presence of external sutures creates a potential route of ingress for bacterial infection.

Continue to: Bone suture anchor techniques...

 

 

Bone suture anchor techniques were later utilized to repair FDP avulsions in an attempt to decrease complications associated with the external suture-button construct.7 The use of a transosseous suture without external button fixation has also been proposed. Sood and Elliot8 described a technique where the suture is passed through a hole, drilled transversely through the tuft of the distal phalanx, and affixed to the other limb. In 1999, Schultz and colleagues9 described a technique where transosseous tunnels are placed in the distal phalanx in a dorsal-to-volar direction. The suture is then passed through and tied on the dorsal surface. In this article, we propose a transosseous suture technique that may provide advantages over previously described methods.

SURGICAL TECHNIQUE

TYPES I, II, AND III

A Bruner incision is performed on the volar aspect of the affected finger, and full thickness flaps are elevated off the flexor sheath (Figures 1A-1C). 

The avulsed FDP tendon is retrieved in the usual fashion, and its insertion is identified. A 2-0 braided polyester suture is run in a Krakow fashion along the distal aspect of the FDP tendon and passed along its normal course under the A4 pulley (Figure 1B). Using a K-wire driver, 2 Keith needles are then driven through the base of the distal phalanx. The needles exit dorsally proximal to the germinal matrix. Once the appropriate positioning of the Keith needles is confirmed through fluoroscopic imaging (Figure 2), a dorsal counterincision is made, and the skin flaps are bluntly elevated. 
Each limb of the 2-0 suture is passed individually through 1 of the Keith needles, and the FDP tendon is inspected to ensure that it can be brought distally to its insertion with good tendon-to-bone contact (Figure 1C). The finger is brought into flexion, and the sutures are securely tied dorsally over the distal phalanx and the extensor tendon (Figure 3). 
The incisions are closed, and a dorsal blocking splint is applied with the wrist and fingers in flexion.

TYPES IV AND V

In cases of type IV or V injury (Figure 4A), a screw or plate construct is first used to allow for the successful reduction and fixation of the fracture (Figure 4B). 

Once completed, the tendon avulsion is addressed in the same fashion as previously described, with the repair being performed atop the affixed fragment.

DISCUSSION

The avulsion of the FDP tendon from its insertion (zone I) on the distal phalanx is commonly called “jersey finger” and is a well-described injury that occurs most commonly in the ring finger.10 These injuries can be difficult to treat and are associated with a complication rate of as high as 60%.11,12 Bunnell’s initial description of a suture passed through the fingernail and then tied over a polypropylene button has been associated with multiple complications. Kang and colleagues13 reported abnormal nail growth, nail fold necrosis, fingertip deformity, stiffness, infection, and amputation, 43% of all complications were directly related to the button. As an alternative to the button, sutures may be tied directly over the nail plate itself via 2 separate holes.14 While this technique eliminates the complications directly associated with the button, the potential for infection remains. Additionally, increased direct pressure is placed on the nail plate and nail bed, thus potentially increasing the risk of nail deformity.

In 1994, Hallock7 initially described the use of bone anchors as an “internal fixation” alternative and cited the “expense of the apparatus” as the major drawback of this technique. McCallister and colleagues15 compared the clinical outcome of suture anchor fixation with that of the button-over-nail technique. Although they ultimately demonstrated that the clinical outcomes of the 2 techniques are not significantly different, they noted that suture anchor fixation is associated with decreased infection rate (7% vs 0%) and time to return to work. Poor bone mineral density and low cortical thickness are correlated with anchor pull-out, thus limiting its universal use.16 Furthermore, the universal use of many commonly available anchors is limited given that they are too large to be accommodated within many phalanges, particularly in women and in the small and ring fingers.17  The use of microanchors rather than mini anchors not only decreases this risk but also decreases construct strength, thus necessitating the use of 2 anchors to restore adequate fixation strength. Anchor use is associated with specific risks, including the dorsal migration of the anchor, the osteolysis of the surrounding bone, as well as the perforation of the dorsal cortex and the possible extrusion of the anchor through the phalanx and into the nail bed.18,19 Additionally, in the wake of a changing healthcare system, the cost of suture anchors, as initially noted by Hallock,7 must be considered. This consideration is particularly relevant to the use of a 2 microanchor construct, which has been advocated given its biomechanical advantage.20,21

Continue to: Transosseous tendon repair...

 

 

Transosseous tendon repair is a cost-effective option that obviates many complications commonly observed with other fixation methods. By keeping the suture within the body, the complications inherent in external sutures and buttons are eliminated, including the loss of fixation as a result of button or suture damage and facilitating hand hygiene maintenance. The rate of infection is also reduced. Moreover, the risk of nail deformities is decreased because the suture is not passed through the nail bed and nail plate in the described technique. Occasionally, some patients do note irritation from the dorsal suture knot under the thin skin proximal to the germinal matrix. This can be easily addressed in the clinic by removing the knot under local anesthesia following sufficient tendon healing. Additionally, the described technique can be used safely in pediatric patients with open physes because the needles can be placed to prevent violating the physis. This technique can be performed in conjunction with the skeletal fixation of type III, IV, and V jersey fingers. In our experience, the transosseous suture repair is more secure than the limited screw fixation, which can be accomplished in many type III jersey fingers, and in at least 1 case, has maintained flexor function when the skeletal fixation of the jersey finger has failed (Figures 5A, 5B).

All internal fixation techniques have been described previously by Sood and Elliot8 and, later, by Schultz and colleagues.9 In contrast to Sood and Elliott’s8 technique, which requires the creation of transverse tunnels, a volar-to-dorsal tunnel is technically easy to create and creates a direct repair to tendon insertion. Our technique is similar to that of Schultz and colleagues'9 but has the following differences and potential improvements:

  1. Keith needles are passed in a volar-to-dorsal fashion, thus allowing for the direct visualization of the transosseous tunnel origin, minimizing the size of the transosseous tunnels, and allowing for the anatomic reduction of the tendon.
  2. Fluoroscopy is used to confirm wire placement prior to skin incision, thus enabling precise placement and potentially allowing the needles to be placed so as to avoid physeal injury in pediatric jersey fingers.
  3. By using Keith needles, sutures can be passed with the same instrument that created the tunnel, thus simplifying surgical technique.
  4. A Krakow suture technique is used. This technique results in less gapping and higher load-to-failure than other suturing techniques.22
  5. A 2-0 braided suture is used, therefore strengthening repair.

This paper will be judged for the Resident Writer’s Award.

References

1. Leddy JP, Packer JW. Avulsion of the profundus tendon insertion in athletes. J Hand Surg Am. 1977;2(1):66-69. doi:https://doi.org/10.1016/S0363-5023(77)80012-9.

2. Langa V, Posner MA. Unusual rupture of a flexor profundus tendon. J Hand Surg Am. 1986;11(2):227-229. doi:https://doi.org/10.1016/S0363-5023(86)80056-9.

3. Ehlert KJ, Gould JS, Black KP. A simultaneous distal phalanx avulsion fracture with profundus tendon avulsion: A case report and review of the literature. Clin Orthop Relat Res. 1992;(283):265-269.

4. Smith JH. Avulsion of a profundus tendon with simultaneous intraarticular fracture of the distal phalanx–case report. J Hand Surg Am. 1981;6(6):600-601. doi:10.1097/00006534-198305000-00081.

5. Al-Qattan MM. Type 5 avulsion of the insertion of the flexor digitorum profundus tendon. J Hand Surg Br. 2001;26(5):427-431. doi:10.1054/jhsb.2001.0619.

6. Bunnell S. Surgery of the hand, 2nd edition. Philadelphia, PA: JB Lippincott; 1948:381-466.

7. Hallock GG. The Mitek Mini GII anchor introduced for tendon reinsertion in the hand. Ann Plast Surg. 1994;33(2):211-213.

8. Sood MK, Elliot D. A new technique of attachment of flexor tendons to the distal phalanx without a button tie-over. J Hand Surg Br. 1996;21(5):629-632. doi:https://doi.org/10.1016/S0266-7681(96)80146-X.

9. Schultz RO, Drake DB, Morgan RF. A new technique for the treatment of flexor digitorum profundus tendon avulsion. Ann Plast Surg. 1999;42(1):46-48. doi:10.1097/00000637-199901000-00008.

10. Manske PR, Lesker PA. Avulsion of the ring finger flexor digitorum profundus tendon: An experimental study. Hand 1978;10(1):52-55. doi:https://doi.org/10.1016/S0072-968X(78)80025-4.

11. Gerbino PG, Saldana MJ, Westerbeck P, Schacherer TG. Complications experienced in the rehabilitation of zone I flexor tendon injuries with dynamic traction splinting. J Hand Surg Am. 1991;16(4):680-686. doi:https://doi.org/10.1016/0363-5023(91)90194-G

12. Evans RB. Zone I flexor tendon rehabilitation with limited extension and active flexion. J Hand Ther. 2005;18(2):128-140. doi:10.1197/j.jht.2005.02.001

13. Kang N, Marsh D, Dewar D. The morbidity of the button-over-nail technique for zone 1 flexor tendon repairs. Should we still be using this technique? J Hand Surg Eur Vol. 2008;33(5):566-570. doi:10.1177/1753193408090118

14. Taras JS. Flexor tendon reconstruction: Single stage flexor tendon grafting: FDP, FDS disrupted. In: Green DP, Hotchkiss RN, Pederson WL, Wolfe SW, eds. Green’s Operative Hand Surgery. 5th ed. Philadelphia, PA: Elsevier Health Sciences; 2005:248-249.

15. McCallister WV, Ambrose HC, Katolik LI, Trumble TE. Comparison of pullout button versus suture anchor for zone I flexor tendon repair. J Hand Surg Am. 2006;31:246-251. doi:10.1016/j.jhsa.2005.10.020

16. Matzsuzaki H, Zaegel MA, Gelberman RH, Silva MJ. Effect of suture material and bone quality on the mechanical properties of zone 1 flexor tendon-bone reattachment with bone anchors. J Hand Surg Am. 2008;33(5):709-717. doi:10.1016/j.jhsa.2008.01.025

17. Singh R, Kakarala G, Persaud I, Roberts M, Strandring S, Compson J. The optimal length of tissue anchors for distal phalanges. A study in 395 cadaver digits. J Bone Joint Surg Br. 2006;88-B(SUPP I):37.

18. Giannikas D, Athanaselis E, Matzaroglou C, Saridis A, Tyllianakis M. An unusual complication of Mitek suture anchor use in primary treatment of flexor digitorum         profundus tendon laceration: a case report. Cases J. 2009;2:9319. doi:10.1186/1757-1626-2-9319

19. Tiong WH, O'Sullivan ST. Extrusion of bone anchor suture following flexor digitorum profundus tendon avulsion injury repair. J Plast Reconstr Aesthet Surg. 2011;64(9):1242-1244. doi:10.1016/j.bjps.2011.01.016

20. Silva MJ, Hollstien SB, Brodt MD, Boyer MI, Tetro AM, Gelberman RH. Flexor digitorum profundus tendon-to-bone repair: An ex vivo biomechanical analysis of 3 pullout suture techniques. J Hand Surg Am. 1998;23(1):120-126. doi:10.1016/S0363-5023(98)80099-3

21. Latendresse K, Dona E, Scougall PJ, Schreuder FB, Puchert E, Walsh WR. Cyclic testing of pullout sutures and micro-mitek suture anchors in flexor digitorum profundus tendon distal fixation. J Hand Surg Am. 2005;30(3):471-478. doi:10.1016/j.jhsa.2004.10.014

22. Lee SK, Fajardo M, Kardashian G, Klein J, Tsai P, Christoforou D. Repair of flexor digitorum profundus to distal phalanx: a biomechanical evaluation of four techniques. J      Hand Surg Am. 2011;36(10):1604-1609. doi:10.1016/j.jhsa.2011.07.017

Author and Disclosure Information

Authors’ Disclosure Statement: The authors report no actual or potential conflict of interest in relation to this article.

Dr. Patrick and Dr. Weinheimer are Residents, and Dr. Darowish is Associate Professor, Hand Surgery, Department of Orthopedic Surgery, Penn State Milton S. Hershey Medical Center, Bone and Joint Institute, Hersey, Pennsylvania.

Address correspondence to: Michael Darowish, MD, Department of Orthopedic Surgery, Penn State Milton S. Hershey Medical Center, Bone and Joint Institute, 30 Hope Drive, PO Box 859, Hershey, PA 17033 (email: [email protected]).

Am J Orthop. 2018;47(5). Copyright Frontline Medical Communications Inc. 2018. All rights reserved.

. A Novel Technique for the Treatment of Jersey Fingers. Am J Orthop.

Publications
Topics
Sections
Author and Disclosure Information

Authors’ Disclosure Statement: The authors report no actual or potential conflict of interest in relation to this article.

Dr. Patrick and Dr. Weinheimer are Residents, and Dr. Darowish is Associate Professor, Hand Surgery, Department of Orthopedic Surgery, Penn State Milton S. Hershey Medical Center, Bone and Joint Institute, Hersey, Pennsylvania.

Address correspondence to: Michael Darowish, MD, Department of Orthopedic Surgery, Penn State Milton S. Hershey Medical Center, Bone and Joint Institute, 30 Hope Drive, PO Box 859, Hershey, PA 17033 (email: [email protected]).

Am J Orthop. 2018;47(5). Copyright Frontline Medical Communications Inc. 2018. All rights reserved.

. A Novel Technique for the Treatment of Jersey Fingers. Am J Orthop.

Author and Disclosure Information

Authors’ Disclosure Statement: The authors report no actual or potential conflict of interest in relation to this article.

Dr. Patrick and Dr. Weinheimer are Residents, and Dr. Darowish is Associate Professor, Hand Surgery, Department of Orthopedic Surgery, Penn State Milton S. Hershey Medical Center, Bone and Joint Institute, Hersey, Pennsylvania.

Address correspondence to: Michael Darowish, MD, Department of Orthopedic Surgery, Penn State Milton S. Hershey Medical Center, Bone and Joint Institute, 30 Hope Drive, PO Box 859, Hershey, PA 17033 (email: [email protected]).

Am J Orthop. 2018;47(5). Copyright Frontline Medical Communications Inc. 2018. All rights reserved.

. A Novel Technique for the Treatment of Jersey Fingers. Am J Orthop.

ABSTRACT

The avulsion of the flexor digitorum profundus from its insertion, or “jersey finger,” is a relatively common injury. Numerous modifications have been made to the classification and treatment of this injury since its initial description. We describe a novel variation of the surgical management of jersey finger.

The avulsion-type injury of the flexor digitorum profundus (FDP) from its insertion on the distal phalanx is relatively common. FDP avulsions are seen in athletes and nonathletes, and are the result of the sudden hyperextension of the distal interphalangeal joint during active flexion. These injuries usually occur while grasping the jersey of an opposing player and are thus commonly referred to as “jersey finger.” Initially described in 1977 by Leddy and Packer1, FDP avulsions are classified on the basis of the proximal extent of the retraction of the FDP and the presence or absence of a bony avulsion fracture fragment. Type I injuries are defined by tendon retraction to the level of the palm, where it is tethered by the lumbricals. At this level, the vinculum longus profundus (VLP) and vinculum brevis profundus (VBP) are ruptured, resulting in the substantial loss of intrinsic and extrinsic vascular supply to the tendon. In type II injuries, which are the most common type of FDP avulsions, the FDP tendon retracts to the level of the proximal interphalangeal (PIP) joint. Although the VBP is disrupted in this scenario, the VLP remains preserved because it arises at the level of the volar plate of the PIP joint.  Type III lesions involve tendon avulsions with an associated bony fragment that is typically sufficiently large to not pass through the flexor sheath, thus limiting retraction to the level of the A4 pulley. Both vincula remain intact, given that the VBP originates at the distal portion of the middle phalanx. The Leddy and Packer classification was later expanded to include type IV and V injury patterns, which are less common than other injury patterns. Similar to type III injuries, type IV injuries involve a bony avulsion; however, the FDP subsequently ruptures from this fragment and the tendon subsequently retracts into the finger or palm.2,3 Type V injuries are more complex than other injury types because they involve a concomitant distal phalanx fracture with the FDP avulsion.4 Al-Qattan5 subclassified type V injuries into extra-articular (type Va) and intra-articular (type Vb) distal phalanx fractures on the basis of the distinct management of these 2 entities.

Numerous techniques have been proposed and described for the repair of FDP avulsion injuries. The pullout suture-dorsal button combination is the most widely described technique and was initially described by Bunnell.6 Unfortunately, this technique is accompanied by numerous potential postoperative complications.6 Nail plate deformity is the most commonly described complication. Other complications include local wound irritation, pain, button snagging, and repair failure. Additionally, the presence of external sutures creates a potential route of ingress for bacterial infection.

Continue to: Bone suture anchor techniques...

 

 

Bone suture anchor techniques were later utilized to repair FDP avulsions in an attempt to decrease complications associated with the external suture-button construct.7 The use of a transosseous suture without external button fixation has also been proposed. Sood and Elliot8 described a technique where the suture is passed through a hole, drilled transversely through the tuft of the distal phalanx, and affixed to the other limb. In 1999, Schultz and colleagues9 described a technique where transosseous tunnels are placed in the distal phalanx in a dorsal-to-volar direction. The suture is then passed through and tied on the dorsal surface. In this article, we propose a transosseous suture technique that may provide advantages over previously described methods.

SURGICAL TECHNIQUE

TYPES I, II, AND III

A Bruner incision is performed on the volar aspect of the affected finger, and full thickness flaps are elevated off the flexor sheath (Figures 1A-1C). 

The avulsed FDP tendon is retrieved in the usual fashion, and its insertion is identified. A 2-0 braided polyester suture is run in a Krakow fashion along the distal aspect of the FDP tendon and passed along its normal course under the A4 pulley (Figure 1B). Using a K-wire driver, 2 Keith needles are then driven through the base of the distal phalanx. The needles exit dorsally proximal to the germinal matrix. Once the appropriate positioning of the Keith needles is confirmed through fluoroscopic imaging (Figure 2), a dorsal counterincision is made, and the skin flaps are bluntly elevated. 
Each limb of the 2-0 suture is passed individually through 1 of the Keith needles, and the FDP tendon is inspected to ensure that it can be brought distally to its insertion with good tendon-to-bone contact (Figure 1C). The finger is brought into flexion, and the sutures are securely tied dorsally over the distal phalanx and the extensor tendon (Figure 3). 
The incisions are closed, and a dorsal blocking splint is applied with the wrist and fingers in flexion.

TYPES IV AND V

In cases of type IV or V injury (Figure 4A), a screw or plate construct is first used to allow for the successful reduction and fixation of the fracture (Figure 4B). 

Once completed, the tendon avulsion is addressed in the same fashion as previously described, with the repair being performed atop the affixed fragment.

DISCUSSION

The avulsion of the FDP tendon from its insertion (zone I) on the distal phalanx is commonly called “jersey finger” and is a well-described injury that occurs most commonly in the ring finger.10 These injuries can be difficult to treat and are associated with a complication rate of as high as 60%.11,12 Bunnell’s initial description of a suture passed through the fingernail and then tied over a polypropylene button has been associated with multiple complications. Kang and colleagues13 reported abnormal nail growth, nail fold necrosis, fingertip deformity, stiffness, infection, and amputation, 43% of all complications were directly related to the button. As an alternative to the button, sutures may be tied directly over the nail plate itself via 2 separate holes.14 While this technique eliminates the complications directly associated with the button, the potential for infection remains. Additionally, increased direct pressure is placed on the nail plate and nail bed, thus potentially increasing the risk of nail deformity.

In 1994, Hallock7 initially described the use of bone anchors as an “internal fixation” alternative and cited the “expense of the apparatus” as the major drawback of this technique. McCallister and colleagues15 compared the clinical outcome of suture anchor fixation with that of the button-over-nail technique. Although they ultimately demonstrated that the clinical outcomes of the 2 techniques are not significantly different, they noted that suture anchor fixation is associated with decreased infection rate (7% vs 0%) and time to return to work. Poor bone mineral density and low cortical thickness are correlated with anchor pull-out, thus limiting its universal use.16 Furthermore, the universal use of many commonly available anchors is limited given that they are too large to be accommodated within many phalanges, particularly in women and in the small and ring fingers.17  The use of microanchors rather than mini anchors not only decreases this risk but also decreases construct strength, thus necessitating the use of 2 anchors to restore adequate fixation strength. Anchor use is associated with specific risks, including the dorsal migration of the anchor, the osteolysis of the surrounding bone, as well as the perforation of the dorsal cortex and the possible extrusion of the anchor through the phalanx and into the nail bed.18,19 Additionally, in the wake of a changing healthcare system, the cost of suture anchors, as initially noted by Hallock,7 must be considered. This consideration is particularly relevant to the use of a 2 microanchor construct, which has been advocated given its biomechanical advantage.20,21

Continue to: Transosseous tendon repair...

 

 

Transosseous tendon repair is a cost-effective option that obviates many complications commonly observed with other fixation methods. By keeping the suture within the body, the complications inherent in external sutures and buttons are eliminated, including the loss of fixation as a result of button or suture damage and facilitating hand hygiene maintenance. The rate of infection is also reduced. Moreover, the risk of nail deformities is decreased because the suture is not passed through the nail bed and nail plate in the described technique. Occasionally, some patients do note irritation from the dorsal suture knot under the thin skin proximal to the germinal matrix. This can be easily addressed in the clinic by removing the knot under local anesthesia following sufficient tendon healing. Additionally, the described technique can be used safely in pediatric patients with open physes because the needles can be placed to prevent violating the physis. This technique can be performed in conjunction with the skeletal fixation of type III, IV, and V jersey fingers. In our experience, the transosseous suture repair is more secure than the limited screw fixation, which can be accomplished in many type III jersey fingers, and in at least 1 case, has maintained flexor function when the skeletal fixation of the jersey finger has failed (Figures 5A, 5B).

All internal fixation techniques have been described previously by Sood and Elliot8 and, later, by Schultz and colleagues.9 In contrast to Sood and Elliott’s8 technique, which requires the creation of transverse tunnels, a volar-to-dorsal tunnel is technically easy to create and creates a direct repair to tendon insertion. Our technique is similar to that of Schultz and colleagues'9 but has the following differences and potential improvements:

  1. Keith needles are passed in a volar-to-dorsal fashion, thus allowing for the direct visualization of the transosseous tunnel origin, minimizing the size of the transosseous tunnels, and allowing for the anatomic reduction of the tendon.
  2. Fluoroscopy is used to confirm wire placement prior to skin incision, thus enabling precise placement and potentially allowing the needles to be placed so as to avoid physeal injury in pediatric jersey fingers.
  3. By using Keith needles, sutures can be passed with the same instrument that created the tunnel, thus simplifying surgical technique.
  4. A Krakow suture technique is used. This technique results in less gapping and higher load-to-failure than other suturing techniques.22
  5. A 2-0 braided suture is used, therefore strengthening repair.

This paper will be judged for the Resident Writer’s Award.

ABSTRACT

The avulsion of the flexor digitorum profundus from its insertion, or “jersey finger,” is a relatively common injury. Numerous modifications have been made to the classification and treatment of this injury since its initial description. We describe a novel variation of the surgical management of jersey finger.

The avulsion-type injury of the flexor digitorum profundus (FDP) from its insertion on the distal phalanx is relatively common. FDP avulsions are seen in athletes and nonathletes, and are the result of the sudden hyperextension of the distal interphalangeal joint during active flexion. These injuries usually occur while grasping the jersey of an opposing player and are thus commonly referred to as “jersey finger.” Initially described in 1977 by Leddy and Packer1, FDP avulsions are classified on the basis of the proximal extent of the retraction of the FDP and the presence or absence of a bony avulsion fracture fragment. Type I injuries are defined by tendon retraction to the level of the palm, where it is tethered by the lumbricals. At this level, the vinculum longus profundus (VLP) and vinculum brevis profundus (VBP) are ruptured, resulting in the substantial loss of intrinsic and extrinsic vascular supply to the tendon. In type II injuries, which are the most common type of FDP avulsions, the FDP tendon retracts to the level of the proximal interphalangeal (PIP) joint. Although the VBP is disrupted in this scenario, the VLP remains preserved because it arises at the level of the volar plate of the PIP joint.  Type III lesions involve tendon avulsions with an associated bony fragment that is typically sufficiently large to not pass through the flexor sheath, thus limiting retraction to the level of the A4 pulley. Both vincula remain intact, given that the VBP originates at the distal portion of the middle phalanx. The Leddy and Packer classification was later expanded to include type IV and V injury patterns, which are less common than other injury patterns. Similar to type III injuries, type IV injuries involve a bony avulsion; however, the FDP subsequently ruptures from this fragment and the tendon subsequently retracts into the finger or palm.2,3 Type V injuries are more complex than other injury types because they involve a concomitant distal phalanx fracture with the FDP avulsion.4 Al-Qattan5 subclassified type V injuries into extra-articular (type Va) and intra-articular (type Vb) distal phalanx fractures on the basis of the distinct management of these 2 entities.

Numerous techniques have been proposed and described for the repair of FDP avulsion injuries. The pullout suture-dorsal button combination is the most widely described technique and was initially described by Bunnell.6 Unfortunately, this technique is accompanied by numerous potential postoperative complications.6 Nail plate deformity is the most commonly described complication. Other complications include local wound irritation, pain, button snagging, and repair failure. Additionally, the presence of external sutures creates a potential route of ingress for bacterial infection.

Continue to: Bone suture anchor techniques...

 

 

Bone suture anchor techniques were later utilized to repair FDP avulsions in an attempt to decrease complications associated with the external suture-button construct.7 The use of a transosseous suture without external button fixation has also been proposed. Sood and Elliot8 described a technique where the suture is passed through a hole, drilled transversely through the tuft of the distal phalanx, and affixed to the other limb. In 1999, Schultz and colleagues9 described a technique where transosseous tunnels are placed in the distal phalanx in a dorsal-to-volar direction. The suture is then passed through and tied on the dorsal surface. In this article, we propose a transosseous suture technique that may provide advantages over previously described methods.

SURGICAL TECHNIQUE

TYPES I, II, AND III

A Bruner incision is performed on the volar aspect of the affected finger, and full thickness flaps are elevated off the flexor sheath (Figures 1A-1C). 

The avulsed FDP tendon is retrieved in the usual fashion, and its insertion is identified. A 2-0 braided polyester suture is run in a Krakow fashion along the distal aspect of the FDP tendon and passed along its normal course under the A4 pulley (Figure 1B). Using a K-wire driver, 2 Keith needles are then driven through the base of the distal phalanx. The needles exit dorsally proximal to the germinal matrix. Once the appropriate positioning of the Keith needles is confirmed through fluoroscopic imaging (Figure 2), a dorsal counterincision is made, and the skin flaps are bluntly elevated. 
Each limb of the 2-0 suture is passed individually through 1 of the Keith needles, and the FDP tendon is inspected to ensure that it can be brought distally to its insertion with good tendon-to-bone contact (Figure 1C). The finger is brought into flexion, and the sutures are securely tied dorsally over the distal phalanx and the extensor tendon (Figure 3). 
The incisions are closed, and a dorsal blocking splint is applied with the wrist and fingers in flexion.

TYPES IV AND V

In cases of type IV or V injury (Figure 4A), a screw or plate construct is first used to allow for the successful reduction and fixation of the fracture (Figure 4B). 

Once completed, the tendon avulsion is addressed in the same fashion as previously described, with the repair being performed atop the affixed fragment.

DISCUSSION

The avulsion of the FDP tendon from its insertion (zone I) on the distal phalanx is commonly called “jersey finger” and is a well-described injury that occurs most commonly in the ring finger.10 These injuries can be difficult to treat and are associated with a complication rate of as high as 60%.11,12 Bunnell’s initial description of a suture passed through the fingernail and then tied over a polypropylene button has been associated with multiple complications. Kang and colleagues13 reported abnormal nail growth, nail fold necrosis, fingertip deformity, stiffness, infection, and amputation, 43% of all complications were directly related to the button. As an alternative to the button, sutures may be tied directly over the nail plate itself via 2 separate holes.14 While this technique eliminates the complications directly associated with the button, the potential for infection remains. Additionally, increased direct pressure is placed on the nail plate and nail bed, thus potentially increasing the risk of nail deformity.

In 1994, Hallock7 initially described the use of bone anchors as an “internal fixation” alternative and cited the “expense of the apparatus” as the major drawback of this technique. McCallister and colleagues15 compared the clinical outcome of suture anchor fixation with that of the button-over-nail technique. Although they ultimately demonstrated that the clinical outcomes of the 2 techniques are not significantly different, they noted that suture anchor fixation is associated with decreased infection rate (7% vs 0%) and time to return to work. Poor bone mineral density and low cortical thickness are correlated with anchor pull-out, thus limiting its universal use.16 Furthermore, the universal use of many commonly available anchors is limited given that they are too large to be accommodated within many phalanges, particularly in women and in the small and ring fingers.17  The use of microanchors rather than mini anchors not only decreases this risk but also decreases construct strength, thus necessitating the use of 2 anchors to restore adequate fixation strength. Anchor use is associated with specific risks, including the dorsal migration of the anchor, the osteolysis of the surrounding bone, as well as the perforation of the dorsal cortex and the possible extrusion of the anchor through the phalanx and into the nail bed.18,19 Additionally, in the wake of a changing healthcare system, the cost of suture anchors, as initially noted by Hallock,7 must be considered. This consideration is particularly relevant to the use of a 2 microanchor construct, which has been advocated given its biomechanical advantage.20,21

Continue to: Transosseous tendon repair...

 

 

Transosseous tendon repair is a cost-effective option that obviates many complications commonly observed with other fixation methods. By keeping the suture within the body, the complications inherent in external sutures and buttons are eliminated, including the loss of fixation as a result of button or suture damage and facilitating hand hygiene maintenance. The rate of infection is also reduced. Moreover, the risk of nail deformities is decreased because the suture is not passed through the nail bed and nail plate in the described technique. Occasionally, some patients do note irritation from the dorsal suture knot under the thin skin proximal to the germinal matrix. This can be easily addressed in the clinic by removing the knot under local anesthesia following sufficient tendon healing. Additionally, the described technique can be used safely in pediatric patients with open physes because the needles can be placed to prevent violating the physis. This technique can be performed in conjunction with the skeletal fixation of type III, IV, and V jersey fingers. In our experience, the transosseous suture repair is more secure than the limited screw fixation, which can be accomplished in many type III jersey fingers, and in at least 1 case, has maintained flexor function when the skeletal fixation of the jersey finger has failed (Figures 5A, 5B).

All internal fixation techniques have been described previously by Sood and Elliot8 and, later, by Schultz and colleagues.9 In contrast to Sood and Elliott’s8 technique, which requires the creation of transverse tunnels, a volar-to-dorsal tunnel is technically easy to create and creates a direct repair to tendon insertion. Our technique is similar to that of Schultz and colleagues'9 but has the following differences and potential improvements:

  1. Keith needles are passed in a volar-to-dorsal fashion, thus allowing for the direct visualization of the transosseous tunnel origin, minimizing the size of the transosseous tunnels, and allowing for the anatomic reduction of the tendon.
  2. Fluoroscopy is used to confirm wire placement prior to skin incision, thus enabling precise placement and potentially allowing the needles to be placed so as to avoid physeal injury in pediatric jersey fingers.
  3. By using Keith needles, sutures can be passed with the same instrument that created the tunnel, thus simplifying surgical technique.
  4. A Krakow suture technique is used. This technique results in less gapping and higher load-to-failure than other suturing techniques.22
  5. A 2-0 braided suture is used, therefore strengthening repair.

This paper will be judged for the Resident Writer’s Award.

References

1. Leddy JP, Packer JW. Avulsion of the profundus tendon insertion in athletes. J Hand Surg Am. 1977;2(1):66-69. doi:https://doi.org/10.1016/S0363-5023(77)80012-9.

2. Langa V, Posner MA. Unusual rupture of a flexor profundus tendon. J Hand Surg Am. 1986;11(2):227-229. doi:https://doi.org/10.1016/S0363-5023(86)80056-9.

3. Ehlert KJ, Gould JS, Black KP. A simultaneous distal phalanx avulsion fracture with profundus tendon avulsion: A case report and review of the literature. Clin Orthop Relat Res. 1992;(283):265-269.

4. Smith JH. Avulsion of a profundus tendon with simultaneous intraarticular fracture of the distal phalanx–case report. J Hand Surg Am. 1981;6(6):600-601. doi:10.1097/00006534-198305000-00081.

5. Al-Qattan MM. Type 5 avulsion of the insertion of the flexor digitorum profundus tendon. J Hand Surg Br. 2001;26(5):427-431. doi:10.1054/jhsb.2001.0619.

6. Bunnell S. Surgery of the hand, 2nd edition. Philadelphia, PA: JB Lippincott; 1948:381-466.

7. Hallock GG. The Mitek Mini GII anchor introduced for tendon reinsertion in the hand. Ann Plast Surg. 1994;33(2):211-213.

8. Sood MK, Elliot D. A new technique of attachment of flexor tendons to the distal phalanx without a button tie-over. J Hand Surg Br. 1996;21(5):629-632. doi:https://doi.org/10.1016/S0266-7681(96)80146-X.

9. Schultz RO, Drake DB, Morgan RF. A new technique for the treatment of flexor digitorum profundus tendon avulsion. Ann Plast Surg. 1999;42(1):46-48. doi:10.1097/00000637-199901000-00008.

10. Manske PR, Lesker PA. Avulsion of the ring finger flexor digitorum profundus tendon: An experimental study. Hand 1978;10(1):52-55. doi:https://doi.org/10.1016/S0072-968X(78)80025-4.

11. Gerbino PG, Saldana MJ, Westerbeck P, Schacherer TG. Complications experienced in the rehabilitation of zone I flexor tendon injuries with dynamic traction splinting. J Hand Surg Am. 1991;16(4):680-686. doi:https://doi.org/10.1016/0363-5023(91)90194-G

12. Evans RB. Zone I flexor tendon rehabilitation with limited extension and active flexion. J Hand Ther. 2005;18(2):128-140. doi:10.1197/j.jht.2005.02.001

13. Kang N, Marsh D, Dewar D. The morbidity of the button-over-nail technique for zone 1 flexor tendon repairs. Should we still be using this technique? J Hand Surg Eur Vol. 2008;33(5):566-570. doi:10.1177/1753193408090118

14. Taras JS. Flexor tendon reconstruction: Single stage flexor tendon grafting: FDP, FDS disrupted. In: Green DP, Hotchkiss RN, Pederson WL, Wolfe SW, eds. Green’s Operative Hand Surgery. 5th ed. Philadelphia, PA: Elsevier Health Sciences; 2005:248-249.

15. McCallister WV, Ambrose HC, Katolik LI, Trumble TE. Comparison of pullout button versus suture anchor for zone I flexor tendon repair. J Hand Surg Am. 2006;31:246-251. doi:10.1016/j.jhsa.2005.10.020

16. Matzsuzaki H, Zaegel MA, Gelberman RH, Silva MJ. Effect of suture material and bone quality on the mechanical properties of zone 1 flexor tendon-bone reattachment with bone anchors. J Hand Surg Am. 2008;33(5):709-717. doi:10.1016/j.jhsa.2008.01.025

17. Singh R, Kakarala G, Persaud I, Roberts M, Strandring S, Compson J. The optimal length of tissue anchors for distal phalanges. A study in 395 cadaver digits. J Bone Joint Surg Br. 2006;88-B(SUPP I):37.

18. Giannikas D, Athanaselis E, Matzaroglou C, Saridis A, Tyllianakis M. An unusual complication of Mitek suture anchor use in primary treatment of flexor digitorum         profundus tendon laceration: a case report. Cases J. 2009;2:9319. doi:10.1186/1757-1626-2-9319

19. Tiong WH, O'Sullivan ST. Extrusion of bone anchor suture following flexor digitorum profundus tendon avulsion injury repair. J Plast Reconstr Aesthet Surg. 2011;64(9):1242-1244. doi:10.1016/j.bjps.2011.01.016

20. Silva MJ, Hollstien SB, Brodt MD, Boyer MI, Tetro AM, Gelberman RH. Flexor digitorum profundus tendon-to-bone repair: An ex vivo biomechanical analysis of 3 pullout suture techniques. J Hand Surg Am. 1998;23(1):120-126. doi:10.1016/S0363-5023(98)80099-3

21. Latendresse K, Dona E, Scougall PJ, Schreuder FB, Puchert E, Walsh WR. Cyclic testing of pullout sutures and micro-mitek suture anchors in flexor digitorum profundus tendon distal fixation. J Hand Surg Am. 2005;30(3):471-478. doi:10.1016/j.jhsa.2004.10.014

22. Lee SK, Fajardo M, Kardashian G, Klein J, Tsai P, Christoforou D. Repair of flexor digitorum profundus to distal phalanx: a biomechanical evaluation of four techniques. J      Hand Surg Am. 2011;36(10):1604-1609. doi:10.1016/j.jhsa.2011.07.017

References

1. Leddy JP, Packer JW. Avulsion of the profundus tendon insertion in athletes. J Hand Surg Am. 1977;2(1):66-69. doi:https://doi.org/10.1016/S0363-5023(77)80012-9.

2. Langa V, Posner MA. Unusual rupture of a flexor profundus tendon. J Hand Surg Am. 1986;11(2):227-229. doi:https://doi.org/10.1016/S0363-5023(86)80056-9.

3. Ehlert KJ, Gould JS, Black KP. A simultaneous distal phalanx avulsion fracture with profundus tendon avulsion: A case report and review of the literature. Clin Orthop Relat Res. 1992;(283):265-269.

4. Smith JH. Avulsion of a profundus tendon with simultaneous intraarticular fracture of the distal phalanx–case report. J Hand Surg Am. 1981;6(6):600-601. doi:10.1097/00006534-198305000-00081.

5. Al-Qattan MM. Type 5 avulsion of the insertion of the flexor digitorum profundus tendon. J Hand Surg Br. 2001;26(5):427-431. doi:10.1054/jhsb.2001.0619.

6. Bunnell S. Surgery of the hand, 2nd edition. Philadelphia, PA: JB Lippincott; 1948:381-466.

7. Hallock GG. The Mitek Mini GII anchor introduced for tendon reinsertion in the hand. Ann Plast Surg. 1994;33(2):211-213.

8. Sood MK, Elliot D. A new technique of attachment of flexor tendons to the distal phalanx without a button tie-over. J Hand Surg Br. 1996;21(5):629-632. doi:https://doi.org/10.1016/S0266-7681(96)80146-X.

9. Schultz RO, Drake DB, Morgan RF. A new technique for the treatment of flexor digitorum profundus tendon avulsion. Ann Plast Surg. 1999;42(1):46-48. doi:10.1097/00000637-199901000-00008.

10. Manske PR, Lesker PA. Avulsion of the ring finger flexor digitorum profundus tendon: An experimental study. Hand 1978;10(1):52-55. doi:https://doi.org/10.1016/S0072-968X(78)80025-4.

11. Gerbino PG, Saldana MJ, Westerbeck P, Schacherer TG. Complications experienced in the rehabilitation of zone I flexor tendon injuries with dynamic traction splinting. J Hand Surg Am. 1991;16(4):680-686. doi:https://doi.org/10.1016/0363-5023(91)90194-G

12. Evans RB. Zone I flexor tendon rehabilitation with limited extension and active flexion. J Hand Ther. 2005;18(2):128-140. doi:10.1197/j.jht.2005.02.001

13. Kang N, Marsh D, Dewar D. The morbidity of the button-over-nail technique for zone 1 flexor tendon repairs. Should we still be using this technique? J Hand Surg Eur Vol. 2008;33(5):566-570. doi:10.1177/1753193408090118

14. Taras JS. Flexor tendon reconstruction: Single stage flexor tendon grafting: FDP, FDS disrupted. In: Green DP, Hotchkiss RN, Pederson WL, Wolfe SW, eds. Green’s Operative Hand Surgery. 5th ed. Philadelphia, PA: Elsevier Health Sciences; 2005:248-249.

15. McCallister WV, Ambrose HC, Katolik LI, Trumble TE. Comparison of pullout button versus suture anchor for zone I flexor tendon repair. J Hand Surg Am. 2006;31:246-251. doi:10.1016/j.jhsa.2005.10.020

16. Matzsuzaki H, Zaegel MA, Gelberman RH, Silva MJ. Effect of suture material and bone quality on the mechanical properties of zone 1 flexor tendon-bone reattachment with bone anchors. J Hand Surg Am. 2008;33(5):709-717. doi:10.1016/j.jhsa.2008.01.025

17. Singh R, Kakarala G, Persaud I, Roberts M, Strandring S, Compson J. The optimal length of tissue anchors for distal phalanges. A study in 395 cadaver digits. J Bone Joint Surg Br. 2006;88-B(SUPP I):37.

18. Giannikas D, Athanaselis E, Matzaroglou C, Saridis A, Tyllianakis M. An unusual complication of Mitek suture anchor use in primary treatment of flexor digitorum         profundus tendon laceration: a case report. Cases J. 2009;2:9319. doi:10.1186/1757-1626-2-9319

19. Tiong WH, O'Sullivan ST. Extrusion of bone anchor suture following flexor digitorum profundus tendon avulsion injury repair. J Plast Reconstr Aesthet Surg. 2011;64(9):1242-1244. doi:10.1016/j.bjps.2011.01.016

20. Silva MJ, Hollstien SB, Brodt MD, Boyer MI, Tetro AM, Gelberman RH. Flexor digitorum profundus tendon-to-bone repair: An ex vivo biomechanical analysis of 3 pullout suture techniques. J Hand Surg Am. 1998;23(1):120-126. doi:10.1016/S0363-5023(98)80099-3

21. Latendresse K, Dona E, Scougall PJ, Schreuder FB, Puchert E, Walsh WR. Cyclic testing of pullout sutures and micro-mitek suture anchors in flexor digitorum profundus tendon distal fixation. J Hand Surg Am. 2005;30(3):471-478. doi:10.1016/j.jhsa.2004.10.014

22. Lee SK, Fajardo M, Kardashian G, Klein J, Tsai P, Christoforou D. Repair of flexor digitorum profundus to distal phalanx: a biomechanical evaluation of four techniques. J      Hand Surg Am. 2011;36(10):1604-1609. doi:10.1016/j.jhsa.2011.07.017

Publications
Publications
Topics
Article Type
Display Headline
A Novel Technique for the Treatment of Jersey Fingers
Display Headline
A Novel Technique for the Treatment of Jersey Fingers
Sections
Inside the Article

TAKE-HOME POINTS

  • Transosseous repair of FDP has been long utilized, tying the sutures over a polyethylene button at the nail plate, which is associated with significant complications.
  • Avoiding use of a button decreases these complications, eliminating damage to the nailbed and eliminating external sutures, thus decreasing infection risk.
  • Keith needles can be utilized to pass the sutures from volar to dorsal, and can be inserted using a wire drive; their position can be checked fluoroscopically prior to suture passage.
  • This technique can be used in conjunction with skeletal fixation of associated fractures.
  • This technique can be utilized in pediatric patients, placing the sutures distal to the physis.
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Gate On Date
Mon, 03/25/2019 - 12:30
Un-Gate On Date
Mon, 03/25/2019 - 12:30
Use ProPublica
CFC Schedule Remove Status
Mon, 03/25/2019 - 12:30
Hide sidebar & use full width
render the right sidebar.

Recurrence of Extranodal Natural Killer/T-cell Lymphoma Presenting as Tarsal Tunnel Syndrome

Article Type
Changed
Thu, 09/19/2019 - 13:18
Display Headline
Recurrence of Extranodal Natural Killer/T-cell Lymphoma Presenting as Tarsal Tunnel Syndrome

ABSTRACT

This case report is a rare form of lymphoma recurrence which presented as tarsal tunnel syndrome. The patient had been previously treated for the malignancy and was presumed to be in remission; however, standard radiology imaging protocols failed to include the distal extremities on these scans. The patient presented to the orthopedic clinic with tarsal tunnel symptoms and a mass in the tarsal tunnel. A complete evaluation resulted in a diagnosis of recurrence of the malignancy. This case illustrates the importance of a thorough medical history and personal review of imaging studies, and how a systematic approach can produce the correct diagnosis for any unknown lesion. Furthermore, this case may prompt oncologists to consider obtaining whole-body fluorodeoxyglucose positron emission tomography computed tomography when evaluating for recurrence in patients.

Nasal-type, extranodal natural killer/T-cell lymphoma (ENKTL) is a rare form of non-Hodgkin lymphoma (NHL). Malignancies account for only 10% of NHL in Asian and South American populations. However, in Caucasians, it represents <1% of all cases. In addition, at 3:1 male to female ratio, the disease most commonly affects male patients who are 50 to 59 years old.1-3 The etiology of this malignancy is strongly related to prior infection with Epstein-Barr virus (EBV) as EBV-encoded early small ribonucleic acid on in situ hybridization of lymphoma cells is positive in 95% of cases.4-6

Typical sites of involvement include the nasal cavity, nasopharynx, and sinuses, causing patients to present with nasal obstruction, chronic sinusitis, or epistaxis. Additionally, ENKTL can occur primarily in the skin, gastrointestinal tract, spleen, and testis, whereas the bone marrow may be involved in 10% of cases. Although rare, unusual sites, including muscle, adrenals, and ovaries, have been published.7,8

Staging is best performed using the T-staging system, which accounts for the extent of local tumor involvement. Higher stages, such as T3 /T4, equate to locally advanced disease and imply a worse prognosis.9,10 Computed tomography (CT) and magnetic resonance imaging (MRI) help define local soft tissues and bony involvement. Furthermore, CT of the chest, abdomen, and pelvis as well as bone marrow biopsy are performed as part of the staging process. Lastly, fluorine-18 fluorodeoxyglucose positron emission tomography CT (18-FDG PET-CT) is often used to detect extranodal spread, define the extent of involvement, differentiate between lymphoma and inflammatory masses, and monitor for recurrence.11

Treatment for local ENKTL involves concurrent chemoradiotherapy followed by 3 cycles of etoposide, ifosfamide, cisplatin, and dexamethasone, which results in a complete response rate of 80%, and is the most favorable when comparing treatment modalities.12 Unfortunately, recurrence rates reach as high as 50%, whereas the 5-year survival rate is 59%.13,14 For recurrent or disseminated disease, high-dose chemotherapy and hematopoietic stem cell transplantation remain as alternative treatments for patients who have undergone 2 complete remissions and can be curative in some instances.13,15

Continue to: In summary, ENKTL is a rare form...

 

 

In summary, ENKTL is a rare form of NHL which classically presents in the nasal cavity; however, this type of lymphoma may present in a variety of extranodal sites.7,8 Despite the numerous published reports on ENKTL, no study has reported either primary or recurrent ENKTL in the feet or hands. To our knowledge, this is one of the first published cases of a patient who developed a rare and recurring ENKTL in the foot and ankle. The patient provided written informed consent for print and electronic publication of this case report.

CASE

A 59-year-old Caucasian woman was referred to the orthopedic foot and ankle clinic by her primary care physician for right medial ankle pain, skin ulceration, and numbness over the plantar aspect of her right foot. Upon questioning, the patient noted that the pain and numbness were present for almost 6 months. She denied trauma to the concerned area. Previously, the patient was observed and treated elsewhere for plantar fasciitis and was prescribed a brace before being immobilized in a controlled ankle motion (CAM) boot for 6 weeks. At follow-up with her outside provider, the patient had developed skin breakdown over the medial aspect of the right ankle, and this condition was presumed to be caused by the boot. After local wound care failed to improve her skin ulceration, she returned to her primary care physician, who ordered an MRI of the area and referred her to our specialty clinic.

Upon review, the patient’s past medical history included a diagnosis of nasal-type ENKTL. Her malignancy was treated with chemoradiotherapy 2 years prior to her consultation with the foot and ankle clinic.

The patient was noted by her medical oncologist and interventional radiologist to be in complete stage 4 remission since being treated. She underwent routine MRI and CT scans of the head and neck at 6-month intervals and FDG PET-CT scans at 3-month intervals, as per institutional protocol. The examinations showed no evidence of malignancy or metabolically active disease. The last imaging study occurred 2 months prior to admission to the foot and ankle clinic.

The patient consulted her medical oncologist 1 month prior to presenting to our clinic and was noted to exhibit an “excellent response to chemoradiotherapy” and “continues to remain disease free at 2 years.” She was instructed to continue routine follow-up. However, the office notes mentioned no ankle pain and non-healing wounds.

During physical examination, the patient presented an antalgic gait on the right side. Inspection demonstrated an increased circumference of the right ankle compared with the left, with a soft, palpable mass over the medial aspect of her right ankle. A 3 cm × 2 cm, grade 2 abrasion of the skin was observed over the medial mass just posterior to her medial malleolus. Range of motion was within normal limits. The patient exhibited a palpable posterior tibial artery pulse and full strength upon muscle testing of the lower extremities. She featured a positive Tinel’s sign and discomfort over the mass itself, with the pain radiating down to the plantar aspect of her foot and diffuse numbness over the plantar aspect of the foot.

Continue to: Review of her plain radiographs...

 

 

Review of her plain radiographs demonstrated no bony abnormalities, fractures, nor visible deformity (Figures 1A, 1B). 
MRI of the foot and ankle was reviewed and demonstrated a large soft-tissue mass over the medial aspect of the ankle extending posteriorly to engulf the medial flexor tendons and medial neurovascular bundle (Figures 2A-2C). 
Interestingly, the radiologist’s report only mentioned a “large region of devitalized tissue underlying the known medial ankle ulcer which extended to the tibiotalar and subtalar joints and bone marrow changes in the talus most compatible with osteomyelitis.” FDG PET-CT images from the patient’s past 2 years were reviewed, and the radiologist was contacted to confirm the negative findings. Unfortunately, FDG PET-CT performs no routine imaging below the elbow or knee when evaluating for this particular malignancy (Figure 3).

At presentation, our differential diagnosis included recurrence of the malignancy, secondary malignancy, infection, and inflammatory disease. After a lengthy discussion with the patient and consultation with our institution’s musculoskeletal oncologist, the decision was made to perform a right-ankle mass biopsy and marginal excision with wound irrigation and débridement and tarsal tunnel release.

The patient was placed in the supine position with standard prepping and draping. The medial eschar was excised in an elliptical fashion, and a curvilinear, longitudinal approach was performed within the compartment to access the mass along the posteromedial aspect of the ankle. Although no evidence of infection was observed, the tissue was thickened with areas of necrosis down to the flexor retinaculum. Once the flexor retinaculum was opened, a fibrous, plaque-like mass was observed, and it was encased with flexor tendons and neurovascular structures of the tarsal tunnel. After mass excision, a complete tarsal tunnel release was performed until the neurovascular bundle was free. Irrigation and débridement of the ulcer were performed along with complicated wound closure, and the patient was placed in a well-padded postoperative splint.

Pathology was finalized as a recurrent, EBV-positive, and nasal-type ENKTL. The patient underwent bone marrow biopsy, which yielded negative results. CT of the chest, abdomen, and pelvis were negative for the disease. FDG PET-CT, which included the extremities, was performed and demonstrated increased uptake in the right ankle, consistent with the malignancy (Figure 4). 

The patient was placed on her second cycle of chemoradiotherapy and again showed complete remission. At over 1-year follow-up, the patient’s wound had completely healed, and FDG PET-CT of the extremity was negative for ENKTL recurrence (Figure 5). 
At present, the patient’s medical oncologists recommend a stem cell transplant as the patient exhibited 2 positive responses to chemoradiotherapy.

DISCUSSION

ENKTL is an uncommon form of lymphoma and is exceedingly rare in Caucasian females.1-3 Although the patient’s primary occurrence was in the nasal cavity, recurrence in the foot and ankle must still be described.7,8 To our knowledge, this article is one of the first published cases of a patient who developed a rare-recurrence ENKTL about the foot and ankle. Occurrence in extremities is extremely rare that the staging protocol does not include FDG PET-CT of these areas. The patient’s “negative” scans led many providers to neglect the symptoms in her right ankle until the lesion had ulcerated through the skin. If one would have relied on imaging reports and outside records alone, the diagnosis would have been delayed longer or missed all together. This case illustrates the importance of a thorough medical history and personal review of imaging studies, and how a systematic approach can produce the correct diagnosis for any unknown lesion. Furthermore, this case may prompt oncologists to consider obtaining whole-body FDG PET-CT when evaluating for recurrence in patients.

References

1. Quintanilla-Martinez L, Kremer M, Keller G, et al. p53 mutations in nasal natural killer/T-cell lymphoma from Mexico: association with large cell morphology and advanced disease. Am J Pathol. 2001;159(6):2095-2105. doi:10.1016/S0002-9440(10)63061-1.

2. Au WY, Ma SY, Chim CS, et al. Clinicopathologic features and treatment outcome of mature T-cell and natural killer-cell lymphomas diagnosed according to the World Health Organization classification scheme: a single center experience of 10 years. Ann Oncol. 2005;16(2):206-214. doi:10.1093/annonc/mdi037.

3. Armitage JO. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin’s lymphoma. Blood. 1997;89(11):3909-3918.

4. Medeiros LJ, Peiper SC, Elwood L, Yano T, Raffeld M, Jaffe ES. Angiocentric immunoproliferative lesions: a molecular analysis of eight cases. Hum Pathol. 1991;22(11):1150-1157. doi:10.1016/0046-8177(91)90269-U.

5. Ho FC, Srivastava G, Loke SL, et al. Presence of Epstein-Barr virus DNA in nasal lymphomas of B and ‘T’ cell type. Hematol Oncol. 1990;8(5):271-281. doi:10.1002/hon.2900080505.

6. Gelb AB, van de Rijn M, Regula DP Jr, et al. Epstein-Barr virus-associated natural killer-large granular lymphocyte leukemia. Hum Pathol. 1994;25(9):953-960. doi:10.1016/0046-8177(94)90018-3.

7. Petrella T, Delfau-Larue MH, Caillot D, et al. Nasopharyngeal lymphomas: further evidence for a natural killer cell origin. Hum Pathol. 1996;27(8):827-833. doi:10.1016/S0046-8177(96)90457-8.

8. Hasserjian RP, Harris NL. NK-cell lymphomas and leukemias: a spectrum of tumors with variable manifestations and immunophenotype. Am J Clin Pathol. 2007;127(6):860-868. doi:10.1309/2F39NX1AL3L54WU8.

9. Robbins KT, Fuller LM, Vlasak M. Primary lymphomas of the nasal cavity and paranasal sinuses. Cancer. 1985;56(4):814-819. doi:10.1002/1097-0142(19850815)56.

10. Ooi GC, Chim CS, Liang R, Tsang KW, Kwong YL. Nasal T-cell/natural killer cell lymphoma: CT and MR imaging features of a new clinicopathologic entity. Am J Roentgenol. 2000;174(4):1141-1145. doi:10.2214/ajr.174.4.1741141.

11. Khong PL, Pang CB, Liang R, Kwong YL, Au WY. Fluorine-18 fluorodeoxyglucose positron emission tomography in mature T-cell and natural killer cell malignancies. Ann Hematol. 2008;87(8):613-621. doi:10.1007/s00277-008-0494-8.

12. Kim SJ, Kim K, Kim BS, et al. Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK/T-cell lymphoma: consortium for improving survival of lymphoma study. J Clin Oncol. 2009;27(35):6027-6032. doi:10.1200/JCO.2009.23.8592.

13. Kwong YL. Natural killer-cell malignancies: diagnosis and treatment. Leukemia. 2005;19(12):2186-2194. doi:10.1038/sj.leu.2403955.

14. Liang R. Advances in the management and monitoring of extranodal NK/T-cell lymphoma, nasal type. Br J Haematol. 2009;147(1):13-21. doi:10.1111/j.1365-2141.2009.07802.x.

15. Yokoyama H, Yamamoto J, Tohmiya Y, et al. Allogeneic hematopoietic stem cell transplant following chemotherapy containing l-asparaginase as a promising treatment for patients with relapsed or refractory extranodal natural killer/T cell lymphoma, nasal type. Leuk Lymphoma. 2010;51(8):1509-1512. doi:10.3109/10428194.2010.487958.

Author and Disclosure Information

Authors’ Disclosure Statement: The authors report no actual or potential conflict of interest in relation to this article.

Dr. Aynardi is an Assistant Professor of Orthopaedic Surgery, Pennsylvania State University Milton S. Hershey Medical Center, Hershey, Pennsylvania. Dr. Raikin is Director, Foot and Ankle Service, Rothman Institute; Professor of Orthopaedic Surgery, Jefferson Medical College; and Director, Foot and Ankle Fellowship Program, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania.

Address correspondence to: Michael Aynardi, MD, Department of Orthopaedic Surgery, Pennsylvania State University Milton S. Hershey Medical Center, 30 Hope Drive, Hershey, Pennsylvania 17033 (tel, 717-531-5638; fax, 717-531-0983; email, [email protected]).

Am J Orthop. 2018;47(5). Copyright Frontline Medical Communications Inc. 2018. All rights reserved.

. Recurrence of Extranodal Natural Killer/T-cell Lymphoma Presenting as Tarsal Tunnel Syndrome. Am J Orthop.

Publications
Topics
Sections
Author and Disclosure Information

Authors’ Disclosure Statement: The authors report no actual or potential conflict of interest in relation to this article.

Dr. Aynardi is an Assistant Professor of Orthopaedic Surgery, Pennsylvania State University Milton S. Hershey Medical Center, Hershey, Pennsylvania. Dr. Raikin is Director, Foot and Ankle Service, Rothman Institute; Professor of Orthopaedic Surgery, Jefferson Medical College; and Director, Foot and Ankle Fellowship Program, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania.

Address correspondence to: Michael Aynardi, MD, Department of Orthopaedic Surgery, Pennsylvania State University Milton S. Hershey Medical Center, 30 Hope Drive, Hershey, Pennsylvania 17033 (tel, 717-531-5638; fax, 717-531-0983; email, [email protected]).

Am J Orthop. 2018;47(5). Copyright Frontline Medical Communications Inc. 2018. All rights reserved.

. Recurrence of Extranodal Natural Killer/T-cell Lymphoma Presenting as Tarsal Tunnel Syndrome. Am J Orthop.

Author and Disclosure Information

Authors’ Disclosure Statement: The authors report no actual or potential conflict of interest in relation to this article.

Dr. Aynardi is an Assistant Professor of Orthopaedic Surgery, Pennsylvania State University Milton S. Hershey Medical Center, Hershey, Pennsylvania. Dr. Raikin is Director, Foot and Ankle Service, Rothman Institute; Professor of Orthopaedic Surgery, Jefferson Medical College; and Director, Foot and Ankle Fellowship Program, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania.

Address correspondence to: Michael Aynardi, MD, Department of Orthopaedic Surgery, Pennsylvania State University Milton S. Hershey Medical Center, 30 Hope Drive, Hershey, Pennsylvania 17033 (tel, 717-531-5638; fax, 717-531-0983; email, [email protected]).

Am J Orthop. 2018;47(5). Copyright Frontline Medical Communications Inc. 2018. All rights reserved.

. Recurrence of Extranodal Natural Killer/T-cell Lymphoma Presenting as Tarsal Tunnel Syndrome. Am J Orthop.

ABSTRACT

This case report is a rare form of lymphoma recurrence which presented as tarsal tunnel syndrome. The patient had been previously treated for the malignancy and was presumed to be in remission; however, standard radiology imaging protocols failed to include the distal extremities on these scans. The patient presented to the orthopedic clinic with tarsal tunnel symptoms and a mass in the tarsal tunnel. A complete evaluation resulted in a diagnosis of recurrence of the malignancy. This case illustrates the importance of a thorough medical history and personal review of imaging studies, and how a systematic approach can produce the correct diagnosis for any unknown lesion. Furthermore, this case may prompt oncologists to consider obtaining whole-body fluorodeoxyglucose positron emission tomography computed tomography when evaluating for recurrence in patients.

Nasal-type, extranodal natural killer/T-cell lymphoma (ENKTL) is a rare form of non-Hodgkin lymphoma (NHL). Malignancies account for only 10% of NHL in Asian and South American populations. However, in Caucasians, it represents <1% of all cases. In addition, at 3:1 male to female ratio, the disease most commonly affects male patients who are 50 to 59 years old.1-3 The etiology of this malignancy is strongly related to prior infection with Epstein-Barr virus (EBV) as EBV-encoded early small ribonucleic acid on in situ hybridization of lymphoma cells is positive in 95% of cases.4-6

Typical sites of involvement include the nasal cavity, nasopharynx, and sinuses, causing patients to present with nasal obstruction, chronic sinusitis, or epistaxis. Additionally, ENKTL can occur primarily in the skin, gastrointestinal tract, spleen, and testis, whereas the bone marrow may be involved in 10% of cases. Although rare, unusual sites, including muscle, adrenals, and ovaries, have been published.7,8

Staging is best performed using the T-staging system, which accounts for the extent of local tumor involvement. Higher stages, such as T3 /T4, equate to locally advanced disease and imply a worse prognosis.9,10 Computed tomography (CT) and magnetic resonance imaging (MRI) help define local soft tissues and bony involvement. Furthermore, CT of the chest, abdomen, and pelvis as well as bone marrow biopsy are performed as part of the staging process. Lastly, fluorine-18 fluorodeoxyglucose positron emission tomography CT (18-FDG PET-CT) is often used to detect extranodal spread, define the extent of involvement, differentiate between lymphoma and inflammatory masses, and monitor for recurrence.11

Treatment for local ENKTL involves concurrent chemoradiotherapy followed by 3 cycles of etoposide, ifosfamide, cisplatin, and dexamethasone, which results in a complete response rate of 80%, and is the most favorable when comparing treatment modalities.12 Unfortunately, recurrence rates reach as high as 50%, whereas the 5-year survival rate is 59%.13,14 For recurrent or disseminated disease, high-dose chemotherapy and hematopoietic stem cell transplantation remain as alternative treatments for patients who have undergone 2 complete remissions and can be curative in some instances.13,15

Continue to: In summary, ENKTL is a rare form...

 

 

In summary, ENKTL is a rare form of NHL which classically presents in the nasal cavity; however, this type of lymphoma may present in a variety of extranodal sites.7,8 Despite the numerous published reports on ENKTL, no study has reported either primary or recurrent ENKTL in the feet or hands. To our knowledge, this is one of the first published cases of a patient who developed a rare and recurring ENKTL in the foot and ankle. The patient provided written informed consent for print and electronic publication of this case report.

CASE

A 59-year-old Caucasian woman was referred to the orthopedic foot and ankle clinic by her primary care physician for right medial ankle pain, skin ulceration, and numbness over the plantar aspect of her right foot. Upon questioning, the patient noted that the pain and numbness were present for almost 6 months. She denied trauma to the concerned area. Previously, the patient was observed and treated elsewhere for plantar fasciitis and was prescribed a brace before being immobilized in a controlled ankle motion (CAM) boot for 6 weeks. At follow-up with her outside provider, the patient had developed skin breakdown over the medial aspect of the right ankle, and this condition was presumed to be caused by the boot. After local wound care failed to improve her skin ulceration, she returned to her primary care physician, who ordered an MRI of the area and referred her to our specialty clinic.

Upon review, the patient’s past medical history included a diagnosis of nasal-type ENKTL. Her malignancy was treated with chemoradiotherapy 2 years prior to her consultation with the foot and ankle clinic.

The patient was noted by her medical oncologist and interventional radiologist to be in complete stage 4 remission since being treated. She underwent routine MRI and CT scans of the head and neck at 6-month intervals and FDG PET-CT scans at 3-month intervals, as per institutional protocol. The examinations showed no evidence of malignancy or metabolically active disease. The last imaging study occurred 2 months prior to admission to the foot and ankle clinic.

The patient consulted her medical oncologist 1 month prior to presenting to our clinic and was noted to exhibit an “excellent response to chemoradiotherapy” and “continues to remain disease free at 2 years.” She was instructed to continue routine follow-up. However, the office notes mentioned no ankle pain and non-healing wounds.

During physical examination, the patient presented an antalgic gait on the right side. Inspection demonstrated an increased circumference of the right ankle compared with the left, with a soft, palpable mass over the medial aspect of her right ankle. A 3 cm × 2 cm, grade 2 abrasion of the skin was observed over the medial mass just posterior to her medial malleolus. Range of motion was within normal limits. The patient exhibited a palpable posterior tibial artery pulse and full strength upon muscle testing of the lower extremities. She featured a positive Tinel’s sign and discomfort over the mass itself, with the pain radiating down to the plantar aspect of her foot and diffuse numbness over the plantar aspect of the foot.

Continue to: Review of her plain radiographs...

 

 

Review of her plain radiographs demonstrated no bony abnormalities, fractures, nor visible deformity (Figures 1A, 1B). 
MRI of the foot and ankle was reviewed and demonstrated a large soft-tissue mass over the medial aspect of the ankle extending posteriorly to engulf the medial flexor tendons and medial neurovascular bundle (Figures 2A-2C). 
Interestingly, the radiologist’s report only mentioned a “large region of devitalized tissue underlying the known medial ankle ulcer which extended to the tibiotalar and subtalar joints and bone marrow changes in the talus most compatible with osteomyelitis.” FDG PET-CT images from the patient’s past 2 years were reviewed, and the radiologist was contacted to confirm the negative findings. Unfortunately, FDG PET-CT performs no routine imaging below the elbow or knee when evaluating for this particular malignancy (Figure 3).

At presentation, our differential diagnosis included recurrence of the malignancy, secondary malignancy, infection, and inflammatory disease. After a lengthy discussion with the patient and consultation with our institution’s musculoskeletal oncologist, the decision was made to perform a right-ankle mass biopsy and marginal excision with wound irrigation and débridement and tarsal tunnel release.

The patient was placed in the supine position with standard prepping and draping. The medial eschar was excised in an elliptical fashion, and a curvilinear, longitudinal approach was performed within the compartment to access the mass along the posteromedial aspect of the ankle. Although no evidence of infection was observed, the tissue was thickened with areas of necrosis down to the flexor retinaculum. Once the flexor retinaculum was opened, a fibrous, plaque-like mass was observed, and it was encased with flexor tendons and neurovascular structures of the tarsal tunnel. After mass excision, a complete tarsal tunnel release was performed until the neurovascular bundle was free. Irrigation and débridement of the ulcer were performed along with complicated wound closure, and the patient was placed in a well-padded postoperative splint.

Pathology was finalized as a recurrent, EBV-positive, and nasal-type ENKTL. The patient underwent bone marrow biopsy, which yielded negative results. CT of the chest, abdomen, and pelvis were negative for the disease. FDG PET-CT, which included the extremities, was performed and demonstrated increased uptake in the right ankle, consistent with the malignancy (Figure 4). 

The patient was placed on her second cycle of chemoradiotherapy and again showed complete remission. At over 1-year follow-up, the patient’s wound had completely healed, and FDG PET-CT of the extremity was negative for ENKTL recurrence (Figure 5). 
At present, the patient’s medical oncologists recommend a stem cell transplant as the patient exhibited 2 positive responses to chemoradiotherapy.

DISCUSSION

ENKTL is an uncommon form of lymphoma and is exceedingly rare in Caucasian females.1-3 Although the patient’s primary occurrence was in the nasal cavity, recurrence in the foot and ankle must still be described.7,8 To our knowledge, this article is one of the first published cases of a patient who developed a rare-recurrence ENKTL about the foot and ankle. Occurrence in extremities is extremely rare that the staging protocol does not include FDG PET-CT of these areas. The patient’s “negative” scans led many providers to neglect the symptoms in her right ankle until the lesion had ulcerated through the skin. If one would have relied on imaging reports and outside records alone, the diagnosis would have been delayed longer or missed all together. This case illustrates the importance of a thorough medical history and personal review of imaging studies, and how a systematic approach can produce the correct diagnosis for any unknown lesion. Furthermore, this case may prompt oncologists to consider obtaining whole-body FDG PET-CT when evaluating for recurrence in patients.

ABSTRACT

This case report is a rare form of lymphoma recurrence which presented as tarsal tunnel syndrome. The patient had been previously treated for the malignancy and was presumed to be in remission; however, standard radiology imaging protocols failed to include the distal extremities on these scans. The patient presented to the orthopedic clinic with tarsal tunnel symptoms and a mass in the tarsal tunnel. A complete evaluation resulted in a diagnosis of recurrence of the malignancy. This case illustrates the importance of a thorough medical history and personal review of imaging studies, and how a systematic approach can produce the correct diagnosis for any unknown lesion. Furthermore, this case may prompt oncologists to consider obtaining whole-body fluorodeoxyglucose positron emission tomography computed tomography when evaluating for recurrence in patients.

Nasal-type, extranodal natural killer/T-cell lymphoma (ENKTL) is a rare form of non-Hodgkin lymphoma (NHL). Malignancies account for only 10% of NHL in Asian and South American populations. However, in Caucasians, it represents <1% of all cases. In addition, at 3:1 male to female ratio, the disease most commonly affects male patients who are 50 to 59 years old.1-3 The etiology of this malignancy is strongly related to prior infection with Epstein-Barr virus (EBV) as EBV-encoded early small ribonucleic acid on in situ hybridization of lymphoma cells is positive in 95% of cases.4-6

Typical sites of involvement include the nasal cavity, nasopharynx, and sinuses, causing patients to present with nasal obstruction, chronic sinusitis, or epistaxis. Additionally, ENKTL can occur primarily in the skin, gastrointestinal tract, spleen, and testis, whereas the bone marrow may be involved in 10% of cases. Although rare, unusual sites, including muscle, adrenals, and ovaries, have been published.7,8

Staging is best performed using the T-staging system, which accounts for the extent of local tumor involvement. Higher stages, such as T3 /T4, equate to locally advanced disease and imply a worse prognosis.9,10 Computed tomography (CT) and magnetic resonance imaging (MRI) help define local soft tissues and bony involvement. Furthermore, CT of the chest, abdomen, and pelvis as well as bone marrow biopsy are performed as part of the staging process. Lastly, fluorine-18 fluorodeoxyglucose positron emission tomography CT (18-FDG PET-CT) is often used to detect extranodal spread, define the extent of involvement, differentiate between lymphoma and inflammatory masses, and monitor for recurrence.11

Treatment for local ENKTL involves concurrent chemoradiotherapy followed by 3 cycles of etoposide, ifosfamide, cisplatin, and dexamethasone, which results in a complete response rate of 80%, and is the most favorable when comparing treatment modalities.12 Unfortunately, recurrence rates reach as high as 50%, whereas the 5-year survival rate is 59%.13,14 For recurrent or disseminated disease, high-dose chemotherapy and hematopoietic stem cell transplantation remain as alternative treatments for patients who have undergone 2 complete remissions and can be curative in some instances.13,15

Continue to: In summary, ENKTL is a rare form...

 

 

In summary, ENKTL is a rare form of NHL which classically presents in the nasal cavity; however, this type of lymphoma may present in a variety of extranodal sites.7,8 Despite the numerous published reports on ENKTL, no study has reported either primary or recurrent ENKTL in the feet or hands. To our knowledge, this is one of the first published cases of a patient who developed a rare and recurring ENKTL in the foot and ankle. The patient provided written informed consent for print and electronic publication of this case report.

CASE

A 59-year-old Caucasian woman was referred to the orthopedic foot and ankle clinic by her primary care physician for right medial ankle pain, skin ulceration, and numbness over the plantar aspect of her right foot. Upon questioning, the patient noted that the pain and numbness were present for almost 6 months. She denied trauma to the concerned area. Previously, the patient was observed and treated elsewhere for plantar fasciitis and was prescribed a brace before being immobilized in a controlled ankle motion (CAM) boot for 6 weeks. At follow-up with her outside provider, the patient had developed skin breakdown over the medial aspect of the right ankle, and this condition was presumed to be caused by the boot. After local wound care failed to improve her skin ulceration, she returned to her primary care physician, who ordered an MRI of the area and referred her to our specialty clinic.

Upon review, the patient’s past medical history included a diagnosis of nasal-type ENKTL. Her malignancy was treated with chemoradiotherapy 2 years prior to her consultation with the foot and ankle clinic.

The patient was noted by her medical oncologist and interventional radiologist to be in complete stage 4 remission since being treated. She underwent routine MRI and CT scans of the head and neck at 6-month intervals and FDG PET-CT scans at 3-month intervals, as per institutional protocol. The examinations showed no evidence of malignancy or metabolically active disease. The last imaging study occurred 2 months prior to admission to the foot and ankle clinic.

The patient consulted her medical oncologist 1 month prior to presenting to our clinic and was noted to exhibit an “excellent response to chemoradiotherapy” and “continues to remain disease free at 2 years.” She was instructed to continue routine follow-up. However, the office notes mentioned no ankle pain and non-healing wounds.

During physical examination, the patient presented an antalgic gait on the right side. Inspection demonstrated an increased circumference of the right ankle compared with the left, with a soft, palpable mass over the medial aspect of her right ankle. A 3 cm × 2 cm, grade 2 abrasion of the skin was observed over the medial mass just posterior to her medial malleolus. Range of motion was within normal limits. The patient exhibited a palpable posterior tibial artery pulse and full strength upon muscle testing of the lower extremities. She featured a positive Tinel’s sign and discomfort over the mass itself, with the pain radiating down to the plantar aspect of her foot and diffuse numbness over the plantar aspect of the foot.

Continue to: Review of her plain radiographs...

 

 

Review of her plain radiographs demonstrated no bony abnormalities, fractures, nor visible deformity (Figures 1A, 1B). 
MRI of the foot and ankle was reviewed and demonstrated a large soft-tissue mass over the medial aspect of the ankle extending posteriorly to engulf the medial flexor tendons and medial neurovascular bundle (Figures 2A-2C). 
Interestingly, the radiologist’s report only mentioned a “large region of devitalized tissue underlying the known medial ankle ulcer which extended to the tibiotalar and subtalar joints and bone marrow changes in the talus most compatible with osteomyelitis.” FDG PET-CT images from the patient’s past 2 years were reviewed, and the radiologist was contacted to confirm the negative findings. Unfortunately, FDG PET-CT performs no routine imaging below the elbow or knee when evaluating for this particular malignancy (Figure 3).

At presentation, our differential diagnosis included recurrence of the malignancy, secondary malignancy, infection, and inflammatory disease. After a lengthy discussion with the patient and consultation with our institution’s musculoskeletal oncologist, the decision was made to perform a right-ankle mass biopsy and marginal excision with wound irrigation and débridement and tarsal tunnel release.

The patient was placed in the supine position with standard prepping and draping. The medial eschar was excised in an elliptical fashion, and a curvilinear, longitudinal approach was performed within the compartment to access the mass along the posteromedial aspect of the ankle. Although no evidence of infection was observed, the tissue was thickened with areas of necrosis down to the flexor retinaculum. Once the flexor retinaculum was opened, a fibrous, plaque-like mass was observed, and it was encased with flexor tendons and neurovascular structures of the tarsal tunnel. After mass excision, a complete tarsal tunnel release was performed until the neurovascular bundle was free. Irrigation and débridement of the ulcer were performed along with complicated wound closure, and the patient was placed in a well-padded postoperative splint.

Pathology was finalized as a recurrent, EBV-positive, and nasal-type ENKTL. The patient underwent bone marrow biopsy, which yielded negative results. CT of the chest, abdomen, and pelvis were negative for the disease. FDG PET-CT, which included the extremities, was performed and demonstrated increased uptake in the right ankle, consistent with the malignancy (Figure 4). 

The patient was placed on her second cycle of chemoradiotherapy and again showed complete remission. At over 1-year follow-up, the patient’s wound had completely healed, and FDG PET-CT of the extremity was negative for ENKTL recurrence (Figure 5). 
At present, the patient’s medical oncologists recommend a stem cell transplant as the patient exhibited 2 positive responses to chemoradiotherapy.

DISCUSSION

ENKTL is an uncommon form of lymphoma and is exceedingly rare in Caucasian females.1-3 Although the patient’s primary occurrence was in the nasal cavity, recurrence in the foot and ankle must still be described.7,8 To our knowledge, this article is one of the first published cases of a patient who developed a rare-recurrence ENKTL about the foot and ankle. Occurrence in extremities is extremely rare that the staging protocol does not include FDG PET-CT of these areas. The patient’s “negative” scans led many providers to neglect the symptoms in her right ankle until the lesion had ulcerated through the skin. If one would have relied on imaging reports and outside records alone, the diagnosis would have been delayed longer or missed all together. This case illustrates the importance of a thorough medical history and personal review of imaging studies, and how a systematic approach can produce the correct diagnosis for any unknown lesion. Furthermore, this case may prompt oncologists to consider obtaining whole-body FDG PET-CT when evaluating for recurrence in patients.

References

1. Quintanilla-Martinez L, Kremer M, Keller G, et al. p53 mutations in nasal natural killer/T-cell lymphoma from Mexico: association with large cell morphology and advanced disease. Am J Pathol. 2001;159(6):2095-2105. doi:10.1016/S0002-9440(10)63061-1.

2. Au WY, Ma SY, Chim CS, et al. Clinicopathologic features and treatment outcome of mature T-cell and natural killer-cell lymphomas diagnosed according to the World Health Organization classification scheme: a single center experience of 10 years. Ann Oncol. 2005;16(2):206-214. doi:10.1093/annonc/mdi037.

3. Armitage JO. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin’s lymphoma. Blood. 1997;89(11):3909-3918.

4. Medeiros LJ, Peiper SC, Elwood L, Yano T, Raffeld M, Jaffe ES. Angiocentric immunoproliferative lesions: a molecular analysis of eight cases. Hum Pathol. 1991;22(11):1150-1157. doi:10.1016/0046-8177(91)90269-U.

5. Ho FC, Srivastava G, Loke SL, et al. Presence of Epstein-Barr virus DNA in nasal lymphomas of B and ‘T’ cell type. Hematol Oncol. 1990;8(5):271-281. doi:10.1002/hon.2900080505.

6. Gelb AB, van de Rijn M, Regula DP Jr, et al. Epstein-Barr virus-associated natural killer-large granular lymphocyte leukemia. Hum Pathol. 1994;25(9):953-960. doi:10.1016/0046-8177(94)90018-3.

7. Petrella T, Delfau-Larue MH, Caillot D, et al. Nasopharyngeal lymphomas: further evidence for a natural killer cell origin. Hum Pathol. 1996;27(8):827-833. doi:10.1016/S0046-8177(96)90457-8.

8. Hasserjian RP, Harris NL. NK-cell lymphomas and leukemias: a spectrum of tumors with variable manifestations and immunophenotype. Am J Clin Pathol. 2007;127(6):860-868. doi:10.1309/2F39NX1AL3L54WU8.

9. Robbins KT, Fuller LM, Vlasak M. Primary lymphomas of the nasal cavity and paranasal sinuses. Cancer. 1985;56(4):814-819. doi:10.1002/1097-0142(19850815)56.

10. Ooi GC, Chim CS, Liang R, Tsang KW, Kwong YL. Nasal T-cell/natural killer cell lymphoma: CT and MR imaging features of a new clinicopathologic entity. Am J Roentgenol. 2000;174(4):1141-1145. doi:10.2214/ajr.174.4.1741141.

11. Khong PL, Pang CB, Liang R, Kwong YL, Au WY. Fluorine-18 fluorodeoxyglucose positron emission tomography in mature T-cell and natural killer cell malignancies. Ann Hematol. 2008;87(8):613-621. doi:10.1007/s00277-008-0494-8.

12. Kim SJ, Kim K, Kim BS, et al. Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK/T-cell lymphoma: consortium for improving survival of lymphoma study. J Clin Oncol. 2009;27(35):6027-6032. doi:10.1200/JCO.2009.23.8592.

13. Kwong YL. Natural killer-cell malignancies: diagnosis and treatment. Leukemia. 2005;19(12):2186-2194. doi:10.1038/sj.leu.2403955.

14. Liang R. Advances in the management and monitoring of extranodal NK/T-cell lymphoma, nasal type. Br J Haematol. 2009;147(1):13-21. doi:10.1111/j.1365-2141.2009.07802.x.

15. Yokoyama H, Yamamoto J, Tohmiya Y, et al. Allogeneic hematopoietic stem cell transplant following chemotherapy containing l-asparaginase as a promising treatment for patients with relapsed or refractory extranodal natural killer/T cell lymphoma, nasal type. Leuk Lymphoma. 2010;51(8):1509-1512. doi:10.3109/10428194.2010.487958.

References

1. Quintanilla-Martinez L, Kremer M, Keller G, et al. p53 mutations in nasal natural killer/T-cell lymphoma from Mexico: association with large cell morphology and advanced disease. Am J Pathol. 2001;159(6):2095-2105. doi:10.1016/S0002-9440(10)63061-1.

2. Au WY, Ma SY, Chim CS, et al. Clinicopathologic features and treatment outcome of mature T-cell and natural killer-cell lymphomas diagnosed according to the World Health Organization classification scheme: a single center experience of 10 years. Ann Oncol. 2005;16(2):206-214. doi:10.1093/annonc/mdi037.

3. Armitage JO. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin’s lymphoma. Blood. 1997;89(11):3909-3918.

4. Medeiros LJ, Peiper SC, Elwood L, Yano T, Raffeld M, Jaffe ES. Angiocentric immunoproliferative lesions: a molecular analysis of eight cases. Hum Pathol. 1991;22(11):1150-1157. doi:10.1016/0046-8177(91)90269-U.

5. Ho FC, Srivastava G, Loke SL, et al. Presence of Epstein-Barr virus DNA in nasal lymphomas of B and ‘T’ cell type. Hematol Oncol. 1990;8(5):271-281. doi:10.1002/hon.2900080505.

6. Gelb AB, van de Rijn M, Regula DP Jr, et al. Epstein-Barr virus-associated natural killer-large granular lymphocyte leukemia. Hum Pathol. 1994;25(9):953-960. doi:10.1016/0046-8177(94)90018-3.

7. Petrella T, Delfau-Larue MH, Caillot D, et al. Nasopharyngeal lymphomas: further evidence for a natural killer cell origin. Hum Pathol. 1996;27(8):827-833. doi:10.1016/S0046-8177(96)90457-8.

8. Hasserjian RP, Harris NL. NK-cell lymphomas and leukemias: a spectrum of tumors with variable manifestations and immunophenotype. Am J Clin Pathol. 2007;127(6):860-868. doi:10.1309/2F39NX1AL3L54WU8.

9. Robbins KT, Fuller LM, Vlasak M. Primary lymphomas of the nasal cavity and paranasal sinuses. Cancer. 1985;56(4):814-819. doi:10.1002/1097-0142(19850815)56.

10. Ooi GC, Chim CS, Liang R, Tsang KW, Kwong YL. Nasal T-cell/natural killer cell lymphoma: CT and MR imaging features of a new clinicopathologic entity. Am J Roentgenol. 2000;174(4):1141-1145. doi:10.2214/ajr.174.4.1741141.

11. Khong PL, Pang CB, Liang R, Kwong YL, Au WY. Fluorine-18 fluorodeoxyglucose positron emission tomography in mature T-cell and natural killer cell malignancies. Ann Hematol. 2008;87(8):613-621. doi:10.1007/s00277-008-0494-8.

12. Kim SJ, Kim K, Kim BS, et al. Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK/T-cell lymphoma: consortium for improving survival of lymphoma study. J Clin Oncol. 2009;27(35):6027-6032. doi:10.1200/JCO.2009.23.8592.

13. Kwong YL. Natural killer-cell malignancies: diagnosis and treatment. Leukemia. 2005;19(12):2186-2194. doi:10.1038/sj.leu.2403955.

14. Liang R. Advances in the management and monitoring of extranodal NK/T-cell lymphoma, nasal type. Br J Haematol. 2009;147(1):13-21. doi:10.1111/j.1365-2141.2009.07802.x.

15. Yokoyama H, Yamamoto J, Tohmiya Y, et al. Allogeneic hematopoietic stem cell transplant following chemotherapy containing l-asparaginase as a promising treatment for patients with relapsed or refractory extranodal natural killer/T cell lymphoma, nasal type. Leuk Lymphoma. 2010;51(8):1509-1512. doi:10.3109/10428194.2010.487958.

Publications
Publications
Topics
Article Type
Display Headline
Recurrence of Extranodal Natural Killer/T-cell Lymphoma Presenting as Tarsal Tunnel Syndrome
Display Headline
Recurrence of Extranodal Natural Killer/T-cell Lymphoma Presenting as Tarsal Tunnel Syndrome
Sections
Inside the Article

TAKE-HOME POINTS

  • A thorough review of systems, physical examination, and personal review of a patient’s advanced imaging is critical to avoid missed diagnosis or delays in diagnosis.
  • Any mass lesion encountered in clinical practice, no matter how benign appearing, should be presumed malignant until proven otherwise.
  • Fluorine-18 fluorodeoxyglucose positron emission tomography CT (18-FDG PET-CT) should include whole-body scans when evaluating patients for recurrence of malignancy.
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Gate On Date
Tue, 03/26/2019 - 14:45
Un-Gate On Date
Tue, 03/26/2019 - 14:45
Use ProPublica
CFC Schedule Remove Status
Tue, 03/26/2019 - 14:45
Hide sidebar & use full width
render the right sidebar.

Avulsion of the Anterior Lateral Meniscal Root Secondary to Tibial Eminence Fracture

Article Type
Changed
Thu, 09/19/2019 - 13:18
Display Headline
Avulsion of the Anterior Lateral Meniscal Root Secondary to Tibial Eminence Fracture

ABSTRACT

The lateral tibial eminence shares a close relationship with the anterior root of the lateral meniscus. Limited studies have reported traumatic injury to the anterior meniscal roots in the setting of tibial eminence fractures, and reported rates of occurrence of concomitant meniscal and chondral injuries vary widely. The purpose of this article is to describe the case of a 28-year-old woman who had a complete avulsion of the anterolateral meniscal root caused by a tibial eminence fracture with resultant malunion and root displacement. The anterolateral meniscal root was anatomically repaired following arthroscopic resection of the malunited fragment.

The lateral tibial eminence is intimately associated with the root attachment of the anterior horn of the lateral meniscus.1-3 Previous studies have demonstrated both the close proximity of the anterior cruciate ligament (ACL) insertion to the meniscal roots and the potential for disruption in surgical interventions, such as tibial tunnel drilling in ACL reconstruction or placement of intramedullary tibial nails.4-6 The meniscal roots play a crucial role in force distribution, and disruption of these structures has been shown to significantly increase joint contact forces. Despite the deleterious effects of this injury, limited studies have reported on traumatic injury to the meniscal roots in the setting of tibial eminence fractures.

Reported rates of occurrence of concomitant meniscal and chondral injuries occurring with tibial eminence fractures vary widely, ranging from <5% to 40%.7,8 Although fractures to the tibial eminence are more common in children, an association between these injuries and concomitant soft tissue injuries, including meniscal, chondral, and collateral ligament injuries, in the adult population has been reported.7 Monto and Cameron-Donaldson8 used magnetic resonance imaging (MRI) to evaluate tibial eminence fractures in adults and found that 23% of study subjects had associated medial meniscus tears and 18% had lateral meniscus tears. In a similar study, Ishibashi and colleagues9 found that 25% of tibial eminence fractures were associated with lateral meniscus tears and 16% with medial meniscus tears.

These studies demonstrate the potential for meniscus injuries during tibial eminence fractures. However, the authors are unaware of any reports of complete tearing of the anterior horn of the lateral meniscus in association with this injury. This is an important injury to recognize and identify intraoperatively because an injury of this nature could potentially compromise the mechanical loading patterns and health of the articular cartilage of the lateral compartment of the knee. The purpose of this article is to describe a complete avulsion of the anterolateral meniscal root due to a tibial eminence fracture with resultant malunion and displacement of the root in a nonanatomical position. The patient provided written informed consent for print and electronic publication of this case report.

Continue to: A 28-year-old active woman...

 

 

CASE

A 28-year-old active woman presented to our clinic 22 months after sustaining a right knee tibial eminence fracture that was initially treated with extension immobilization, which resulted in a fibrous malunion. She subsequently sustained a second injury resulting in displacement of the malunion fracture fragment, and was treated at another institution 10 months prior to presentation at our clinic with arthroscopic reduction and internal fixation with a cannulated screw and washer of the tibial eminence fracture. This was followed by hardware removal 6 months prior to her office visit at our clinic. At presentation, she reported worsening right knee pain, mechanical symptoms, and loss of both flexion and extension compared with her uninjured knee. Conservative management, including activity modification, extensive physical therapy, and anti-inflammatory medication following her most recent procedure, had not resulted in improvement of her symptoms.

Physical examination revealed significantly reduced knee flexion and extension (+15°-120° on the affected side compared with 5° of hyperextension to 130° flexion of the contralateral knee). Ligamentous examination demonstrated no laxity with varus or valgus stress at 0° to 30° of flexion, negative posterior drawer, and a Grade 2 Lachman and positive pivot shift. She also exhibited pain with attempted right knee terminal extension. Radiographs and computed tomography scans were obtained and reviewed. They revealed a malunited tibial eminence fracture (Figures 1A-1D).  

The fragment was located anterior and lateral to its native location, which created a mechanical block during knee motion. Additionally, MRI demonstrated that the anterior horn of the lateral meniscus was displaced and attached to the malunited fragment (Figures 2A, 2B) as well as to nonfunctional ACL fibers.
  On the basis of the mechanical block restricting extension and the displaced anterior horn of the lateral meniscus compromising meniscal function, we recommended arthroscopic surgery. After discussion of the risks and benefits of the procedure with the patient, she provided informed consent, and it was decided that the patient would undergo arthroscopic fragment excision followed by anatomic repair of the anterior root of the lateral meniscus, and that we would proceed with ACL reconstruction in the future given her subjective instability and physical examination findings of ACL insufficiency.

Arthroscopic assessment of the right knee demonstrated the large osseous fragment located in the anterolateral aspect of the joint with the displaced anterior horn of the lateral meniscus attached as well as significant anterior impingement limiting knee extension. Probing of the anterolateral meniscal root in the lateral compartment showed abundant surrounding scar tissue with an abnormal attachment, representing a chronic root avulsion. A mechanical shaver was used to débride the scar tissue and expose the malunited fragment, followed by complete osseous fragment excision with a high-speed burr (Figure 3). 

The knee was taken through full range of motion (ROM) from 5° of hyperextension to 130° of flexion with arthroscopic confirmation of no further anterior impingement.

A soft tissue anterolateral meniscal root repair was performed by creating a 2-cm to 3-cm incision on the anterolateral tibia, just distal to the medial aspect of the Gerdy tubercle. To best restore the footprint of the repair and increase the potential for biologic healing, 2 transtibial tunnels were created at the location of the root attachment. An ACL aiming device with a cannulated sleeve was used to drill 2 bony tunnels approximately 5 mm apart, exiting at the anatomic root footprint. The drill pins were removed, leaving the 2 cannulas in place for later suture passage. A suture-passing device was used to pass 2 separate sutures through the detached meniscal root. 

A looped passing wire was directed up the previously placed cannulas, and 1 suture was shuttled down each tunnel. The sutures were securely tied down over a bony bridge with a cortical fixation button on the anterolateral tibia. This was visualized arthroscopically to ensure proper positioning and tension of the root to its native footprint (Figure 4).  A comparison of preoperative and postoperative anteroposterior and lateral knee radiographs is shown in Figures 5A, 5B.

Continue to: Postoperatively, the patient was placed...

 

 

Postoperatively, the patient was placed on a non-weight-bearing protocol for her operative lower extremity for 6 weeks. A brace locked in extension was used for the same period of time (being removed only for physical therapy exercises). Enoxaparin was used for the first 2 weeks for deep vein thrombosis prophylaxis, followed by aspirin for an additional 4 weeks. Physical therapy was started on postoperative day 1 to begin working on early passive ROM exercises. Knee flexion was limited to 0° to 90° of flexion for the first 2 weeks and then progressed as tolerated.

DISCUSSION

This article describes a rare case of a patient with lateral meniscal anterior root avulsion in the setting of a tibial eminence fracture with subsequent malunion and root displacement. In a case such as this, delineation of the true extent of the injury is difficult because the anterior meniscal root can be torn, displaced, and nonanatomically scarred to surrounding soft tissues, making MRI interpretation challenging. Clinically, patients can present with a wide range of symptoms, including pain, mechanical symptoms, instability, and loss of knee motion.10

The anterior root of the lateral meniscus has been reported to be attached anterior to the lateral tibial eminence and adjacent to the insertion of the ACL. Fibrous connections extending from the anterior horn of the lateral meniscus attachment to the lateral tibial eminence are constant.11 Furumatsu and colleagues12 demonstrated the existence of dense fibers linking the anterior root of the lateral meniscus with the lateral aspect of the ACL tibial insertion. Acknowledging the close relationship of these structures is key to comprehending the importance of evaluating the anterior horn of the lateral meniscus in cases of tibial eminence fractures at the initial time of injury. Failure to diagnose this pathology can lead to poor clinical outcomes and early degenerative changes of the knee.

Tibial intercondylar eminence avulsion fractures are most likely to occur in children and adolescents, and are equivalent to an ACL tear in adults.13 When tibial eminence fractures occur in an older cohort, they are often combined with lesions of the menisci, capsule, or collateral ligaments.14 The initial injury in our patient demonstrated concomitant anterior root injury that progressed with time to nonanatomical healing of the root, leading to altered biomechanics. Surgical techniques available for meniscal root repair are broadly divided into transosseous suture repairs and suture anchor repairs.10 The transtibial pullout technique using 2 transtibial bone tunnels as described in this report is the senior author’s (RFL) preference because it provides a strong construct with minimal displacement of the repaired meniscus.15-17

This article describes a complete avulsion of the anterolateral meniscal root caused by a tibial eminence fracture with resultant malunion and displacement of the root in a nonanatomic position. Anterior meniscal root tears have been reported to result in altered biomechanics and force transmission across the knee, and therefore, anatomic repair of the anterior root is indicated.

References

1. James EW, LaPrade CM, Ellman MB, Wijdicks CA, Engebretsen L, LaPrade RF. Radiographic identification of the anterior and posterior root attachments of the medial and lateral menisci. Am J Sports Med. 2014;42(11):2707-2714. doi:10.1177/0363546514545863.

2. LaPrade CM, Foad A, Smith SD, et al. Biomechanical consequences of a nonanatomic posterior medial meniscal root repair. Am J Sports Med. 2015;43(4):912-920. doi:10.1177/0363546514566191.

3. LaPrade CM, James EW, Cram TR, Feagin JA, Engebretsen L, LaPrade RF. Meniscal root tears: a classification system based on tear morphology. Am J Sports Med. 2015;43(2):363-369. doi:10.1177/0363546514559684.

4. Ellman MB, James EW, LaPrade CM, LaPrade RF. Anterior meniscus root avulsion following intramedullary nailing for a tibial shaft fracture. Knee Surg Sports Traumatol Arthrosc. 2015;23(4):1188-1191. doi:10.1007/s00167-014-2941-5.

5. Padalecki JR, Jansson KS, Smith SD, et al. Biomechanical consequences of a complete radial tear adjacent to the medial meniscus posterior root attachment site: in situ pull-out repair restores derangement of joint mechanics. Am J Sports Med. 2014;42(3):699-707. doi:10.1177/0363546513499314.

6. LaPrade CM, Jisa KA, Cram TR, LaPrade RF. Posterior lateral meniscal root tear due to a malpositioned double-bundle anterior cruciate ligament reconstruction tibial tunnel. Knee Surg Sports Traumatol Arthrosc. 2015;23(12):3670-3673. doi:10.1007/s00167-014-3273-1.

7. Mitchell JJ, Sjostrom R, Mansour AA, et al. Incidence of meniscal injury and chondral pathology in anterior tibial spine fractures of children. J Pediatr Orthop. 2015;35(2):130-135. doi:10.1097/BPO.0000000000000249.

8. Monto RR, Cameron-Donaldson ML. Magnetic resonance imaging in the evaluation of tibial eminence fractures in adults. J Knee Surg. 2006;19(3):187-190.

9. Ishibashi Y, Tsuda E, Sasaki T, Toh S. Magnetic resonance imaging AIDS in detecting concomitant injuries in patients with tibial spine fractures. Clin Orthop Relat Res. 2005;(434):207-212.

10. Bhatia S, LaPrade CM, Ellman MB, LaPrade RF. Meniscal root tears significance, diagnosis, and treatment. Am J Sports Med. 2014;42(12):3016-3030. doi:10.1177/0363546514524162.

11. Ziegler CG, Pietrini SD, Westerhaus BD, et al. Arthroscopically pertinent landmarks for tunnel positioning in single-bundle and double-bundle anterior cruciate ligament reconstructions. Am J Sports Med. 2011;39(4):743-752. doi:10.1177/0363546510387511.

12. Furumatsu T, Kodama Y, Maehara A, et al. The anterior cruciate ligament-lateral meniscus complex: a histological study. Connect Tissue Res. 2016;57(2):91-98. doi:10.3109/03008207.2015.1081899.

13. Lubowitz JH, Grauer JD. Arthroscopic treatment of anterior cruciate ligament avulsion. Clin Orthop Rel Res. 1993;(294):242-246.

14. Falstie-Jensen S, Sondergard Petersen PE. Incarceration of the meniscus in fractures of the intercondylar eminence of the tibia in children. Injury. 1984;15(4):236-238.

15. LaPrade CM, LaPrade MD, Turnbull TL, Wijdicks CA, LaPrade RF. Biomechanical evaluation of the transtibial pull-out technique for posterior medial meniscal root repairs using 1 and 2 transtibial bone tunnels. Am J Sports Med. 2015;43(4):899-904. doi:10.1177/0363546514563278.

16. Menge TJ, Chahla J, Dean CS, Mitchell JJ, Moatshe G, LaPrade RF. Anterior meniscal root repair using a transtibial double-tunnel pullout technique. Arthrosc Tech. 2016;5(3):e679-e684. doi:10.1016/j.eats.2016.02.026.

17. Menge TJ, Dean CS, Chahla J, Mitchell JJ, LaPrade RF. Anterior horn meniscal repair using an outside-in suture technique. Arthrosc Tech. 2016;5(5):e1111-e1116. doi:10.1016/j.eats.2016.06.005.

Author and Disclosure Information

Authors’ Disclosure Statement: Dr. LaPrade reports that he receives royalties and is a paid consultant for Smith and Nephew, Arthrex, and Össur. Dr. Menge reports that he is a paid consultant for Smith and Nephew. Dr. Mitchell reports that he has received educational and grant support from Arthrex, Smith and Nephew, and DJO, LLC. The other authors report no actual or potential conflict of interest in relation to this article.

Dr. Menge is an Orthopaedic and Sports Medicine Surgeon, Spectrum Health Medical Group, Grand Rapids, Michigan. Dr. Mitchell is an Orthopaedic and Sports Medicine Surgeon, Gundersen Health System, La Crosse, Wisconsin. Dr. Chahla is a Clinical Fellow, Cedars Sinai Kerlan Jobe Institute, Santa Monica, California. Dr. Dean is an Orthopaedic Surgical Resident, University of Colorado Hospital, Denver, Colorado. Dr. LaPrade is an Orthopaedic Complex Knee and Sports Medicine Surgeon, and Chief Medical Officer and Co-Director of the Sports Medicine Fellowship, Steadman Philippon Research Institute, The Steadman Clinic, Vail, Colorado.

Address correspondence to: Robert F. LaPrade MD, PhD, Steadman Philippon Research Institute, The Steadman Clinic, 181 West Meadow Drive, Suite 400, Vail, Colorado 81657 (email, [email protected]).

Am J Orthop. 2018;47(5). Copyright Frontline Medical Communications Inc. 2018. All rights reserved.

. Avulsion of the Anterior Lateral Meniscal Root Secondary to Tibial Eminence Fracture. Am J Orthop.

Publications
Topics
Sections
Author and Disclosure Information

Authors’ Disclosure Statement: Dr. LaPrade reports that he receives royalties and is a paid consultant for Smith and Nephew, Arthrex, and Össur. Dr. Menge reports that he is a paid consultant for Smith and Nephew. Dr. Mitchell reports that he has received educational and grant support from Arthrex, Smith and Nephew, and DJO, LLC. The other authors report no actual or potential conflict of interest in relation to this article.

Dr. Menge is an Orthopaedic and Sports Medicine Surgeon, Spectrum Health Medical Group, Grand Rapids, Michigan. Dr. Mitchell is an Orthopaedic and Sports Medicine Surgeon, Gundersen Health System, La Crosse, Wisconsin. Dr. Chahla is a Clinical Fellow, Cedars Sinai Kerlan Jobe Institute, Santa Monica, California. Dr. Dean is an Orthopaedic Surgical Resident, University of Colorado Hospital, Denver, Colorado. Dr. LaPrade is an Orthopaedic Complex Knee and Sports Medicine Surgeon, and Chief Medical Officer and Co-Director of the Sports Medicine Fellowship, Steadman Philippon Research Institute, The Steadman Clinic, Vail, Colorado.

Address correspondence to: Robert F. LaPrade MD, PhD, Steadman Philippon Research Institute, The Steadman Clinic, 181 West Meadow Drive, Suite 400, Vail, Colorado 81657 (email, [email protected]).

Am J Orthop. 2018;47(5). Copyright Frontline Medical Communications Inc. 2018. All rights reserved.

. Avulsion of the Anterior Lateral Meniscal Root Secondary to Tibial Eminence Fracture. Am J Orthop.

Author and Disclosure Information

Authors’ Disclosure Statement: Dr. LaPrade reports that he receives royalties and is a paid consultant for Smith and Nephew, Arthrex, and Össur. Dr. Menge reports that he is a paid consultant for Smith and Nephew. Dr. Mitchell reports that he has received educational and grant support from Arthrex, Smith and Nephew, and DJO, LLC. The other authors report no actual or potential conflict of interest in relation to this article.

Dr. Menge is an Orthopaedic and Sports Medicine Surgeon, Spectrum Health Medical Group, Grand Rapids, Michigan. Dr. Mitchell is an Orthopaedic and Sports Medicine Surgeon, Gundersen Health System, La Crosse, Wisconsin. Dr. Chahla is a Clinical Fellow, Cedars Sinai Kerlan Jobe Institute, Santa Monica, California. Dr. Dean is an Orthopaedic Surgical Resident, University of Colorado Hospital, Denver, Colorado. Dr. LaPrade is an Orthopaedic Complex Knee and Sports Medicine Surgeon, and Chief Medical Officer and Co-Director of the Sports Medicine Fellowship, Steadman Philippon Research Institute, The Steadman Clinic, Vail, Colorado.

Address correspondence to: Robert F. LaPrade MD, PhD, Steadman Philippon Research Institute, The Steadman Clinic, 181 West Meadow Drive, Suite 400, Vail, Colorado 81657 (email, [email protected]).

Am J Orthop. 2018;47(5). Copyright Frontline Medical Communications Inc. 2018. All rights reserved.

. Avulsion of the Anterior Lateral Meniscal Root Secondary to Tibial Eminence Fracture. Am J Orthop.

ABSTRACT

The lateral tibial eminence shares a close relationship with the anterior root of the lateral meniscus. Limited studies have reported traumatic injury to the anterior meniscal roots in the setting of tibial eminence fractures, and reported rates of occurrence of concomitant meniscal and chondral injuries vary widely. The purpose of this article is to describe the case of a 28-year-old woman who had a complete avulsion of the anterolateral meniscal root caused by a tibial eminence fracture with resultant malunion and root displacement. The anterolateral meniscal root was anatomically repaired following arthroscopic resection of the malunited fragment.

The lateral tibial eminence is intimately associated with the root attachment of the anterior horn of the lateral meniscus.1-3 Previous studies have demonstrated both the close proximity of the anterior cruciate ligament (ACL) insertion to the meniscal roots and the potential for disruption in surgical interventions, such as tibial tunnel drilling in ACL reconstruction or placement of intramedullary tibial nails.4-6 The meniscal roots play a crucial role in force distribution, and disruption of these structures has been shown to significantly increase joint contact forces. Despite the deleterious effects of this injury, limited studies have reported on traumatic injury to the meniscal roots in the setting of tibial eminence fractures.

Reported rates of occurrence of concomitant meniscal and chondral injuries occurring with tibial eminence fractures vary widely, ranging from <5% to 40%.7,8 Although fractures to the tibial eminence are more common in children, an association between these injuries and concomitant soft tissue injuries, including meniscal, chondral, and collateral ligament injuries, in the adult population has been reported.7 Monto and Cameron-Donaldson8 used magnetic resonance imaging (MRI) to evaluate tibial eminence fractures in adults and found that 23% of study subjects had associated medial meniscus tears and 18% had lateral meniscus tears. In a similar study, Ishibashi and colleagues9 found that 25% of tibial eminence fractures were associated with lateral meniscus tears and 16% with medial meniscus tears.

These studies demonstrate the potential for meniscus injuries during tibial eminence fractures. However, the authors are unaware of any reports of complete tearing of the anterior horn of the lateral meniscus in association with this injury. This is an important injury to recognize and identify intraoperatively because an injury of this nature could potentially compromise the mechanical loading patterns and health of the articular cartilage of the lateral compartment of the knee. The purpose of this article is to describe a complete avulsion of the anterolateral meniscal root due to a tibial eminence fracture with resultant malunion and displacement of the root in a nonanatomical position. The patient provided written informed consent for print and electronic publication of this case report.

Continue to: A 28-year-old active woman...

 

 

CASE

A 28-year-old active woman presented to our clinic 22 months after sustaining a right knee tibial eminence fracture that was initially treated with extension immobilization, which resulted in a fibrous malunion. She subsequently sustained a second injury resulting in displacement of the malunion fracture fragment, and was treated at another institution 10 months prior to presentation at our clinic with arthroscopic reduction and internal fixation with a cannulated screw and washer of the tibial eminence fracture. This was followed by hardware removal 6 months prior to her office visit at our clinic. At presentation, she reported worsening right knee pain, mechanical symptoms, and loss of both flexion and extension compared with her uninjured knee. Conservative management, including activity modification, extensive physical therapy, and anti-inflammatory medication following her most recent procedure, had not resulted in improvement of her symptoms.

Physical examination revealed significantly reduced knee flexion and extension (+15°-120° on the affected side compared with 5° of hyperextension to 130° flexion of the contralateral knee). Ligamentous examination demonstrated no laxity with varus or valgus stress at 0° to 30° of flexion, negative posterior drawer, and a Grade 2 Lachman and positive pivot shift. She also exhibited pain with attempted right knee terminal extension. Radiographs and computed tomography scans were obtained and reviewed. They revealed a malunited tibial eminence fracture (Figures 1A-1D).  

The fragment was located anterior and lateral to its native location, which created a mechanical block during knee motion. Additionally, MRI demonstrated that the anterior horn of the lateral meniscus was displaced and attached to the malunited fragment (Figures 2A, 2B) as well as to nonfunctional ACL fibers.
  On the basis of the mechanical block restricting extension and the displaced anterior horn of the lateral meniscus compromising meniscal function, we recommended arthroscopic surgery. After discussion of the risks and benefits of the procedure with the patient, she provided informed consent, and it was decided that the patient would undergo arthroscopic fragment excision followed by anatomic repair of the anterior root of the lateral meniscus, and that we would proceed with ACL reconstruction in the future given her subjective instability and physical examination findings of ACL insufficiency.

Arthroscopic assessment of the right knee demonstrated the large osseous fragment located in the anterolateral aspect of the joint with the displaced anterior horn of the lateral meniscus attached as well as significant anterior impingement limiting knee extension. Probing of the anterolateral meniscal root in the lateral compartment showed abundant surrounding scar tissue with an abnormal attachment, representing a chronic root avulsion. A mechanical shaver was used to débride the scar tissue and expose the malunited fragment, followed by complete osseous fragment excision with a high-speed burr (Figure 3). 

The knee was taken through full range of motion (ROM) from 5° of hyperextension to 130° of flexion with arthroscopic confirmation of no further anterior impingement.

A soft tissue anterolateral meniscal root repair was performed by creating a 2-cm to 3-cm incision on the anterolateral tibia, just distal to the medial aspect of the Gerdy tubercle. To best restore the footprint of the repair and increase the potential for biologic healing, 2 transtibial tunnels were created at the location of the root attachment. An ACL aiming device with a cannulated sleeve was used to drill 2 bony tunnels approximately 5 mm apart, exiting at the anatomic root footprint. The drill pins were removed, leaving the 2 cannulas in place for later suture passage. A suture-passing device was used to pass 2 separate sutures through the detached meniscal root. 

A looped passing wire was directed up the previously placed cannulas, and 1 suture was shuttled down each tunnel. The sutures were securely tied down over a bony bridge with a cortical fixation button on the anterolateral tibia. This was visualized arthroscopically to ensure proper positioning and tension of the root to its native footprint (Figure 4).  A comparison of preoperative and postoperative anteroposterior and lateral knee radiographs is shown in Figures 5A, 5B.

Continue to: Postoperatively, the patient was placed...

 

 

Postoperatively, the patient was placed on a non-weight-bearing protocol for her operative lower extremity for 6 weeks. A brace locked in extension was used for the same period of time (being removed only for physical therapy exercises). Enoxaparin was used for the first 2 weeks for deep vein thrombosis prophylaxis, followed by aspirin for an additional 4 weeks. Physical therapy was started on postoperative day 1 to begin working on early passive ROM exercises. Knee flexion was limited to 0° to 90° of flexion for the first 2 weeks and then progressed as tolerated.

DISCUSSION

This article describes a rare case of a patient with lateral meniscal anterior root avulsion in the setting of a tibial eminence fracture with subsequent malunion and root displacement. In a case such as this, delineation of the true extent of the injury is difficult because the anterior meniscal root can be torn, displaced, and nonanatomically scarred to surrounding soft tissues, making MRI interpretation challenging. Clinically, patients can present with a wide range of symptoms, including pain, mechanical symptoms, instability, and loss of knee motion.10

The anterior root of the lateral meniscus has been reported to be attached anterior to the lateral tibial eminence and adjacent to the insertion of the ACL. Fibrous connections extending from the anterior horn of the lateral meniscus attachment to the lateral tibial eminence are constant.11 Furumatsu and colleagues12 demonstrated the existence of dense fibers linking the anterior root of the lateral meniscus with the lateral aspect of the ACL tibial insertion. Acknowledging the close relationship of these structures is key to comprehending the importance of evaluating the anterior horn of the lateral meniscus in cases of tibial eminence fractures at the initial time of injury. Failure to diagnose this pathology can lead to poor clinical outcomes and early degenerative changes of the knee.

Tibial intercondylar eminence avulsion fractures are most likely to occur in children and adolescents, and are equivalent to an ACL tear in adults.13 When tibial eminence fractures occur in an older cohort, they are often combined with lesions of the menisci, capsule, or collateral ligaments.14 The initial injury in our patient demonstrated concomitant anterior root injury that progressed with time to nonanatomical healing of the root, leading to altered biomechanics. Surgical techniques available for meniscal root repair are broadly divided into transosseous suture repairs and suture anchor repairs.10 The transtibial pullout technique using 2 transtibial bone tunnels as described in this report is the senior author’s (RFL) preference because it provides a strong construct with minimal displacement of the repaired meniscus.15-17

This article describes a complete avulsion of the anterolateral meniscal root caused by a tibial eminence fracture with resultant malunion and displacement of the root in a nonanatomic position. Anterior meniscal root tears have been reported to result in altered biomechanics and force transmission across the knee, and therefore, anatomic repair of the anterior root is indicated.

ABSTRACT

The lateral tibial eminence shares a close relationship with the anterior root of the lateral meniscus. Limited studies have reported traumatic injury to the anterior meniscal roots in the setting of tibial eminence fractures, and reported rates of occurrence of concomitant meniscal and chondral injuries vary widely. The purpose of this article is to describe the case of a 28-year-old woman who had a complete avulsion of the anterolateral meniscal root caused by a tibial eminence fracture with resultant malunion and root displacement. The anterolateral meniscal root was anatomically repaired following arthroscopic resection of the malunited fragment.

The lateral tibial eminence is intimately associated with the root attachment of the anterior horn of the lateral meniscus.1-3 Previous studies have demonstrated both the close proximity of the anterior cruciate ligament (ACL) insertion to the meniscal roots and the potential for disruption in surgical interventions, such as tibial tunnel drilling in ACL reconstruction or placement of intramedullary tibial nails.4-6 The meniscal roots play a crucial role in force distribution, and disruption of these structures has been shown to significantly increase joint contact forces. Despite the deleterious effects of this injury, limited studies have reported on traumatic injury to the meniscal roots in the setting of tibial eminence fractures.

Reported rates of occurrence of concomitant meniscal and chondral injuries occurring with tibial eminence fractures vary widely, ranging from <5% to 40%.7,8 Although fractures to the tibial eminence are more common in children, an association between these injuries and concomitant soft tissue injuries, including meniscal, chondral, and collateral ligament injuries, in the adult population has been reported.7 Monto and Cameron-Donaldson8 used magnetic resonance imaging (MRI) to evaluate tibial eminence fractures in adults and found that 23% of study subjects had associated medial meniscus tears and 18% had lateral meniscus tears. In a similar study, Ishibashi and colleagues9 found that 25% of tibial eminence fractures were associated with lateral meniscus tears and 16% with medial meniscus tears.

These studies demonstrate the potential for meniscus injuries during tibial eminence fractures. However, the authors are unaware of any reports of complete tearing of the anterior horn of the lateral meniscus in association with this injury. This is an important injury to recognize and identify intraoperatively because an injury of this nature could potentially compromise the mechanical loading patterns and health of the articular cartilage of the lateral compartment of the knee. The purpose of this article is to describe a complete avulsion of the anterolateral meniscal root due to a tibial eminence fracture with resultant malunion and displacement of the root in a nonanatomical position. The patient provided written informed consent for print and electronic publication of this case report.

Continue to: A 28-year-old active woman...

 

 

CASE

A 28-year-old active woman presented to our clinic 22 months after sustaining a right knee tibial eminence fracture that was initially treated with extension immobilization, which resulted in a fibrous malunion. She subsequently sustained a second injury resulting in displacement of the malunion fracture fragment, and was treated at another institution 10 months prior to presentation at our clinic with arthroscopic reduction and internal fixation with a cannulated screw and washer of the tibial eminence fracture. This was followed by hardware removal 6 months prior to her office visit at our clinic. At presentation, she reported worsening right knee pain, mechanical symptoms, and loss of both flexion and extension compared with her uninjured knee. Conservative management, including activity modification, extensive physical therapy, and anti-inflammatory medication following her most recent procedure, had not resulted in improvement of her symptoms.

Physical examination revealed significantly reduced knee flexion and extension (+15°-120° on the affected side compared with 5° of hyperextension to 130° flexion of the contralateral knee). Ligamentous examination demonstrated no laxity with varus or valgus stress at 0° to 30° of flexion, negative posterior drawer, and a Grade 2 Lachman and positive pivot shift. She also exhibited pain with attempted right knee terminal extension. Radiographs and computed tomography scans were obtained and reviewed. They revealed a malunited tibial eminence fracture (Figures 1A-1D).  

The fragment was located anterior and lateral to its native location, which created a mechanical block during knee motion. Additionally, MRI demonstrated that the anterior horn of the lateral meniscus was displaced and attached to the malunited fragment (Figures 2A, 2B) as well as to nonfunctional ACL fibers.
  On the basis of the mechanical block restricting extension and the displaced anterior horn of the lateral meniscus compromising meniscal function, we recommended arthroscopic surgery. After discussion of the risks and benefits of the procedure with the patient, she provided informed consent, and it was decided that the patient would undergo arthroscopic fragment excision followed by anatomic repair of the anterior root of the lateral meniscus, and that we would proceed with ACL reconstruction in the future given her subjective instability and physical examination findings of ACL insufficiency.

Arthroscopic assessment of the right knee demonstrated the large osseous fragment located in the anterolateral aspect of the joint with the displaced anterior horn of the lateral meniscus attached as well as significant anterior impingement limiting knee extension. Probing of the anterolateral meniscal root in the lateral compartment showed abundant surrounding scar tissue with an abnormal attachment, representing a chronic root avulsion. A mechanical shaver was used to débride the scar tissue and expose the malunited fragment, followed by complete osseous fragment excision with a high-speed burr (Figure 3). 

The knee was taken through full range of motion (ROM) from 5° of hyperextension to 130° of flexion with arthroscopic confirmation of no further anterior impingement.

A soft tissue anterolateral meniscal root repair was performed by creating a 2-cm to 3-cm incision on the anterolateral tibia, just distal to the medial aspect of the Gerdy tubercle. To best restore the footprint of the repair and increase the potential for biologic healing, 2 transtibial tunnels were created at the location of the root attachment. An ACL aiming device with a cannulated sleeve was used to drill 2 bony tunnels approximately 5 mm apart, exiting at the anatomic root footprint. The drill pins were removed, leaving the 2 cannulas in place for later suture passage. A suture-passing device was used to pass 2 separate sutures through the detached meniscal root. 

A looped passing wire was directed up the previously placed cannulas, and 1 suture was shuttled down each tunnel. The sutures were securely tied down over a bony bridge with a cortical fixation button on the anterolateral tibia. This was visualized arthroscopically to ensure proper positioning and tension of the root to its native footprint (Figure 4).  A comparison of preoperative and postoperative anteroposterior and lateral knee radiographs is shown in Figures 5A, 5B.

Continue to: Postoperatively, the patient was placed...

 

 

Postoperatively, the patient was placed on a non-weight-bearing protocol for her operative lower extremity for 6 weeks. A brace locked in extension was used for the same period of time (being removed only for physical therapy exercises). Enoxaparin was used for the first 2 weeks for deep vein thrombosis prophylaxis, followed by aspirin for an additional 4 weeks. Physical therapy was started on postoperative day 1 to begin working on early passive ROM exercises. Knee flexion was limited to 0° to 90° of flexion for the first 2 weeks and then progressed as tolerated.

DISCUSSION

This article describes a rare case of a patient with lateral meniscal anterior root avulsion in the setting of a tibial eminence fracture with subsequent malunion and root displacement. In a case such as this, delineation of the true extent of the injury is difficult because the anterior meniscal root can be torn, displaced, and nonanatomically scarred to surrounding soft tissues, making MRI interpretation challenging. Clinically, patients can present with a wide range of symptoms, including pain, mechanical symptoms, instability, and loss of knee motion.10

The anterior root of the lateral meniscus has been reported to be attached anterior to the lateral tibial eminence and adjacent to the insertion of the ACL. Fibrous connections extending from the anterior horn of the lateral meniscus attachment to the lateral tibial eminence are constant.11 Furumatsu and colleagues12 demonstrated the existence of dense fibers linking the anterior root of the lateral meniscus with the lateral aspect of the ACL tibial insertion. Acknowledging the close relationship of these structures is key to comprehending the importance of evaluating the anterior horn of the lateral meniscus in cases of tibial eminence fractures at the initial time of injury. Failure to diagnose this pathology can lead to poor clinical outcomes and early degenerative changes of the knee.

Tibial intercondylar eminence avulsion fractures are most likely to occur in children and adolescents, and are equivalent to an ACL tear in adults.13 When tibial eminence fractures occur in an older cohort, they are often combined with lesions of the menisci, capsule, or collateral ligaments.14 The initial injury in our patient demonstrated concomitant anterior root injury that progressed with time to nonanatomical healing of the root, leading to altered biomechanics. Surgical techniques available for meniscal root repair are broadly divided into transosseous suture repairs and suture anchor repairs.10 The transtibial pullout technique using 2 transtibial bone tunnels as described in this report is the senior author’s (RFL) preference because it provides a strong construct with minimal displacement of the repaired meniscus.15-17

This article describes a complete avulsion of the anterolateral meniscal root caused by a tibial eminence fracture with resultant malunion and displacement of the root in a nonanatomic position. Anterior meniscal root tears have been reported to result in altered biomechanics and force transmission across the knee, and therefore, anatomic repair of the anterior root is indicated.

References

1. James EW, LaPrade CM, Ellman MB, Wijdicks CA, Engebretsen L, LaPrade RF. Radiographic identification of the anterior and posterior root attachments of the medial and lateral menisci. Am J Sports Med. 2014;42(11):2707-2714. doi:10.1177/0363546514545863.

2. LaPrade CM, Foad A, Smith SD, et al. Biomechanical consequences of a nonanatomic posterior medial meniscal root repair. Am J Sports Med. 2015;43(4):912-920. doi:10.1177/0363546514566191.

3. LaPrade CM, James EW, Cram TR, Feagin JA, Engebretsen L, LaPrade RF. Meniscal root tears: a classification system based on tear morphology. Am J Sports Med. 2015;43(2):363-369. doi:10.1177/0363546514559684.

4. Ellman MB, James EW, LaPrade CM, LaPrade RF. Anterior meniscus root avulsion following intramedullary nailing for a tibial shaft fracture. Knee Surg Sports Traumatol Arthrosc. 2015;23(4):1188-1191. doi:10.1007/s00167-014-2941-5.

5. Padalecki JR, Jansson KS, Smith SD, et al. Biomechanical consequences of a complete radial tear adjacent to the medial meniscus posterior root attachment site: in situ pull-out repair restores derangement of joint mechanics. Am J Sports Med. 2014;42(3):699-707. doi:10.1177/0363546513499314.

6. LaPrade CM, Jisa KA, Cram TR, LaPrade RF. Posterior lateral meniscal root tear due to a malpositioned double-bundle anterior cruciate ligament reconstruction tibial tunnel. Knee Surg Sports Traumatol Arthrosc. 2015;23(12):3670-3673. doi:10.1007/s00167-014-3273-1.

7. Mitchell JJ, Sjostrom R, Mansour AA, et al. Incidence of meniscal injury and chondral pathology in anterior tibial spine fractures of children. J Pediatr Orthop. 2015;35(2):130-135. doi:10.1097/BPO.0000000000000249.

8. Monto RR, Cameron-Donaldson ML. Magnetic resonance imaging in the evaluation of tibial eminence fractures in adults. J Knee Surg. 2006;19(3):187-190.

9. Ishibashi Y, Tsuda E, Sasaki T, Toh S. Magnetic resonance imaging AIDS in detecting concomitant injuries in patients with tibial spine fractures. Clin Orthop Relat Res. 2005;(434):207-212.

10. Bhatia S, LaPrade CM, Ellman MB, LaPrade RF. Meniscal root tears significance, diagnosis, and treatment. Am J Sports Med. 2014;42(12):3016-3030. doi:10.1177/0363546514524162.

11. Ziegler CG, Pietrini SD, Westerhaus BD, et al. Arthroscopically pertinent landmarks for tunnel positioning in single-bundle and double-bundle anterior cruciate ligament reconstructions. Am J Sports Med. 2011;39(4):743-752. doi:10.1177/0363546510387511.

12. Furumatsu T, Kodama Y, Maehara A, et al. The anterior cruciate ligament-lateral meniscus complex: a histological study. Connect Tissue Res. 2016;57(2):91-98. doi:10.3109/03008207.2015.1081899.

13. Lubowitz JH, Grauer JD. Arthroscopic treatment of anterior cruciate ligament avulsion. Clin Orthop Rel Res. 1993;(294):242-246.

14. Falstie-Jensen S, Sondergard Petersen PE. Incarceration of the meniscus in fractures of the intercondylar eminence of the tibia in children. Injury. 1984;15(4):236-238.

15. LaPrade CM, LaPrade MD, Turnbull TL, Wijdicks CA, LaPrade RF. Biomechanical evaluation of the transtibial pull-out technique for posterior medial meniscal root repairs using 1 and 2 transtibial bone tunnels. Am J Sports Med. 2015;43(4):899-904. doi:10.1177/0363546514563278.

16. Menge TJ, Chahla J, Dean CS, Mitchell JJ, Moatshe G, LaPrade RF. Anterior meniscal root repair using a transtibial double-tunnel pullout technique. Arthrosc Tech. 2016;5(3):e679-e684. doi:10.1016/j.eats.2016.02.026.

17. Menge TJ, Dean CS, Chahla J, Mitchell JJ, LaPrade RF. Anterior horn meniscal repair using an outside-in suture technique. Arthrosc Tech. 2016;5(5):e1111-e1116. doi:10.1016/j.eats.2016.06.005.

References

1. James EW, LaPrade CM, Ellman MB, Wijdicks CA, Engebretsen L, LaPrade RF. Radiographic identification of the anterior and posterior root attachments of the medial and lateral menisci. Am J Sports Med. 2014;42(11):2707-2714. doi:10.1177/0363546514545863.

2. LaPrade CM, Foad A, Smith SD, et al. Biomechanical consequences of a nonanatomic posterior medial meniscal root repair. Am J Sports Med. 2015;43(4):912-920. doi:10.1177/0363546514566191.

3. LaPrade CM, James EW, Cram TR, Feagin JA, Engebretsen L, LaPrade RF. Meniscal root tears: a classification system based on tear morphology. Am J Sports Med. 2015;43(2):363-369. doi:10.1177/0363546514559684.

4. Ellman MB, James EW, LaPrade CM, LaPrade RF. Anterior meniscus root avulsion following intramedullary nailing for a tibial shaft fracture. Knee Surg Sports Traumatol Arthrosc. 2015;23(4):1188-1191. doi:10.1007/s00167-014-2941-5.

5. Padalecki JR, Jansson KS, Smith SD, et al. Biomechanical consequences of a complete radial tear adjacent to the medial meniscus posterior root attachment site: in situ pull-out repair restores derangement of joint mechanics. Am J Sports Med. 2014;42(3):699-707. doi:10.1177/0363546513499314.

6. LaPrade CM, Jisa KA, Cram TR, LaPrade RF. Posterior lateral meniscal root tear due to a malpositioned double-bundle anterior cruciate ligament reconstruction tibial tunnel. Knee Surg Sports Traumatol Arthrosc. 2015;23(12):3670-3673. doi:10.1007/s00167-014-3273-1.

7. Mitchell JJ, Sjostrom R, Mansour AA, et al. Incidence of meniscal injury and chondral pathology in anterior tibial spine fractures of children. J Pediatr Orthop. 2015;35(2):130-135. doi:10.1097/BPO.0000000000000249.

8. Monto RR, Cameron-Donaldson ML. Magnetic resonance imaging in the evaluation of tibial eminence fractures in adults. J Knee Surg. 2006;19(3):187-190.

9. Ishibashi Y, Tsuda E, Sasaki T, Toh S. Magnetic resonance imaging AIDS in detecting concomitant injuries in patients with tibial spine fractures. Clin Orthop Relat Res. 2005;(434):207-212.

10. Bhatia S, LaPrade CM, Ellman MB, LaPrade RF. Meniscal root tears significance, diagnosis, and treatment. Am J Sports Med. 2014;42(12):3016-3030. doi:10.1177/0363546514524162.

11. Ziegler CG, Pietrini SD, Westerhaus BD, et al. Arthroscopically pertinent landmarks for tunnel positioning in single-bundle and double-bundle anterior cruciate ligament reconstructions. Am J Sports Med. 2011;39(4):743-752. doi:10.1177/0363546510387511.

12. Furumatsu T, Kodama Y, Maehara A, et al. The anterior cruciate ligament-lateral meniscus complex: a histological study. Connect Tissue Res. 2016;57(2):91-98. doi:10.3109/03008207.2015.1081899.

13. Lubowitz JH, Grauer JD. Arthroscopic treatment of anterior cruciate ligament avulsion. Clin Orthop Rel Res. 1993;(294):242-246.

14. Falstie-Jensen S, Sondergard Petersen PE. Incarceration of the meniscus in fractures of the intercondylar eminence of the tibia in children. Injury. 1984;15(4):236-238.

15. LaPrade CM, LaPrade MD, Turnbull TL, Wijdicks CA, LaPrade RF. Biomechanical evaluation of the transtibial pull-out technique for posterior medial meniscal root repairs using 1 and 2 transtibial bone tunnels. Am J Sports Med. 2015;43(4):899-904. doi:10.1177/0363546514563278.

16. Menge TJ, Chahla J, Dean CS, Mitchell JJ, Moatshe G, LaPrade RF. Anterior meniscal root repair using a transtibial double-tunnel pullout technique. Arthrosc Tech. 2016;5(3):e679-e684. doi:10.1016/j.eats.2016.02.026.

17. Menge TJ, Dean CS, Chahla J, Mitchell JJ, LaPrade RF. Anterior horn meniscal repair using an outside-in suture technique. Arthrosc Tech. 2016;5(5):e1111-e1116. doi:10.1016/j.eats.2016.06.005.

Publications
Publications
Topics
Article Type
Display Headline
Avulsion of the Anterior Lateral Meniscal Root Secondary to Tibial Eminence Fracture
Display Headline
Avulsion of the Anterior Lateral Meniscal Root Secondary to Tibial Eminence Fracture
Sections
Inside the Article

TAKE-HOME POINTS

  • Root tears of all meniscal attachments have been described. A comprehensive anatomic understanding of the meniscal roots is of utmost importance to suspect root lesions.
  • A detailed physical examination along with imaging methods should be performed to make the correct diagnosis. In cases of evident injuries, such as a tibial spine fracture, additional soft tissue pathology should also be assessed.
  • It is important to restore all torn root attachments to restore joint loading and contact areas. An anatomical root repair is needed to yield optimal results.
  • Progressive rehabilitation with early ROM starting on postoperative day 1 can help avoid loss of knee motion and arthrofibrosis.
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Gate On Date
Thu, 03/21/2019 - 11:45
Un-Gate On Date
Thu, 03/21/2019 - 11:45
Use ProPublica
CFC Schedule Remove Status
Thu, 03/21/2019 - 11:45
Hide sidebar & use full width
render the right sidebar.

Current Concepts in Clinical Research: Anterior Cruciate Ligament Outcome Instruments

Article Type
Changed
Thu, 09/19/2019 - 13:18
Display Headline
Current Concepts in Clinical Research: Anterior Cruciate Ligament Outcome Instruments

ABSTRACT

Outcome instruments have become an essential part of the evaluation of functional recovery after anterior cruciate ligament (ACL) reconstruction. Although the clinical examination provides important objective information to assess graft integrity, stability, range of motion, and strength, these measurements do not take the patient’s perception into account. There are many knee outcome instruments, and it is challenging for surgeons to understand how to interpret clinical research and utilize these measures in a practical way. The purpose of this review is to provide an overview of the most commonly used outcome measures in patients undergoing ACL reconstruction and to examine and compare the psychometric performance (validity, reliability, responsiveness) of these measurement tools.

Anterior cruciate ligament (ACL) reconstruction is one of the most common elective orthopedic procedures.1 Despite advances in surgical techniques, ACL reconstruction is associated with a lengthy recovery time, decreased performance, and increased rate of reinjury.2 Patients undergoing ACL reconstruction are often active individuals who participate in demanding activities, and accurate assessment of their recovery helps to guide recovery counseling. In addition to objective clinical outcomes measured through physical examination, patient-reported outcome (PRO) instruments add the patient’s perspective, information critical in determining a successful outcome. A variety of outcome instruments have been used and validated for patients with ACL tears. It is important for orthopedic surgeons to know the advantages and disadvantages of each outcome tool in order to interpret clinical studies and assess postoperative patients.

Over the last 10 years, there has been an increase in the number of knee instruments and rating scales designed to measure PROs, with >54 scores designed for the ACL-deficient knee.3 No standardized instrument is currently universally accepted as superior following ACL reconstruction across the spectrum of patient populations. Clinicians and researchers must carefully consider an outcome instrument’s utility based on specific patient populations in which it has been evaluated. Appropriate selection of outcome measures is of fundamental importance for adequate demonstration of the efficacy and value of treatment interventions, especially in an era of healthcare reform with a focus on providing high-quality and cost-effective care.

The purpose of this review is to highlight current tools used to measure outcomes after ACL reconstruction. Current outcome measures vary widely in regards to their validity, reliability, minimal clinically important difference, and applicability to specific patient populations. We have thus identified the measures most commonly used today in studies and clinical follow-up after ACL reconstruction and their various advantages and limitations. This information may enhance the orthopedic surgeon’s understanding of what outcome measures may be utilized in clinical studies.

Continue to: Patient-Reported Outcome Instruments...

 

 

PATIENT-REPORTED OUTCOME INSTRUMENTS

Recently, there has been a transition to increased use of PRO instruments rather than clinician-based postoperative assessment, largely due to the increasing emphasis on patient satisfaction in determining the value of an orthopedic intervention.4 PRO instruments are widely used to capture the patient’s perception of general health, quality of life (QOL), daily function, and pain. PRO instruments offer the benefit of allowing patients to subjectively assess their knee function during daily living and sports activities, conveying to the provider the impact of ACL reconstruction on physical, psychological, and social aspects of everyday activities. Furthermore, patient satisfaction has been shown to closely follow outcome scores related to symptoms and function.5 A multitude of specific knee-related PRO instruments have been developed and validated to measure outcomes after ACL reconstruction for both research and clinical purposes (Table).

Table. ACL Outcome Measures

 

 

 

 

 

Outcome Measure

Condition/Intervention

Measures

Internal Consistency (Cronbach’s a)

Test-Retest Reliability

Minimal Clinically Important Difference

Ref

AAOS Sports Knee Scale

Many Knee

Stiffness, swelling, pain/function, locking/catching, giving way, limitation of activity, pain with activity

0.86-0.95

0.68-0.96

Unknown

59, 60

ACL-QOL

Chronic ACL deficiency

Physical complaints, work, recreation and sports competition, lifestyle, social and emotional functioning

0.93-0.98

6% average error

Unknown

35, 36

Cincinnati Knee Rating System

ACL

Symptoms, daily and sports activities, physical examination, stability, radiographs, functional testing

 

0.80-0.97

14 points (6 months), 26 points (12 months)

39, 40, 47, 52

IKDC (Subjective Knee Form)

ACL

Symptoms, function, sports activity

0.92

0.91-0.93

11.5 points; 6.3 at 6 months, 16.7 at 12 months

48, 52, 54

KOOS

ACL

Pain, symptoms, activities of daily living, sport/recreation, knee-related quality of life

0.71-0.95

0.75-0.93

8-10 points

17

Lysholm

ACL

Pain, instability, locking, squatting, limp, support, swelling, stair-climbing

0.72

0.94

8.9

46, 47, 55

Marx

Healthy patients

Activity level

0.87

0.97

Unknown

42, 56, 57

Tegner

ACL

Activity level

0.81

0.82

1

55, 56

PROMIS
(PF CAT)

Many lower extremity orthopedic conditions

Lower extremity function, central body function, activities of daily living

0.98

0.96-0.99

 

30, 31

WOMAC

Hip/knee OA

Physical function, pain, stiffness

0.81-0.95

0.80-0.92

12% baseline score or 6% max score; 9-12 points

13, 14

Abbreviations: AAOS, American Academy of Orthopaedic Surgeons; ACL, anterior cruciate ligament; ACL-QOL, anterior cruciate ligament quality of life score; CAT, computer-adapting testing; IKDC, International Knee Documentation Committee; KOOS, Knee Injury and Osteoarthritis Outcome Score; OA, osteoarthritis; PF, physical function; PROMIS, Patient-Reported Outcome Measurement Information System; Ref, references; WOMAC, Western Ontario and McMaster Universities Osteoarthritis Index.

MEASUREMENT PROPERTIES

In general, clinicians and investigators should use health-related outcome measures with established reliability, validity, patient relevance, and responsiveness for assessing the specific condition.6

Reliability refers to the degree to which a measurement score is free from random error, reflecting how consistent or reproducible the instrument is when administered under the same testing conditions. Internal consistency, test-retest reliability, and measurement error are measures of reliability. Internal consistency is tested after a single administration and assesses how well items within a scale measure a single underlying dimension, represented using item-total correlation coefficients and Cronbach’s alpha. A Cronbach’s alpha of 0.70 to 0.95 is generally defined as good.7 Test-retest reliability is designed to appraise variation over time in stable patients and is represented using the intraclass correlation coefficient (ICC).8 An ICC >0.7 is considered acceptable; >0.8, good; and >0.9, excellent.9 An aspect of accuracy is whether the scoring system measures the full range of the disease or complaints. The incidence of minimum (floor) and maximum (ceiling) scores can be calculated for outcome scores. An instrument with low floor and ceiling effects, below 10% to 15%, is more inconclusive and can be more reliably used to measure patients at the high and low end of the scoring system.10

Validity is the ability of an outcome instrument to measure what it is intended to measure. Establishing validity is complex and requires evaluation of several facets, including content validity, construct validity, and criterion validity. Content validity is a relatively subjective judgment explaining the ability of an instrument to assess the critical features of the problem. Construct validity evaluates whether the questionnaire measures what it intends to measure, and is often assessed by correlating scores form one instrument to those from other proven instruments that are already accepted as valid. Finally, criterion validity assesses the correlation between the score and a previously established “gold standard” instrument.

Responsiveness is the ability of the instrument to detect a change or identify improvement or worsening of a clinical condition over time. Most frequently, the effect size (observed change/standard deviation of baseline scores) and standardized response mean (observed change/standard deviation of change) are used as measures of responsiveness. The minimal clinically important difference of an outcome measure is the smallest change in an outcome score that corresponds to a change in patient condition.

Continue to: ACL Outcome Instruments...

 

 

ACL OUTCOME INSTRUMENTS

WESTERN ONTARIO AND MCMASTER UNIVERSITIES OSTEOARTHRITIS INDEX (WOMAC LK 3.0)

The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC LK 3.0) was developed in 1982 and is a widely used, disease-specific instrument recommended for the evaluation of treatment effects in patients with hip and knee osteoarthritis.11 Available in more than 80 languages, it is a self-administered, generic health status questionnaire developed to assess pain, function, and stiffness in daily living, taking respondents between 3 to 7.5 minutes for completion.12 Using visual analog scales, the 24 items probe the 3 subscales: pain (5 items), stiffness (2 items), and functional difficulty (17 items). Scores are calculated for each dimension, and the total score is normalized to a 100-point scale, with 0 indicating severe symptoms and 100 indicating no symptoms and higher function. The WOMAC score can also be calculated from the Knee Injury and Osteoarthritis Outcome Score (KOOS). The WOMAC questionnaire is well recognized for its good validity, reliability, and responsiveness, and is the most commonly used outcome measure for osteoarthritis.13-15 Considering its focus on older patients with osteoarthritis, it may not be appropriate for use in a young and active population.

KNEE INJURY AND OSTEOARTHRITIS OUTCOME SCORE (KOOS)

The KOOS is a knee-specific questionnaire developed as an extension of the WOMAC to evaluate the functional status and QOL of patients with any type of knee injury who are at an increased risk of developing osteoarthritis.16 The patient-based questionnaire is available in over 30 languages and covers both the short- and long-term consequences of an injury of the knee causing traumatic damage to cartilage, ligaments, and menisci. The KOOS is 42 items graded on a 5-point Likert scale, covering 5 subscales: pain (9 items), symptoms (7 items), function in activities of daily living (17 items), function in sports/recreation (5 items), and knee-related QOL (4 items). The questionnaire is self-administered and takes about 10 minutes to complete. Scores are calculated for each dimension, and the total score is transformed to a 0 to 100 scale, with 0 representing severe knee problems and 100 representing no knee problems and better outcome. An advantage of the KOOS is that it evaluates both knee injuries and osteoarthritis; therefore, it is arguably more suitable for evaluating patients over the long-term. The KOOS has been validated for several orthopedic interventions, including ACL reconstruction and rehabilitation16,17 as well as meniscectomy18 and total knee replacement.19 Population-based reference data for the adult population according to age and gender have also been established.20 The KOOS is increasingly utilized in clinical studies on ACL reconstruction.21-25 The questions of the WOMAC were retained so that a WOMAC score might be calculated separately and compared with the KOOS score.26

PATIENT-REPORTED OUTCOMES INFORMATION SYSTEM (PROMIS)

Since 2004, The National Institutes of Health (NIH) has funded the development of the Patient-Reported Outcome Measurement Information System (PROMIS), a set of flexible tools that reliably and validly measure PROs. The PROMIS consists of a library of question banks that has been developed and operated by a network of National Institutes of Health-funded research sites and coordinating centers and covers many different health domains including pain, fatigue, anxiety, depression, social functioning, physical functioning, and sleep. PROMIS items are developed using Item Response Theory (IRT), wherein the answer to any individual item has a known mathematical probability of predicting the test taker’s overall measurement of the specific trait being tested. This is commonly administered using computer-adaptive testing (CAT), which presents to the test taker an initial item, scores the response to that item, and from the response then presents the most informative second item, and so forth until a predefined level of precision is reached. Because the items are individually validated, they can be used alone or in any combination, a feature that distinguishes the PROMIS from traditional fixed-length PRO instruments that require the completion of an instrument in its entirety to be valid.27 In recent years, orthopedic research has been published with PROMIS physical function (PF) scores as primary outcome measures.28-30 The PF item bank includes 124 items measuring upper extremity, lower extremity, central and instrumental activities of daily living. PF can be completed as a short form (SF) with a set number of questions or utilizing CAT and evaluates self-reported function and physical activity. An advantage is its ease of use and potential to minimize test burden with very few questions, often as little as 4 items, as compared to other traditional PROMs.31

Previously published work has demonstrated that, in patients undergoing meniscal surgery, the PROMIS PF CAT maintains construct validity and correlates well with currently used knee outcome instruments, including KOOS.28 Work by the same group looking at the performance of the PROMIS PF CAT in patients indicated for ACL reconstruction shows that the PROMIS PF CAT correlates well with other PRO instruments for patients with ACL injuries, (SF-36 PF [r = 0.82, P < 0.01], KOOS Sport [r = 0.70, P < 0.01], KOOS ADL [r = 0.74, P < 0.01]), does not have floor or ceiling effects in this relatively young and healthy population, and has a low test burden.32,33 Papuga and colleagues33 also compared the International Knee Documentation Committee (IKDC) and PROMIS PF CAT on 106 subjects after ACL reconstruction and found good correlation.

Continue to: Quality of Life Outcome Measure...

 

 

QUALITY OF LIFE OUTCOME MEASURE FOR ACL DEFICIENCY (ACL-QOL)

The ACL-QOL Score was developed in 1998 as a disease-specific measure for patients with chronic ACL deficiency.34 This scale consists of 32 separate items in 31 visual analog questions regarding symptoms and physical complaints, work-related concerns, recreational activities and sport participation or competition, lifestyle, and social and emotional health status relating to the knee. The raw score is transformed into a 0- to 100-point scale, with higher scores indicating a better outcome. The scale is valid, reliable, and responsive for patients with ACL insufficiency,35,36 and is not applicable to other disorders of the knee. We recommend the ACL-QOL questionnaire be used in conjunction with other currently available objective and functional outcome measures.

CINCINNATI KNEE RATING SYSTEM

The Cincinnati Knee Rating System (CKRS) was first described in 1983 and was modified to include occupational activities, athletic activities, symptoms, and functional limitations.37,38 There are 11 components, measuring symptoms and disability in sports activity, activities of daily living function, occupational rating, as well as sections that measure physical examination, laxity of the knee, and radiographic evidence of degenerative joint disease.39 The measure is scored on a 100-point scale, with higher scores indicating better outcomes. Scores have been shown to be lower as compared with other outcome measures assessing the same clinical condition.40,41 Barber-Westin and colleagues39 confirmed the reliability, validity, and responsiveness of the CKRS by testing 350 subjects with and without knee ligament injuries. In 2001, Marx42 tested the CKRS subjective form for reliability, validity, and responsiveness and found it to be acceptable for clinical research.

LYSHOLM KNEE SCORE

The Lysholm Knee Score was published in 1982 and modified in 1985, consisting of an 8-question survey that evaluates outcomes after knee ligament surgery. Items include pain, instability, locking, squatting, limping, support usage, swelling, and stair-climbing ability, with pain and instability carrying the highest weight.43 It is scored on a scale of 0 to 100, with high scores indicating higher functioning and fewer symptoms. It has been validated in patients with ACL injuries and meniscal injuries.44 Although it is widely used to measure outcomes after ACL reconstruction,45 it has received criticism in the evaluation of patients with other knee conditions.46 The main advantage of the Lysholm Knee Score is its ability to note changes in activity in the same patient across different time periods (responsiveness). A limitation of the Lysholm Knee Score is that it does not measure the domains of functioning in daily activities, sports, and recreational activities. The Lysholm scoring system’s test-retest reliability and construct validity have been evaluated,42,43,46 although there has been some concern regarding a ceiling effect and its validity, sensitivity, and reliability has been questioned.47 Therefore, it is advised that this score be used in conjunction with other PRO scores.

INTERNATIONAL KNEE DOCUMENTATION COMMITTEE (IKDC) SUBJECTIVE KNEE FORM

In 1987, members of the European Society for Knee Surgery and Arthroscopy and the American Orthopaedic Society for Sports Medicine formed the IKDC to develop a standardized method for evaluating knee injuries and treatment. The IKDC Subjective Knee Evaluation Form was initially published in 1993, and in 2001 the form was revised by the American Orthopaedic Society for Sports Medicine to become a knee-specific assessment tool rather than a disease or condition-specific tool.48 The IKDC subjective form is an 18-question, knee-specific survey designed to detect improvement or deterioration in symptoms, function, and ability to participate in sports activities experienced by patients following knee surgery or other interventions. The individual items are summed and transformed into a 0- to 100-point scale, with high scores representing higher levels of function and minimal symptoms. The IKDC is utilized to assess a variety of knee conditions including ligament, meniscus, articular cartilage, osteoarthritis, and patellofemoral pain.48,49 Thus, this form can be used to assess any condition involving the knee and allow comparison between groups with different diagnoses. The IKDC has been validated for an ACL reconstruction population,47 has been used to assess outcomes in recent clinical studies on ACL reconstruction,50,51 and is one of the most frequently used measures for patients with ACL deficiency.3 The validity, responsiveness, and reliability of the IKDC subjective form has been confirmed for both adult and adolescent populations.48,49,52-54

TEGNER ACTIVITY SCORES

The Tegner activity score was developed in 1985 and was designed to provide an objective value for a patient’s activity level.44 This scale was developed to complement the Lysholm score. It consists of 1 sport-specific activity level question on a 0 to 10 scale that evaluates an individual’s ability to compete in a sporting activity. Scores between 1 and 5 represent work or recreational sports. Scores >5 represent higher-level recreational and competitive sports. The Tegner activity score is one of the most widely used activity scoring systems for patients with knee disorders,55,56 commonly utilized with the Lysholm Knee Score.44 One disadvantage of the Tegner activity score is that it relates to specific sports rather than functional activities, which limits its generalizability. We are not aware of any studies documenting the reliability or validity of this instrument.

Continue on: Marx Activity Rating Scale...

 

 

MARX ACTIVITY RATING SCALE

The Marx activity rating scale was developed to be utilized with other knee rating scales and outcome measures as an activity assessment.57 In contrast to the Tegner activity score, the Marx activity rating scale measures function rather than sport-specific activity. The scale is a short, patient-based activity assessment that consists of a 4-question survey evaluating patients’ knee health by recording the frequency and intensity of participation in a sporting activity. Questions are scored from 0 to 4 on the basis of how often the activity is performed. The 4 sections of the Marx scale that are rated include running, cutting, decelerating, and pivoting. This scale has been validated in patients with ACL injuries, chondromalacia patellae, and meniscal lesions.42,56-58 Acceptable ceiling effects of 3% and floor effects of 8% were noted in the study of ACL-injured patients.57

AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS (AAOS) SPORTS KNEE SCALE

The American Academy of Orthopaedic Surgeons (AAOS) Sports Knee Rating Scale consists of 5 parts and 23 items, including a section addressing stiffness, swelling, pain and function (7 questions), locking/catching (4 questions), giving way (4 questions), limitations of activity (4 questions), and pain with activity (4 questions).59,60 Items may be dropped if patients select particular responses, which can lead to difficulties when using the survey. This scoring system has been found to be satisfactory when all subscales were combined and the mean was calculated.42

DISCUSSION

PRO measures play an increasingly important role in the measurement of success and impact of health care services. Specifically, for ACL reconstruction, patient satisfaction is key for demonstrating the value of operative or other interventions. Selecting a suitable outcome measurement tool can be daunting, as it can be difficult to ascertain which outcome measures are appropriate for the patient or disorder in question. As there is currently no instrument that is universally superior in the evaluation of ACL outcomes, clinicians must consider the specific patient population in which the outcome instrument has been evaluated. Investigators should also use instruments with reported minimal clinically important differences so that variation in scores can be interpreted as either clinically significant or not. When choosing which outcome instrument to use, there is rarely a single appropriate rating system that is entirely comprehensive. In most cases, a general health outcome measure should be used in combination with a condition-specific rating scale. Activity rating scales, such as Marx or Tegner, should be included, especially when evaluating patients with low-activity lifestyles.

CONCLUSION

There are a number of reliable, valid, and responsive outcome measures that can be utilized to evaluate outcomes following ACL reconstruction in an array of patient populations. Outcome measures should be relevant to patients, easy to use, reliable, valid, and responsive to change. By increasing familiarity with these outcome measures, orthopedic surgeons and investigators can develop better studies, interpret data, and implement findings in practice with sound and informed judgment. Future research should focus on identifying the most relevant outcome metrics for assessing function following ACL reconstruction.

This paper will be judged for the Resident Writer’s Award.

References

1. Mall NA, Chalmers PN, Moric M, et al. Incidence and trends of anterior cruciate ligament reconstruction in the United States. Am J Sports Med. 2014;42(10):2363-2370. doi:10.1177/0363546514542796.

2. Brophy RH, Schmitz L, Wright RW, et al. Return to play and future ACL injury risk after ACL reconstruction in soccer athletes from the Multicenter Orthopaedic Outcomes Network (MOON) group. Am J Sports Med. 2012;40(11):2517-2522. doi:10.1177/0363546512459476.

3. Johnson DS, Smith RB. Outcome measurement in the ACL deficient knee- what’s the score? Knee. 2001;8(1):51-57. doi:10.1016/S0968-0160(01)00068-0.

4. Graham B, Green A, James M, Katz J, Swiontkowski M. Measuring patient satisfaction in orthopaedic surgery. J Bone Joint Surg Am. 2015;97(1):80-84. doi:10.2106/JBJS.N.00811.

5. Kocher MS, Steadman JR, Briggs K, Zurakowski D, Sterett WI, Hawkins RJ. Determinants of patient satisfaction with outcome after anterior cruciate ligament reconstruction. J Bone Joint Surg Am. 2002;84(9):1560-1572. doi:10.2106/00004623-200209000-00008.

6. Streiner DL, Norman GR. Health Measurement Scales: A Practical Guide to their Development and Use. Oxford: Oxford University Press; 1989.

7. Terwee CB, Bot SD, de Boer MR, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol. 2007;60(1):34-42. doi:10.1016/j.jclinepi.2006.03.012.

8. Bartko JJ. The intraclass correlation coefficient as a measure of reliability. Psychol Rep. 1966;19(1):3-11. doi:10.2466/pr0.1966.19.1.3.

9. Scholtes VA, Terwee CB, Poolman RW. What makes a measurement instrument valid and reliable? Injury. 2011;42(3):236-240. doi:10.1016/j.injury.2010.11.042.

10. Fries J, Rose M, Krishnan E. The PROMIS of better outcome assessment: responsiveness, floor and ceiling effects, and internet administration. J Rheumatol. 2011;38(8):1759-1764. doi:10.3899/jrheum.110402.

11. Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt L. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol. 1988;15(12):1833-1840.

12. Gandek B. Measurement properties of the Western Ontario and McMaster Universities Osteoarthritis Index: a systematic review. Arthritis Care Res (Hoboken). 2015;67(2):216-229. doi:10.1002/acr.22415.

13. Angst F, Aeschlimann A, Stucki G. Smallest detectable and minimal clinically important differences of rehabilitation intervention with their implications for required sample sizes using WOMAC and SF-36 quality of life measurement instruments in patients with osteoarthritis of the lower extremities. Arthritis Rheum. 2001;45(4):384-391. doi:10.1002/1529-0131(200108)45:4<384::AID-ART352>3.0.CO;2-0.

14. Ryser L, Wright BD, Aeschlimann A, Mariacher-Gehler S, Stuckl G. A new look at the Western Ontario and McMaster Universities Osteoarthritis Index using Rasch analysis. Arthritis Care Res. 1999;12(5):331-335.

15. Wolfe F, Kong SX. Rasch analysis of the Western Ontario MacMaster questionnaire (WOMAC) in 2205 patients with osteoarthritis, rheumatoid arthritis, and fibromyalgia. Ann Rheum Dis. 1999;58(9):563-568. doi:10.1136/ard.58.9.563.

16. Roos EM, Roos HP, Lohmander LS, Ekdahl C, Beynnon BD. Knee Injury and Osteoarthritis Outcome Score (KOOS)—development of a self-administered outcome measure. J Orthop Sports Phys Ther. 1998;28(2):88-96. doi:10.2519/jospt.1998.28.2.88.

17. Salavati M, Akhbari B, Mohammadi F, Mazaheri M, Khorrami M. Knee injury and Osteoarthritis Outcome Score (KOOS): reliability and validity in competitive athletes after anterior cruciate ligament reconstruction. Osteoarthritis Cartilage. 2011;19(4):406-410. doi:10.1016/j.joca.2011.01.010.

18. Roos EM, Roos HP, Lohmander LS. WOMAC Osteoarthritis Index—additional dimensions for use in subjects with post-traumatic osteoarthritis of the knee. Western Ontario and MacMaster Universities. Osteoarthritis Cartilage. 1999;7(2):216-221. doi:10.1053/joca.1998.0153.

19. Roos EM, Toksvig-Larsen S. Knee injury and osteoarthritis outcome score (KOOS)—validation and comparison to the WOMAC in total knee replacement. Health Qual Life Outcomes. 2003;1(1):17. doi:10.1186/1477-7525-1-17.

20. Paradowski PT, Bergman S, Sunden-Lundius A, Lohmander LS, Roos EM. Knee complaints vary with age and gender in the adult population: population-based reference data for the Knee injury and Osteoarthritis Outcome Score (KOOS). BMC Musculoskeletal Disord. 2006;7(1):38. doi:10.1186/1471-2474-7-38.

21. MARS Group. Effect of graft choice on the outcome of revision anterior cruciate ligament reconstruction in the Multicenter ACL Revision Study (MARS) Cohort. Am J Sports Med. 2014;42(10):2301-2310. doi:10.1177/0363546514549005.

22. Ventura A, Legnani C, Terzaghi C, Borgo E, Albisetti W. Revision surgery after failed ACL reconstruction with artificial ligaments: clinical, histologic and radiographic evaluation. Eur J Orthop Surg Traumatol. 2014;21(1):93-98. doi:10.1007/s00590-012-1136-3.

23. Wasserstein D, Huston LJ, Nwosu S, et al. KOOS pain as a marker for significant knee pain two and six years after primary ACL reconstruction: a Multicenter Orthopaedic Outcomes Network (MOON) prospective longitudinal cohort study. Osteoarthritis Cartilage. 2015;23(10):1674-1684. doi:10.1016/j.joca.2015.05.025.

24. Zaffagnini S, Grassi A, Muccioli GM, et al. Return to sport after anterior cruciate ligament reconstruction in professional soccer players. Knee. 2014;21(3):731-735. doi:10.1016/j.knee.2014.02.005.

25. Duffee A, Magnussen RA, Pedroza AD, Flanigan DC; MOON Group, Kaeding CC. Transtibial ACL femoral tunnel preparation increases odds of repeat ipsilateral knee surgery. J Bone Joint Surg Am. 2013;95(22):2035-2042. doi:10.2106/JBJS.M.00187.

26. Bellamy N, Buchanan WW. A preliminary evaluation of the dimensionality and clinical importance of pain and disability in osteoarthritis of the hip and knee. Clin Rheumatol. 1986;5(2):231-241. doi:10.1007/BF02032362.

27. Fries J, Rose M, Krishnan E. The PROMIS of better outcome assessment: responsiveness, floor and ceiling effects, and Internet administration. J Rheumatol. 2011;38(8):1759-1764. doi:10.3899/jrheum.110402.

28. Hancock KJ, Glass NA, Anthony CA, et al. Performance of PROMIS for healthy patients undergoing meniscal surgery. J Bone Joint Surg Am. 2017;99(11):954-958. doi:10.2106/JBJS.16.00848.

29. Hung M, Clegg Do, Greene T, et al. Evaluation of the PROMIS physical function item bank in orthopedic patients. J Orthop Res. 2011;29(6):947-953. doi:10.1002/jor.21308.

30. Hung M, Baumhauer JF, Brodsky JW, et al; Orthopaedic Foot & Ankle Outcomes Research (OFAR) of the American Orthopaedic Foot & Ankle Society (AOFAS). Psychometric comparison of the PROMIS physical function CAT with the FAAM and FFI for measuring patient-reported outcomes. Foot Ankle Int. 2014;35(6):592-599. doi:10.1177/1071100714528492.

31. Hung M, Stuart AR, Higgins TF, Saltzman CL, Kubiak EN. Computerized adaptive testing using the PROMIS physical function item bank reduces test burden with less ceiling effects compared with the short musculoskeletal function assessment in orthopaedic trauma patients. J Orthop Trauma. 2014;28(8):439-443. doi:10.1097/BOT.0000000000000059.

32. Hancock, et al. PROMIS: A valid and efficient outcomes instrument for patients with ACL tears. KSSTA. In press.

33. Scott, et al. Performance of PROMIS physical function compared with KOOS, SF-36, Eq5D, and Marx activity scale in patients who undergo ACL reconstruction. In press.

34. Papuga MO, Beck CA, Kates SL, Schwarz EM, Maloney MD. Validation of GAITRite and PROMIS as high-throughput physical function outcome measures following ACL reconstruction. J Orthop Res. 2014;32(6):793-801. doi:10.1002/jor.22591.

35. Mohtadi N. Development and validation of the quality of life outcome measure (questionnaire) for chronic anterior cruciate ligament deficiency. Am J Sports Med. 1998;26(3):350-359. doi:10.1177/03635465980260030201.

36. Lafave MR, Hiemstra L, Kerslake S, Heard M, Buchko G. Validity, reliability, and responsiveness of the anterior cruciate ligament quality of life measure: a continuation of its overall validation. Clin J Sport Med. 2017;27(1):57-63. doi:10.1097/JSM.0000000000000292.

37. Noyes FR, McGinniss GH, Mooar LA. Functional disability in the anterior cruciate insufficient knee syndrome: Review of knee rating systems and projected risk factors in determining treatment. Sports Med. 1984;1(4):278-302. doi:10.2165/00007256-198401040-00004.

38. Noyes FR, Matthews DS, Mooar PA, Grood ES. The symptomatic anterior cruciate-deficient knee: Part II. The results of rehabilitation, activity modification, and counseling on functional disability. J Bone Joint Surg Am. 1983;65(2):163-174. doi:10.2106/00004623-198365020-00004.

39. Barber-Westin SD, Noyes FR, McCloskey JW. Rigorous statistical reliability, validity, and responsiveness testing of the Cincinnati knee rating system in 350 subjects with uninjured, injured, or anterior cruciate ligament-reconstructed knees. Am J Sports Med. 1999;27(4):402-416. doi:10.1177/03635465990270040201.

40. Bollen S, Seedhorn BB. A comparison of the Lysholm and Cincinnati knee scoring questionnaires. Am J Sports Med. 1991;19(2):189-190. doi:10.1177/036354659101900215.

41. Sgaglione NA, Del Pizzo W, Fox JM, Friedman MJ. Critical analysis of knee ligament rating systems. Am J Sports Med. 1995;23(6):660-667. doi:10.1177/036354659502300604.

42. Marx RG, Jones EC, Allen AA, et al. Reliability, validity, and responsiveness of four knee outcome scales for athletic patients. J Bone Joint Surg Am. 2001;83(10):1459-1469. doi:10.2106/00004623-200110000-00001.

43. Lysholm J, Gillquist J. Evaluation of knee ligament surgery results with special emphasis on use of a scoring scale. Am J Sports Med. 1982;10(3):150-154. doi:10.1177/036354658201000306.

44. Tegner Y, Lysholm J. Rating systems in the evaluation of knee ligament injuries. Clin Orthop Relat Res. 1985;198:43-49. doi:10.1097/00003086-198509000-00007.

45. Lukianov AV, Gillquist J, Grana WA, DeHaven KE. An anterior cruciate ligament (ACL) evaluation format for assessment of artificial or autologous anterior cruciate reconstruction results. Clin Orthop Relat Res. 1987;218:167-180. doi:10.1097/00003086-198705000-00024.

46. Bengtsson J, Mollborg J, Werner S. A study for testing the sensitivity and reliability of the Lysholm knee scoring scale. Knee Surg Sports Traumatol Arthrosc. 1996;4(1):27-31. doi:10.1007/BF01565994.

47. Risberg MA, Holm I, Steen J, Beynnon BD. Sensitivity to changes over time for the IKDC form, the Lysholm score, and the Cincinnati knee score. A prospective study of 120 ACL reconstructed patients with a 2-year follow-up. Knee Surg Sports Traumatol Arthrosc. 1999;7(3):152-159. doi:10.1007/s001670050140.

48. Irrgang JJ, Anderson AF, Boland AL, et al. Development and validation of the international knee documentation committee subjective knee form. Am J Sports Med. 2001;29(5):600-613. doi:10.1177/03635465010290051301.

49. Irrgang JJ, Anderson AF, Boland AL, et al. Responsiveness of the International Knee Documentation Committee Subjective Knee Form. Am J Sports Med. 2006;34(10):1567-1573. doi:10.1177/0363546506288855.

50. Logerstedt D, Di Stasi S, Grindem H, et al. Self-reported knee function can identify athletes who fail return-to-activity criteria up to 1 year after anterior cruciate ligament reconstruction: a Delaware-Oslo ACL cohort study. J Orthop Sports Phys Ther. 2014;44(2):914-923. doi:10.2519/jospt.2014.4852.

51. Lentz TA, Zeppieri G Jr, George SZ, et al. Comparison of physical impairment, functional and psychosocial measures based on fear of reinjury/lack of confidence and return-to-sport status after ACL reconstruction. Am J Sports Med. 2015;43(2):345-353. doi:10.1177/0363546514559707.

52. Greco NJ, Anderson AF, Mann BJ, et al. Responsiveness of the International Knee Documentation Committee Subjective Knee Form in comparison to the Western Ontario and McMaster Universities Osteoarthritis Index, modified Cincinnati Knee Rating System, and Short Form 36 in patients with focal articular cartilage defects. Am J Sports Med. 2010;38(5):891-902. doi:10.1177/0363546509354163.

53. Hefti F, Muller W, Jakob RP, Staubli HU. Evaluation of knee ligament injuries with the IKDC form. Knee Surg Sports Traumatol Arthrosc. 1993;1(3-4):226-234. doi:10.1007/BF01560215.

54. Schmitt LC, Paterno MV, Huang S. Validity and internal consistency of the International Knee Documentation Committee Subjective Knee Evaluation Form in children and adolescents. Am J Sports Med. 2010;38(12):2443-2447. doi:10.1177/0363546510374873.

55. Briggs KK, Lysholm J, Tegner Y, Rodkey WG, Kocher MS, Steadman JR. The reliability, validity, and responsiveness of the Lysholm and Tegner activity scale for anterior cruciate ligament injuries of the knee: 25 years later. Am J Sports Med. 2009;37(5):890-897. doi:10.1177/0363546508330143.

56. Negahban H, Mostafaee N, Sohani SM, et al. Reliability and validity of the Tegner and Marx activity rating scales in Iranian patients with anterior cruciate ligament injury. Disabil Rehabil. 2011;33(23-24):2305-2310. doi:10.3109/09638288.2011.570409.

57. Marx RG, Stump TJ, Jones EC, Wickiewicz TL, Warren RF. Development and evaluation of an activity rating scale for disorders of the knee. Am J Sports Med. 2001;29(2):213-218. doi:10.1177/03635465010290021601.

58. Garratt AM, Brealey S, Gillespie WJ, in collaboration with the DAM-ASK Trial Team. Patient-assessed health instruments for the knee: a structured review. Rheumatology. 2004;43(11):1414-1423. doi:10.1093/rheumatology/keh362.

59. American Academy of Orthopaedic Surgeons. Scoring algorithms for the lower limb: Outcomes data collection instrument. Rosemon, IL: American Academy of Orthopaedic Surgeons; 1998.

60. Johanson NA, Liang MH, Daltroy L, Rudicel S, Richmond J. American Academy of Orthopaedic Surgeons lower limb outcomes assessment instruments. Reliability, validity, and sensitivity to change. J Bone Joint Surg Am. 2004;86-A(5):902-909.

Author and Disclosure Information

Authors’ Disclosure Statement: The authors report no actual or potential conflict of interest in relation to this article.

Dr. Day and Dr. Hancock are Orthopedic Surgery Residents; Dr. Glass is a Statistician; and Dr. Bollier is Congdon Professor in Orthopedic Surgery, Sports Medicine Fellowship Director, and Team Physician, Department of Orthopedics and Rehabilitation, University of Iowa Hospitals and Clinics, Iowa City, Iowa.

Address correspondence to: Matthew J. Bollier, MD, University of Iowa Hospitals and Clinics, Department of Orthopedics and Rehabilitation, 200 Hawkins Drive, Iowa City, IA 52242 (tel, 319-467-8324; fax, 319-356-8999; email, [email protected]).

Am J Orthop. 2018;47(5). Copyright Frontline Medical Communications Inc. 2018. All rights reserved.

. Current Concepts in Clinical Research: Anterior Cruciate Ligament Outcome Instruments. Am J Orthop.

Publications
Topics
Sections
Author and Disclosure Information

Authors’ Disclosure Statement: The authors report no actual or potential conflict of interest in relation to this article.

Dr. Day and Dr. Hancock are Orthopedic Surgery Residents; Dr. Glass is a Statistician; and Dr. Bollier is Congdon Professor in Orthopedic Surgery, Sports Medicine Fellowship Director, and Team Physician, Department of Orthopedics and Rehabilitation, University of Iowa Hospitals and Clinics, Iowa City, Iowa.

Address correspondence to: Matthew J. Bollier, MD, University of Iowa Hospitals and Clinics, Department of Orthopedics and Rehabilitation, 200 Hawkins Drive, Iowa City, IA 52242 (tel, 319-467-8324; fax, 319-356-8999; email, [email protected]).

Am J Orthop. 2018;47(5). Copyright Frontline Medical Communications Inc. 2018. All rights reserved.

. Current Concepts in Clinical Research: Anterior Cruciate Ligament Outcome Instruments. Am J Orthop.

Author and Disclosure Information

Authors’ Disclosure Statement: The authors report no actual or potential conflict of interest in relation to this article.

Dr. Day and Dr. Hancock are Orthopedic Surgery Residents; Dr. Glass is a Statistician; and Dr. Bollier is Congdon Professor in Orthopedic Surgery, Sports Medicine Fellowship Director, and Team Physician, Department of Orthopedics and Rehabilitation, University of Iowa Hospitals and Clinics, Iowa City, Iowa.

Address correspondence to: Matthew J. Bollier, MD, University of Iowa Hospitals and Clinics, Department of Orthopedics and Rehabilitation, 200 Hawkins Drive, Iowa City, IA 52242 (tel, 319-467-8324; fax, 319-356-8999; email, [email protected]).

Am J Orthop. 2018;47(5). Copyright Frontline Medical Communications Inc. 2018. All rights reserved.

. Current Concepts in Clinical Research: Anterior Cruciate Ligament Outcome Instruments. Am J Orthop.

ABSTRACT

Outcome instruments have become an essential part of the evaluation of functional recovery after anterior cruciate ligament (ACL) reconstruction. Although the clinical examination provides important objective information to assess graft integrity, stability, range of motion, and strength, these measurements do not take the patient’s perception into account. There are many knee outcome instruments, and it is challenging for surgeons to understand how to interpret clinical research and utilize these measures in a practical way. The purpose of this review is to provide an overview of the most commonly used outcome measures in patients undergoing ACL reconstruction and to examine and compare the psychometric performance (validity, reliability, responsiveness) of these measurement tools.

Anterior cruciate ligament (ACL) reconstruction is one of the most common elective orthopedic procedures.1 Despite advances in surgical techniques, ACL reconstruction is associated with a lengthy recovery time, decreased performance, and increased rate of reinjury.2 Patients undergoing ACL reconstruction are often active individuals who participate in demanding activities, and accurate assessment of their recovery helps to guide recovery counseling. In addition to objective clinical outcomes measured through physical examination, patient-reported outcome (PRO) instruments add the patient’s perspective, information critical in determining a successful outcome. A variety of outcome instruments have been used and validated for patients with ACL tears. It is important for orthopedic surgeons to know the advantages and disadvantages of each outcome tool in order to interpret clinical studies and assess postoperative patients.

Over the last 10 years, there has been an increase in the number of knee instruments and rating scales designed to measure PROs, with >54 scores designed for the ACL-deficient knee.3 No standardized instrument is currently universally accepted as superior following ACL reconstruction across the spectrum of patient populations. Clinicians and researchers must carefully consider an outcome instrument’s utility based on specific patient populations in which it has been evaluated. Appropriate selection of outcome measures is of fundamental importance for adequate demonstration of the efficacy and value of treatment interventions, especially in an era of healthcare reform with a focus on providing high-quality and cost-effective care.

The purpose of this review is to highlight current tools used to measure outcomes after ACL reconstruction. Current outcome measures vary widely in regards to their validity, reliability, minimal clinically important difference, and applicability to specific patient populations. We have thus identified the measures most commonly used today in studies and clinical follow-up after ACL reconstruction and their various advantages and limitations. This information may enhance the orthopedic surgeon’s understanding of what outcome measures may be utilized in clinical studies.

Continue to: Patient-Reported Outcome Instruments...

 

 

PATIENT-REPORTED OUTCOME INSTRUMENTS

Recently, there has been a transition to increased use of PRO instruments rather than clinician-based postoperative assessment, largely due to the increasing emphasis on patient satisfaction in determining the value of an orthopedic intervention.4 PRO instruments are widely used to capture the patient’s perception of general health, quality of life (QOL), daily function, and pain. PRO instruments offer the benefit of allowing patients to subjectively assess their knee function during daily living and sports activities, conveying to the provider the impact of ACL reconstruction on physical, psychological, and social aspects of everyday activities. Furthermore, patient satisfaction has been shown to closely follow outcome scores related to symptoms and function.5 A multitude of specific knee-related PRO instruments have been developed and validated to measure outcomes after ACL reconstruction for both research and clinical purposes (Table).

Table. ACL Outcome Measures

 

 

 

 

 

Outcome Measure

Condition/Intervention

Measures

Internal Consistency (Cronbach’s a)

Test-Retest Reliability

Minimal Clinically Important Difference

Ref

AAOS Sports Knee Scale

Many Knee

Stiffness, swelling, pain/function, locking/catching, giving way, limitation of activity, pain with activity

0.86-0.95

0.68-0.96

Unknown

59, 60

ACL-QOL

Chronic ACL deficiency

Physical complaints, work, recreation and sports competition, lifestyle, social and emotional functioning

0.93-0.98

6% average error

Unknown

35, 36

Cincinnati Knee Rating System

ACL

Symptoms, daily and sports activities, physical examination, stability, radiographs, functional testing

 

0.80-0.97

14 points (6 months), 26 points (12 months)

39, 40, 47, 52

IKDC (Subjective Knee Form)

ACL

Symptoms, function, sports activity

0.92

0.91-0.93

11.5 points; 6.3 at 6 months, 16.7 at 12 months

48, 52, 54

KOOS

ACL

Pain, symptoms, activities of daily living, sport/recreation, knee-related quality of life

0.71-0.95

0.75-0.93

8-10 points

17

Lysholm

ACL

Pain, instability, locking, squatting, limp, support, swelling, stair-climbing

0.72

0.94

8.9

46, 47, 55

Marx

Healthy patients

Activity level

0.87

0.97

Unknown

42, 56, 57

Tegner

ACL

Activity level

0.81

0.82

1

55, 56

PROMIS
(PF CAT)

Many lower extremity orthopedic conditions

Lower extremity function, central body function, activities of daily living

0.98

0.96-0.99

 

30, 31

WOMAC

Hip/knee OA

Physical function, pain, stiffness

0.81-0.95

0.80-0.92

12% baseline score or 6% max score; 9-12 points

13, 14

Abbreviations: AAOS, American Academy of Orthopaedic Surgeons; ACL, anterior cruciate ligament; ACL-QOL, anterior cruciate ligament quality of life score; CAT, computer-adapting testing; IKDC, International Knee Documentation Committee; KOOS, Knee Injury and Osteoarthritis Outcome Score; OA, osteoarthritis; PF, physical function; PROMIS, Patient-Reported Outcome Measurement Information System; Ref, references; WOMAC, Western Ontario and McMaster Universities Osteoarthritis Index.

MEASUREMENT PROPERTIES

In general, clinicians and investigators should use health-related outcome measures with established reliability, validity, patient relevance, and responsiveness for assessing the specific condition.6

Reliability refers to the degree to which a measurement score is free from random error, reflecting how consistent or reproducible the instrument is when administered under the same testing conditions. Internal consistency, test-retest reliability, and measurement error are measures of reliability. Internal consistency is tested after a single administration and assesses how well items within a scale measure a single underlying dimension, represented using item-total correlation coefficients and Cronbach’s alpha. A Cronbach’s alpha of 0.70 to 0.95 is generally defined as good.7 Test-retest reliability is designed to appraise variation over time in stable patients and is represented using the intraclass correlation coefficient (ICC).8 An ICC >0.7 is considered acceptable; >0.8, good; and >0.9, excellent.9 An aspect of accuracy is whether the scoring system measures the full range of the disease or complaints. The incidence of minimum (floor) and maximum (ceiling) scores can be calculated for outcome scores. An instrument with low floor and ceiling effects, below 10% to 15%, is more inconclusive and can be more reliably used to measure patients at the high and low end of the scoring system.10

Validity is the ability of an outcome instrument to measure what it is intended to measure. Establishing validity is complex and requires evaluation of several facets, including content validity, construct validity, and criterion validity. Content validity is a relatively subjective judgment explaining the ability of an instrument to assess the critical features of the problem. Construct validity evaluates whether the questionnaire measures what it intends to measure, and is often assessed by correlating scores form one instrument to those from other proven instruments that are already accepted as valid. Finally, criterion validity assesses the correlation between the score and a previously established “gold standard” instrument.

Responsiveness is the ability of the instrument to detect a change or identify improvement or worsening of a clinical condition over time. Most frequently, the effect size (observed change/standard deviation of baseline scores) and standardized response mean (observed change/standard deviation of change) are used as measures of responsiveness. The minimal clinically important difference of an outcome measure is the smallest change in an outcome score that corresponds to a change in patient condition.

Continue to: ACL Outcome Instruments...

 

 

ACL OUTCOME INSTRUMENTS

WESTERN ONTARIO AND MCMASTER UNIVERSITIES OSTEOARTHRITIS INDEX (WOMAC LK 3.0)

The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC LK 3.0) was developed in 1982 and is a widely used, disease-specific instrument recommended for the evaluation of treatment effects in patients with hip and knee osteoarthritis.11 Available in more than 80 languages, it is a self-administered, generic health status questionnaire developed to assess pain, function, and stiffness in daily living, taking respondents between 3 to 7.5 minutes for completion.12 Using visual analog scales, the 24 items probe the 3 subscales: pain (5 items), stiffness (2 items), and functional difficulty (17 items). Scores are calculated for each dimension, and the total score is normalized to a 100-point scale, with 0 indicating severe symptoms and 100 indicating no symptoms and higher function. The WOMAC score can also be calculated from the Knee Injury and Osteoarthritis Outcome Score (KOOS). The WOMAC questionnaire is well recognized for its good validity, reliability, and responsiveness, and is the most commonly used outcome measure for osteoarthritis.13-15 Considering its focus on older patients with osteoarthritis, it may not be appropriate for use in a young and active population.

KNEE INJURY AND OSTEOARTHRITIS OUTCOME SCORE (KOOS)

The KOOS is a knee-specific questionnaire developed as an extension of the WOMAC to evaluate the functional status and QOL of patients with any type of knee injury who are at an increased risk of developing osteoarthritis.16 The patient-based questionnaire is available in over 30 languages and covers both the short- and long-term consequences of an injury of the knee causing traumatic damage to cartilage, ligaments, and menisci. The KOOS is 42 items graded on a 5-point Likert scale, covering 5 subscales: pain (9 items), symptoms (7 items), function in activities of daily living (17 items), function in sports/recreation (5 items), and knee-related QOL (4 items). The questionnaire is self-administered and takes about 10 minutes to complete. Scores are calculated for each dimension, and the total score is transformed to a 0 to 100 scale, with 0 representing severe knee problems and 100 representing no knee problems and better outcome. An advantage of the KOOS is that it evaluates both knee injuries and osteoarthritis; therefore, it is arguably more suitable for evaluating patients over the long-term. The KOOS has been validated for several orthopedic interventions, including ACL reconstruction and rehabilitation16,17 as well as meniscectomy18 and total knee replacement.19 Population-based reference data for the adult population according to age and gender have also been established.20 The KOOS is increasingly utilized in clinical studies on ACL reconstruction.21-25 The questions of the WOMAC were retained so that a WOMAC score might be calculated separately and compared with the KOOS score.26

PATIENT-REPORTED OUTCOMES INFORMATION SYSTEM (PROMIS)

Since 2004, The National Institutes of Health (NIH) has funded the development of the Patient-Reported Outcome Measurement Information System (PROMIS), a set of flexible tools that reliably and validly measure PROs. The PROMIS consists of a library of question banks that has been developed and operated by a network of National Institutes of Health-funded research sites and coordinating centers and covers many different health domains including pain, fatigue, anxiety, depression, social functioning, physical functioning, and sleep. PROMIS items are developed using Item Response Theory (IRT), wherein the answer to any individual item has a known mathematical probability of predicting the test taker’s overall measurement of the specific trait being tested. This is commonly administered using computer-adaptive testing (CAT), which presents to the test taker an initial item, scores the response to that item, and from the response then presents the most informative second item, and so forth until a predefined level of precision is reached. Because the items are individually validated, they can be used alone or in any combination, a feature that distinguishes the PROMIS from traditional fixed-length PRO instruments that require the completion of an instrument in its entirety to be valid.27 In recent years, orthopedic research has been published with PROMIS physical function (PF) scores as primary outcome measures.28-30 The PF item bank includes 124 items measuring upper extremity, lower extremity, central and instrumental activities of daily living. PF can be completed as a short form (SF) with a set number of questions or utilizing CAT and evaluates self-reported function and physical activity. An advantage is its ease of use and potential to minimize test burden with very few questions, often as little as 4 items, as compared to other traditional PROMs.31

Previously published work has demonstrated that, in patients undergoing meniscal surgery, the PROMIS PF CAT maintains construct validity and correlates well with currently used knee outcome instruments, including KOOS.28 Work by the same group looking at the performance of the PROMIS PF CAT in patients indicated for ACL reconstruction shows that the PROMIS PF CAT correlates well with other PRO instruments for patients with ACL injuries, (SF-36 PF [r = 0.82, P < 0.01], KOOS Sport [r = 0.70, P < 0.01], KOOS ADL [r = 0.74, P < 0.01]), does not have floor or ceiling effects in this relatively young and healthy population, and has a low test burden.32,33 Papuga and colleagues33 also compared the International Knee Documentation Committee (IKDC) and PROMIS PF CAT on 106 subjects after ACL reconstruction and found good correlation.

Continue to: Quality of Life Outcome Measure...

 

 

QUALITY OF LIFE OUTCOME MEASURE FOR ACL DEFICIENCY (ACL-QOL)

The ACL-QOL Score was developed in 1998 as a disease-specific measure for patients with chronic ACL deficiency.34 This scale consists of 32 separate items in 31 visual analog questions regarding symptoms and physical complaints, work-related concerns, recreational activities and sport participation or competition, lifestyle, and social and emotional health status relating to the knee. The raw score is transformed into a 0- to 100-point scale, with higher scores indicating a better outcome. The scale is valid, reliable, and responsive for patients with ACL insufficiency,35,36 and is not applicable to other disorders of the knee. We recommend the ACL-QOL questionnaire be used in conjunction with other currently available objective and functional outcome measures.

CINCINNATI KNEE RATING SYSTEM

The Cincinnati Knee Rating System (CKRS) was first described in 1983 and was modified to include occupational activities, athletic activities, symptoms, and functional limitations.37,38 There are 11 components, measuring symptoms and disability in sports activity, activities of daily living function, occupational rating, as well as sections that measure physical examination, laxity of the knee, and radiographic evidence of degenerative joint disease.39 The measure is scored on a 100-point scale, with higher scores indicating better outcomes. Scores have been shown to be lower as compared with other outcome measures assessing the same clinical condition.40,41 Barber-Westin and colleagues39 confirmed the reliability, validity, and responsiveness of the CKRS by testing 350 subjects with and without knee ligament injuries. In 2001, Marx42 tested the CKRS subjective form for reliability, validity, and responsiveness and found it to be acceptable for clinical research.

LYSHOLM KNEE SCORE

The Lysholm Knee Score was published in 1982 and modified in 1985, consisting of an 8-question survey that evaluates outcomes after knee ligament surgery. Items include pain, instability, locking, squatting, limping, support usage, swelling, and stair-climbing ability, with pain and instability carrying the highest weight.43 It is scored on a scale of 0 to 100, with high scores indicating higher functioning and fewer symptoms. It has been validated in patients with ACL injuries and meniscal injuries.44 Although it is widely used to measure outcomes after ACL reconstruction,45 it has received criticism in the evaluation of patients with other knee conditions.46 The main advantage of the Lysholm Knee Score is its ability to note changes in activity in the same patient across different time periods (responsiveness). A limitation of the Lysholm Knee Score is that it does not measure the domains of functioning in daily activities, sports, and recreational activities. The Lysholm scoring system’s test-retest reliability and construct validity have been evaluated,42,43,46 although there has been some concern regarding a ceiling effect and its validity, sensitivity, and reliability has been questioned.47 Therefore, it is advised that this score be used in conjunction with other PRO scores.

INTERNATIONAL KNEE DOCUMENTATION COMMITTEE (IKDC) SUBJECTIVE KNEE FORM

In 1987, members of the European Society for Knee Surgery and Arthroscopy and the American Orthopaedic Society for Sports Medicine formed the IKDC to develop a standardized method for evaluating knee injuries and treatment. The IKDC Subjective Knee Evaluation Form was initially published in 1993, and in 2001 the form was revised by the American Orthopaedic Society for Sports Medicine to become a knee-specific assessment tool rather than a disease or condition-specific tool.48 The IKDC subjective form is an 18-question, knee-specific survey designed to detect improvement or deterioration in symptoms, function, and ability to participate in sports activities experienced by patients following knee surgery or other interventions. The individual items are summed and transformed into a 0- to 100-point scale, with high scores representing higher levels of function and minimal symptoms. The IKDC is utilized to assess a variety of knee conditions including ligament, meniscus, articular cartilage, osteoarthritis, and patellofemoral pain.48,49 Thus, this form can be used to assess any condition involving the knee and allow comparison between groups with different diagnoses. The IKDC has been validated for an ACL reconstruction population,47 has been used to assess outcomes in recent clinical studies on ACL reconstruction,50,51 and is one of the most frequently used measures for patients with ACL deficiency.3 The validity, responsiveness, and reliability of the IKDC subjective form has been confirmed for both adult and adolescent populations.48,49,52-54

TEGNER ACTIVITY SCORES

The Tegner activity score was developed in 1985 and was designed to provide an objective value for a patient’s activity level.44 This scale was developed to complement the Lysholm score. It consists of 1 sport-specific activity level question on a 0 to 10 scale that evaluates an individual’s ability to compete in a sporting activity. Scores between 1 and 5 represent work or recreational sports. Scores >5 represent higher-level recreational and competitive sports. The Tegner activity score is one of the most widely used activity scoring systems for patients with knee disorders,55,56 commonly utilized with the Lysholm Knee Score.44 One disadvantage of the Tegner activity score is that it relates to specific sports rather than functional activities, which limits its generalizability. We are not aware of any studies documenting the reliability or validity of this instrument.

Continue on: Marx Activity Rating Scale...

 

 

MARX ACTIVITY RATING SCALE

The Marx activity rating scale was developed to be utilized with other knee rating scales and outcome measures as an activity assessment.57 In contrast to the Tegner activity score, the Marx activity rating scale measures function rather than sport-specific activity. The scale is a short, patient-based activity assessment that consists of a 4-question survey evaluating patients’ knee health by recording the frequency and intensity of participation in a sporting activity. Questions are scored from 0 to 4 on the basis of how often the activity is performed. The 4 sections of the Marx scale that are rated include running, cutting, decelerating, and pivoting. This scale has been validated in patients with ACL injuries, chondromalacia patellae, and meniscal lesions.42,56-58 Acceptable ceiling effects of 3% and floor effects of 8% were noted in the study of ACL-injured patients.57

AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS (AAOS) SPORTS KNEE SCALE

The American Academy of Orthopaedic Surgeons (AAOS) Sports Knee Rating Scale consists of 5 parts and 23 items, including a section addressing stiffness, swelling, pain and function (7 questions), locking/catching (4 questions), giving way (4 questions), limitations of activity (4 questions), and pain with activity (4 questions).59,60 Items may be dropped if patients select particular responses, which can lead to difficulties when using the survey. This scoring system has been found to be satisfactory when all subscales were combined and the mean was calculated.42

DISCUSSION

PRO measures play an increasingly important role in the measurement of success and impact of health care services. Specifically, for ACL reconstruction, patient satisfaction is key for demonstrating the value of operative or other interventions. Selecting a suitable outcome measurement tool can be daunting, as it can be difficult to ascertain which outcome measures are appropriate for the patient or disorder in question. As there is currently no instrument that is universally superior in the evaluation of ACL outcomes, clinicians must consider the specific patient population in which the outcome instrument has been evaluated. Investigators should also use instruments with reported minimal clinically important differences so that variation in scores can be interpreted as either clinically significant or not. When choosing which outcome instrument to use, there is rarely a single appropriate rating system that is entirely comprehensive. In most cases, a general health outcome measure should be used in combination with a condition-specific rating scale. Activity rating scales, such as Marx or Tegner, should be included, especially when evaluating patients with low-activity lifestyles.

CONCLUSION

There are a number of reliable, valid, and responsive outcome measures that can be utilized to evaluate outcomes following ACL reconstruction in an array of patient populations. Outcome measures should be relevant to patients, easy to use, reliable, valid, and responsive to change. By increasing familiarity with these outcome measures, orthopedic surgeons and investigators can develop better studies, interpret data, and implement findings in practice with sound and informed judgment. Future research should focus on identifying the most relevant outcome metrics for assessing function following ACL reconstruction.

This paper will be judged for the Resident Writer’s Award.

ABSTRACT

Outcome instruments have become an essential part of the evaluation of functional recovery after anterior cruciate ligament (ACL) reconstruction. Although the clinical examination provides important objective information to assess graft integrity, stability, range of motion, and strength, these measurements do not take the patient’s perception into account. There are many knee outcome instruments, and it is challenging for surgeons to understand how to interpret clinical research and utilize these measures in a practical way. The purpose of this review is to provide an overview of the most commonly used outcome measures in patients undergoing ACL reconstruction and to examine and compare the psychometric performance (validity, reliability, responsiveness) of these measurement tools.

Anterior cruciate ligament (ACL) reconstruction is one of the most common elective orthopedic procedures.1 Despite advances in surgical techniques, ACL reconstruction is associated with a lengthy recovery time, decreased performance, and increased rate of reinjury.2 Patients undergoing ACL reconstruction are often active individuals who participate in demanding activities, and accurate assessment of their recovery helps to guide recovery counseling. In addition to objective clinical outcomes measured through physical examination, patient-reported outcome (PRO) instruments add the patient’s perspective, information critical in determining a successful outcome. A variety of outcome instruments have been used and validated for patients with ACL tears. It is important for orthopedic surgeons to know the advantages and disadvantages of each outcome tool in order to interpret clinical studies and assess postoperative patients.

Over the last 10 years, there has been an increase in the number of knee instruments and rating scales designed to measure PROs, with >54 scores designed for the ACL-deficient knee.3 No standardized instrument is currently universally accepted as superior following ACL reconstruction across the spectrum of patient populations. Clinicians and researchers must carefully consider an outcome instrument’s utility based on specific patient populations in which it has been evaluated. Appropriate selection of outcome measures is of fundamental importance for adequate demonstration of the efficacy and value of treatment interventions, especially in an era of healthcare reform with a focus on providing high-quality and cost-effective care.

The purpose of this review is to highlight current tools used to measure outcomes after ACL reconstruction. Current outcome measures vary widely in regards to their validity, reliability, minimal clinically important difference, and applicability to specific patient populations. We have thus identified the measures most commonly used today in studies and clinical follow-up after ACL reconstruction and their various advantages and limitations. This information may enhance the orthopedic surgeon’s understanding of what outcome measures may be utilized in clinical studies.

Continue to: Patient-Reported Outcome Instruments...

 

 

PATIENT-REPORTED OUTCOME INSTRUMENTS

Recently, there has been a transition to increased use of PRO instruments rather than clinician-based postoperative assessment, largely due to the increasing emphasis on patient satisfaction in determining the value of an orthopedic intervention.4 PRO instruments are widely used to capture the patient’s perception of general health, quality of life (QOL), daily function, and pain. PRO instruments offer the benefit of allowing patients to subjectively assess their knee function during daily living and sports activities, conveying to the provider the impact of ACL reconstruction on physical, psychological, and social aspects of everyday activities. Furthermore, patient satisfaction has been shown to closely follow outcome scores related to symptoms and function.5 A multitude of specific knee-related PRO instruments have been developed and validated to measure outcomes after ACL reconstruction for both research and clinical purposes (Table).

Table. ACL Outcome Measures

 

 

 

 

 

Outcome Measure

Condition/Intervention

Measures

Internal Consistency (Cronbach’s a)

Test-Retest Reliability

Minimal Clinically Important Difference

Ref

AAOS Sports Knee Scale

Many Knee

Stiffness, swelling, pain/function, locking/catching, giving way, limitation of activity, pain with activity

0.86-0.95

0.68-0.96

Unknown

59, 60

ACL-QOL

Chronic ACL deficiency

Physical complaints, work, recreation and sports competition, lifestyle, social and emotional functioning

0.93-0.98

6% average error

Unknown

35, 36

Cincinnati Knee Rating System

ACL

Symptoms, daily and sports activities, physical examination, stability, radiographs, functional testing

 

0.80-0.97

14 points (6 months), 26 points (12 months)

39, 40, 47, 52

IKDC (Subjective Knee Form)

ACL

Symptoms, function, sports activity

0.92

0.91-0.93

11.5 points; 6.3 at 6 months, 16.7 at 12 months

48, 52, 54

KOOS

ACL

Pain, symptoms, activities of daily living, sport/recreation, knee-related quality of life

0.71-0.95

0.75-0.93

8-10 points

17

Lysholm

ACL

Pain, instability, locking, squatting, limp, support, swelling, stair-climbing

0.72

0.94

8.9

46, 47, 55

Marx

Healthy patients

Activity level

0.87

0.97

Unknown

42, 56, 57

Tegner

ACL

Activity level

0.81

0.82

1

55, 56

PROMIS
(PF CAT)

Many lower extremity orthopedic conditions

Lower extremity function, central body function, activities of daily living

0.98

0.96-0.99

 

30, 31

WOMAC

Hip/knee OA

Physical function, pain, stiffness

0.81-0.95

0.80-0.92

12% baseline score or 6% max score; 9-12 points

13, 14

Abbreviations: AAOS, American Academy of Orthopaedic Surgeons; ACL, anterior cruciate ligament; ACL-QOL, anterior cruciate ligament quality of life score; CAT, computer-adapting testing; IKDC, International Knee Documentation Committee; KOOS, Knee Injury and Osteoarthritis Outcome Score; OA, osteoarthritis; PF, physical function; PROMIS, Patient-Reported Outcome Measurement Information System; Ref, references; WOMAC, Western Ontario and McMaster Universities Osteoarthritis Index.

MEASUREMENT PROPERTIES

In general, clinicians and investigators should use health-related outcome measures with established reliability, validity, patient relevance, and responsiveness for assessing the specific condition.6

Reliability refers to the degree to which a measurement score is free from random error, reflecting how consistent or reproducible the instrument is when administered under the same testing conditions. Internal consistency, test-retest reliability, and measurement error are measures of reliability. Internal consistency is tested after a single administration and assesses how well items within a scale measure a single underlying dimension, represented using item-total correlation coefficients and Cronbach’s alpha. A Cronbach’s alpha of 0.70 to 0.95 is generally defined as good.7 Test-retest reliability is designed to appraise variation over time in stable patients and is represented using the intraclass correlation coefficient (ICC).8 An ICC >0.7 is considered acceptable; >0.8, good; and >0.9, excellent.9 An aspect of accuracy is whether the scoring system measures the full range of the disease or complaints. The incidence of minimum (floor) and maximum (ceiling) scores can be calculated for outcome scores. An instrument with low floor and ceiling effects, below 10% to 15%, is more inconclusive and can be more reliably used to measure patients at the high and low end of the scoring system.10

Validity is the ability of an outcome instrument to measure what it is intended to measure. Establishing validity is complex and requires evaluation of several facets, including content validity, construct validity, and criterion validity. Content validity is a relatively subjective judgment explaining the ability of an instrument to assess the critical features of the problem. Construct validity evaluates whether the questionnaire measures what it intends to measure, and is often assessed by correlating scores form one instrument to those from other proven instruments that are already accepted as valid. Finally, criterion validity assesses the correlation between the score and a previously established “gold standard” instrument.

Responsiveness is the ability of the instrument to detect a change or identify improvement or worsening of a clinical condition over time. Most frequently, the effect size (observed change/standard deviation of baseline scores) and standardized response mean (observed change/standard deviation of change) are used as measures of responsiveness. The minimal clinically important difference of an outcome measure is the smallest change in an outcome score that corresponds to a change in patient condition.

Continue to: ACL Outcome Instruments...

 

 

ACL OUTCOME INSTRUMENTS

WESTERN ONTARIO AND MCMASTER UNIVERSITIES OSTEOARTHRITIS INDEX (WOMAC LK 3.0)

The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC LK 3.0) was developed in 1982 and is a widely used, disease-specific instrument recommended for the evaluation of treatment effects in patients with hip and knee osteoarthritis.11 Available in more than 80 languages, it is a self-administered, generic health status questionnaire developed to assess pain, function, and stiffness in daily living, taking respondents between 3 to 7.5 minutes for completion.12 Using visual analog scales, the 24 items probe the 3 subscales: pain (5 items), stiffness (2 items), and functional difficulty (17 items). Scores are calculated for each dimension, and the total score is normalized to a 100-point scale, with 0 indicating severe symptoms and 100 indicating no symptoms and higher function. The WOMAC score can also be calculated from the Knee Injury and Osteoarthritis Outcome Score (KOOS). The WOMAC questionnaire is well recognized for its good validity, reliability, and responsiveness, and is the most commonly used outcome measure for osteoarthritis.13-15 Considering its focus on older patients with osteoarthritis, it may not be appropriate for use in a young and active population.

KNEE INJURY AND OSTEOARTHRITIS OUTCOME SCORE (KOOS)

The KOOS is a knee-specific questionnaire developed as an extension of the WOMAC to evaluate the functional status and QOL of patients with any type of knee injury who are at an increased risk of developing osteoarthritis.16 The patient-based questionnaire is available in over 30 languages and covers both the short- and long-term consequences of an injury of the knee causing traumatic damage to cartilage, ligaments, and menisci. The KOOS is 42 items graded on a 5-point Likert scale, covering 5 subscales: pain (9 items), symptoms (7 items), function in activities of daily living (17 items), function in sports/recreation (5 items), and knee-related QOL (4 items). The questionnaire is self-administered and takes about 10 minutes to complete. Scores are calculated for each dimension, and the total score is transformed to a 0 to 100 scale, with 0 representing severe knee problems and 100 representing no knee problems and better outcome. An advantage of the KOOS is that it evaluates both knee injuries and osteoarthritis; therefore, it is arguably more suitable for evaluating patients over the long-term. The KOOS has been validated for several orthopedic interventions, including ACL reconstruction and rehabilitation16,17 as well as meniscectomy18 and total knee replacement.19 Population-based reference data for the adult population according to age and gender have also been established.20 The KOOS is increasingly utilized in clinical studies on ACL reconstruction.21-25 The questions of the WOMAC were retained so that a WOMAC score might be calculated separately and compared with the KOOS score.26

PATIENT-REPORTED OUTCOMES INFORMATION SYSTEM (PROMIS)

Since 2004, The National Institutes of Health (NIH) has funded the development of the Patient-Reported Outcome Measurement Information System (PROMIS), a set of flexible tools that reliably and validly measure PROs. The PROMIS consists of a library of question banks that has been developed and operated by a network of National Institutes of Health-funded research sites and coordinating centers and covers many different health domains including pain, fatigue, anxiety, depression, social functioning, physical functioning, and sleep. PROMIS items are developed using Item Response Theory (IRT), wherein the answer to any individual item has a known mathematical probability of predicting the test taker’s overall measurement of the specific trait being tested. This is commonly administered using computer-adaptive testing (CAT), which presents to the test taker an initial item, scores the response to that item, and from the response then presents the most informative second item, and so forth until a predefined level of precision is reached. Because the items are individually validated, they can be used alone or in any combination, a feature that distinguishes the PROMIS from traditional fixed-length PRO instruments that require the completion of an instrument in its entirety to be valid.27 In recent years, orthopedic research has been published with PROMIS physical function (PF) scores as primary outcome measures.28-30 The PF item bank includes 124 items measuring upper extremity, lower extremity, central and instrumental activities of daily living. PF can be completed as a short form (SF) with a set number of questions or utilizing CAT and evaluates self-reported function and physical activity. An advantage is its ease of use and potential to minimize test burden with very few questions, often as little as 4 items, as compared to other traditional PROMs.31

Previously published work has demonstrated that, in patients undergoing meniscal surgery, the PROMIS PF CAT maintains construct validity and correlates well with currently used knee outcome instruments, including KOOS.28 Work by the same group looking at the performance of the PROMIS PF CAT in patients indicated for ACL reconstruction shows that the PROMIS PF CAT correlates well with other PRO instruments for patients with ACL injuries, (SF-36 PF [r = 0.82, P < 0.01], KOOS Sport [r = 0.70, P < 0.01], KOOS ADL [r = 0.74, P < 0.01]), does not have floor or ceiling effects in this relatively young and healthy population, and has a low test burden.32,33 Papuga and colleagues33 also compared the International Knee Documentation Committee (IKDC) and PROMIS PF CAT on 106 subjects after ACL reconstruction and found good correlation.

Continue to: Quality of Life Outcome Measure...

 

 

QUALITY OF LIFE OUTCOME MEASURE FOR ACL DEFICIENCY (ACL-QOL)

The ACL-QOL Score was developed in 1998 as a disease-specific measure for patients with chronic ACL deficiency.34 This scale consists of 32 separate items in 31 visual analog questions regarding symptoms and physical complaints, work-related concerns, recreational activities and sport participation or competition, lifestyle, and social and emotional health status relating to the knee. The raw score is transformed into a 0- to 100-point scale, with higher scores indicating a better outcome. The scale is valid, reliable, and responsive for patients with ACL insufficiency,35,36 and is not applicable to other disorders of the knee. We recommend the ACL-QOL questionnaire be used in conjunction with other currently available objective and functional outcome measures.

CINCINNATI KNEE RATING SYSTEM

The Cincinnati Knee Rating System (CKRS) was first described in 1983 and was modified to include occupational activities, athletic activities, symptoms, and functional limitations.37,38 There are 11 components, measuring symptoms and disability in sports activity, activities of daily living function, occupational rating, as well as sections that measure physical examination, laxity of the knee, and radiographic evidence of degenerative joint disease.39 The measure is scored on a 100-point scale, with higher scores indicating better outcomes. Scores have been shown to be lower as compared with other outcome measures assessing the same clinical condition.40,41 Barber-Westin and colleagues39 confirmed the reliability, validity, and responsiveness of the CKRS by testing 350 subjects with and without knee ligament injuries. In 2001, Marx42 tested the CKRS subjective form for reliability, validity, and responsiveness and found it to be acceptable for clinical research.

LYSHOLM KNEE SCORE

The Lysholm Knee Score was published in 1982 and modified in 1985, consisting of an 8-question survey that evaluates outcomes after knee ligament surgery. Items include pain, instability, locking, squatting, limping, support usage, swelling, and stair-climbing ability, with pain and instability carrying the highest weight.43 It is scored on a scale of 0 to 100, with high scores indicating higher functioning and fewer symptoms. It has been validated in patients with ACL injuries and meniscal injuries.44 Although it is widely used to measure outcomes after ACL reconstruction,45 it has received criticism in the evaluation of patients with other knee conditions.46 The main advantage of the Lysholm Knee Score is its ability to note changes in activity in the same patient across different time periods (responsiveness). A limitation of the Lysholm Knee Score is that it does not measure the domains of functioning in daily activities, sports, and recreational activities. The Lysholm scoring system’s test-retest reliability and construct validity have been evaluated,42,43,46 although there has been some concern regarding a ceiling effect and its validity, sensitivity, and reliability has been questioned.47 Therefore, it is advised that this score be used in conjunction with other PRO scores.

INTERNATIONAL KNEE DOCUMENTATION COMMITTEE (IKDC) SUBJECTIVE KNEE FORM

In 1987, members of the European Society for Knee Surgery and Arthroscopy and the American Orthopaedic Society for Sports Medicine formed the IKDC to develop a standardized method for evaluating knee injuries and treatment. The IKDC Subjective Knee Evaluation Form was initially published in 1993, and in 2001 the form was revised by the American Orthopaedic Society for Sports Medicine to become a knee-specific assessment tool rather than a disease or condition-specific tool.48 The IKDC subjective form is an 18-question, knee-specific survey designed to detect improvement or deterioration in symptoms, function, and ability to participate in sports activities experienced by patients following knee surgery or other interventions. The individual items are summed and transformed into a 0- to 100-point scale, with high scores representing higher levels of function and minimal symptoms. The IKDC is utilized to assess a variety of knee conditions including ligament, meniscus, articular cartilage, osteoarthritis, and patellofemoral pain.48,49 Thus, this form can be used to assess any condition involving the knee and allow comparison between groups with different diagnoses. The IKDC has been validated for an ACL reconstruction population,47 has been used to assess outcomes in recent clinical studies on ACL reconstruction,50,51 and is one of the most frequently used measures for patients with ACL deficiency.3 The validity, responsiveness, and reliability of the IKDC subjective form has been confirmed for both adult and adolescent populations.48,49,52-54

TEGNER ACTIVITY SCORES

The Tegner activity score was developed in 1985 and was designed to provide an objective value for a patient’s activity level.44 This scale was developed to complement the Lysholm score. It consists of 1 sport-specific activity level question on a 0 to 10 scale that evaluates an individual’s ability to compete in a sporting activity. Scores between 1 and 5 represent work or recreational sports. Scores >5 represent higher-level recreational and competitive sports. The Tegner activity score is one of the most widely used activity scoring systems for patients with knee disorders,55,56 commonly utilized with the Lysholm Knee Score.44 One disadvantage of the Tegner activity score is that it relates to specific sports rather than functional activities, which limits its generalizability. We are not aware of any studies documenting the reliability or validity of this instrument.

Continue on: Marx Activity Rating Scale...

 

 

MARX ACTIVITY RATING SCALE

The Marx activity rating scale was developed to be utilized with other knee rating scales and outcome measures as an activity assessment.57 In contrast to the Tegner activity score, the Marx activity rating scale measures function rather than sport-specific activity. The scale is a short, patient-based activity assessment that consists of a 4-question survey evaluating patients’ knee health by recording the frequency and intensity of participation in a sporting activity. Questions are scored from 0 to 4 on the basis of how often the activity is performed. The 4 sections of the Marx scale that are rated include running, cutting, decelerating, and pivoting. This scale has been validated in patients with ACL injuries, chondromalacia patellae, and meniscal lesions.42,56-58 Acceptable ceiling effects of 3% and floor effects of 8% were noted in the study of ACL-injured patients.57

AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS (AAOS) SPORTS KNEE SCALE

The American Academy of Orthopaedic Surgeons (AAOS) Sports Knee Rating Scale consists of 5 parts and 23 items, including a section addressing stiffness, swelling, pain and function (7 questions), locking/catching (4 questions), giving way (4 questions), limitations of activity (4 questions), and pain with activity (4 questions).59,60 Items may be dropped if patients select particular responses, which can lead to difficulties when using the survey. This scoring system has been found to be satisfactory when all subscales were combined and the mean was calculated.42

DISCUSSION

PRO measures play an increasingly important role in the measurement of success and impact of health care services. Specifically, for ACL reconstruction, patient satisfaction is key for demonstrating the value of operative or other interventions. Selecting a suitable outcome measurement tool can be daunting, as it can be difficult to ascertain which outcome measures are appropriate for the patient or disorder in question. As there is currently no instrument that is universally superior in the evaluation of ACL outcomes, clinicians must consider the specific patient population in which the outcome instrument has been evaluated. Investigators should also use instruments with reported minimal clinically important differences so that variation in scores can be interpreted as either clinically significant or not. When choosing which outcome instrument to use, there is rarely a single appropriate rating system that is entirely comprehensive. In most cases, a general health outcome measure should be used in combination with a condition-specific rating scale. Activity rating scales, such as Marx or Tegner, should be included, especially when evaluating patients with low-activity lifestyles.

CONCLUSION

There are a number of reliable, valid, and responsive outcome measures that can be utilized to evaluate outcomes following ACL reconstruction in an array of patient populations. Outcome measures should be relevant to patients, easy to use, reliable, valid, and responsive to change. By increasing familiarity with these outcome measures, orthopedic surgeons and investigators can develop better studies, interpret data, and implement findings in practice with sound and informed judgment. Future research should focus on identifying the most relevant outcome metrics for assessing function following ACL reconstruction.

This paper will be judged for the Resident Writer’s Award.

References

1. Mall NA, Chalmers PN, Moric M, et al. Incidence and trends of anterior cruciate ligament reconstruction in the United States. Am J Sports Med. 2014;42(10):2363-2370. doi:10.1177/0363546514542796.

2. Brophy RH, Schmitz L, Wright RW, et al. Return to play and future ACL injury risk after ACL reconstruction in soccer athletes from the Multicenter Orthopaedic Outcomes Network (MOON) group. Am J Sports Med. 2012;40(11):2517-2522. doi:10.1177/0363546512459476.

3. Johnson DS, Smith RB. Outcome measurement in the ACL deficient knee- what’s the score? Knee. 2001;8(1):51-57. doi:10.1016/S0968-0160(01)00068-0.

4. Graham B, Green A, James M, Katz J, Swiontkowski M. Measuring patient satisfaction in orthopaedic surgery. J Bone Joint Surg Am. 2015;97(1):80-84. doi:10.2106/JBJS.N.00811.

5. Kocher MS, Steadman JR, Briggs K, Zurakowski D, Sterett WI, Hawkins RJ. Determinants of patient satisfaction with outcome after anterior cruciate ligament reconstruction. J Bone Joint Surg Am. 2002;84(9):1560-1572. doi:10.2106/00004623-200209000-00008.

6. Streiner DL, Norman GR. Health Measurement Scales: A Practical Guide to their Development and Use. Oxford: Oxford University Press; 1989.

7. Terwee CB, Bot SD, de Boer MR, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol. 2007;60(1):34-42. doi:10.1016/j.jclinepi.2006.03.012.

8. Bartko JJ. The intraclass correlation coefficient as a measure of reliability. Psychol Rep. 1966;19(1):3-11. doi:10.2466/pr0.1966.19.1.3.

9. Scholtes VA, Terwee CB, Poolman RW. What makes a measurement instrument valid and reliable? Injury. 2011;42(3):236-240. doi:10.1016/j.injury.2010.11.042.

10. Fries J, Rose M, Krishnan E. The PROMIS of better outcome assessment: responsiveness, floor and ceiling effects, and internet administration. J Rheumatol. 2011;38(8):1759-1764. doi:10.3899/jrheum.110402.

11. Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt L. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol. 1988;15(12):1833-1840.

12. Gandek B. Measurement properties of the Western Ontario and McMaster Universities Osteoarthritis Index: a systematic review. Arthritis Care Res (Hoboken). 2015;67(2):216-229. doi:10.1002/acr.22415.

13. Angst F, Aeschlimann A, Stucki G. Smallest detectable and minimal clinically important differences of rehabilitation intervention with their implications for required sample sizes using WOMAC and SF-36 quality of life measurement instruments in patients with osteoarthritis of the lower extremities. Arthritis Rheum. 2001;45(4):384-391. doi:10.1002/1529-0131(200108)45:4<384::AID-ART352>3.0.CO;2-0.

14. Ryser L, Wright BD, Aeschlimann A, Mariacher-Gehler S, Stuckl G. A new look at the Western Ontario and McMaster Universities Osteoarthritis Index using Rasch analysis. Arthritis Care Res. 1999;12(5):331-335.

15. Wolfe F, Kong SX. Rasch analysis of the Western Ontario MacMaster questionnaire (WOMAC) in 2205 patients with osteoarthritis, rheumatoid arthritis, and fibromyalgia. Ann Rheum Dis. 1999;58(9):563-568. doi:10.1136/ard.58.9.563.

16. Roos EM, Roos HP, Lohmander LS, Ekdahl C, Beynnon BD. Knee Injury and Osteoarthritis Outcome Score (KOOS)—development of a self-administered outcome measure. J Orthop Sports Phys Ther. 1998;28(2):88-96. doi:10.2519/jospt.1998.28.2.88.

17. Salavati M, Akhbari B, Mohammadi F, Mazaheri M, Khorrami M. Knee injury and Osteoarthritis Outcome Score (KOOS): reliability and validity in competitive athletes after anterior cruciate ligament reconstruction. Osteoarthritis Cartilage. 2011;19(4):406-410. doi:10.1016/j.joca.2011.01.010.

18. Roos EM, Roos HP, Lohmander LS. WOMAC Osteoarthritis Index—additional dimensions for use in subjects with post-traumatic osteoarthritis of the knee. Western Ontario and MacMaster Universities. Osteoarthritis Cartilage. 1999;7(2):216-221. doi:10.1053/joca.1998.0153.

19. Roos EM, Toksvig-Larsen S. Knee injury and osteoarthritis outcome score (KOOS)—validation and comparison to the WOMAC in total knee replacement. Health Qual Life Outcomes. 2003;1(1):17. doi:10.1186/1477-7525-1-17.

20. Paradowski PT, Bergman S, Sunden-Lundius A, Lohmander LS, Roos EM. Knee complaints vary with age and gender in the adult population: population-based reference data for the Knee injury and Osteoarthritis Outcome Score (KOOS). BMC Musculoskeletal Disord. 2006;7(1):38. doi:10.1186/1471-2474-7-38.

21. MARS Group. Effect of graft choice on the outcome of revision anterior cruciate ligament reconstruction in the Multicenter ACL Revision Study (MARS) Cohort. Am J Sports Med. 2014;42(10):2301-2310. doi:10.1177/0363546514549005.

22. Ventura A, Legnani C, Terzaghi C, Borgo E, Albisetti W. Revision surgery after failed ACL reconstruction with artificial ligaments: clinical, histologic and radiographic evaluation. Eur J Orthop Surg Traumatol. 2014;21(1):93-98. doi:10.1007/s00590-012-1136-3.

23. Wasserstein D, Huston LJ, Nwosu S, et al. KOOS pain as a marker for significant knee pain two and six years after primary ACL reconstruction: a Multicenter Orthopaedic Outcomes Network (MOON) prospective longitudinal cohort study. Osteoarthritis Cartilage. 2015;23(10):1674-1684. doi:10.1016/j.joca.2015.05.025.

24. Zaffagnini S, Grassi A, Muccioli GM, et al. Return to sport after anterior cruciate ligament reconstruction in professional soccer players. Knee. 2014;21(3):731-735. doi:10.1016/j.knee.2014.02.005.

25. Duffee A, Magnussen RA, Pedroza AD, Flanigan DC; MOON Group, Kaeding CC. Transtibial ACL femoral tunnel preparation increases odds of repeat ipsilateral knee surgery. J Bone Joint Surg Am. 2013;95(22):2035-2042. doi:10.2106/JBJS.M.00187.

26. Bellamy N, Buchanan WW. A preliminary evaluation of the dimensionality and clinical importance of pain and disability in osteoarthritis of the hip and knee. Clin Rheumatol. 1986;5(2):231-241. doi:10.1007/BF02032362.

27. Fries J, Rose M, Krishnan E. The PROMIS of better outcome assessment: responsiveness, floor and ceiling effects, and Internet administration. J Rheumatol. 2011;38(8):1759-1764. doi:10.3899/jrheum.110402.

28. Hancock KJ, Glass NA, Anthony CA, et al. Performance of PROMIS for healthy patients undergoing meniscal surgery. J Bone Joint Surg Am. 2017;99(11):954-958. doi:10.2106/JBJS.16.00848.

29. Hung M, Clegg Do, Greene T, et al. Evaluation of the PROMIS physical function item bank in orthopedic patients. J Orthop Res. 2011;29(6):947-953. doi:10.1002/jor.21308.

30. Hung M, Baumhauer JF, Brodsky JW, et al; Orthopaedic Foot & Ankle Outcomes Research (OFAR) of the American Orthopaedic Foot & Ankle Society (AOFAS). Psychometric comparison of the PROMIS physical function CAT with the FAAM and FFI for measuring patient-reported outcomes. Foot Ankle Int. 2014;35(6):592-599. doi:10.1177/1071100714528492.

31. Hung M, Stuart AR, Higgins TF, Saltzman CL, Kubiak EN. Computerized adaptive testing using the PROMIS physical function item bank reduces test burden with less ceiling effects compared with the short musculoskeletal function assessment in orthopaedic trauma patients. J Orthop Trauma. 2014;28(8):439-443. doi:10.1097/BOT.0000000000000059.

32. Hancock, et al. PROMIS: A valid and efficient outcomes instrument for patients with ACL tears. KSSTA. In press.

33. Scott, et al. Performance of PROMIS physical function compared with KOOS, SF-36, Eq5D, and Marx activity scale in patients who undergo ACL reconstruction. In press.

34. Papuga MO, Beck CA, Kates SL, Schwarz EM, Maloney MD. Validation of GAITRite and PROMIS as high-throughput physical function outcome measures following ACL reconstruction. J Orthop Res. 2014;32(6):793-801. doi:10.1002/jor.22591.

35. Mohtadi N. Development and validation of the quality of life outcome measure (questionnaire) for chronic anterior cruciate ligament deficiency. Am J Sports Med. 1998;26(3):350-359. doi:10.1177/03635465980260030201.

36. Lafave MR, Hiemstra L, Kerslake S, Heard M, Buchko G. Validity, reliability, and responsiveness of the anterior cruciate ligament quality of life measure: a continuation of its overall validation. Clin J Sport Med. 2017;27(1):57-63. doi:10.1097/JSM.0000000000000292.

37. Noyes FR, McGinniss GH, Mooar LA. Functional disability in the anterior cruciate insufficient knee syndrome: Review of knee rating systems and projected risk factors in determining treatment. Sports Med. 1984;1(4):278-302. doi:10.2165/00007256-198401040-00004.

38. Noyes FR, Matthews DS, Mooar PA, Grood ES. The symptomatic anterior cruciate-deficient knee: Part II. The results of rehabilitation, activity modification, and counseling on functional disability. J Bone Joint Surg Am. 1983;65(2):163-174. doi:10.2106/00004623-198365020-00004.

39. Barber-Westin SD, Noyes FR, McCloskey JW. Rigorous statistical reliability, validity, and responsiveness testing of the Cincinnati knee rating system in 350 subjects with uninjured, injured, or anterior cruciate ligament-reconstructed knees. Am J Sports Med. 1999;27(4):402-416. doi:10.1177/03635465990270040201.

40. Bollen S, Seedhorn BB. A comparison of the Lysholm and Cincinnati knee scoring questionnaires. Am J Sports Med. 1991;19(2):189-190. doi:10.1177/036354659101900215.

41. Sgaglione NA, Del Pizzo W, Fox JM, Friedman MJ. Critical analysis of knee ligament rating systems. Am J Sports Med. 1995;23(6):660-667. doi:10.1177/036354659502300604.

42. Marx RG, Jones EC, Allen AA, et al. Reliability, validity, and responsiveness of four knee outcome scales for athletic patients. J Bone Joint Surg Am. 2001;83(10):1459-1469. doi:10.2106/00004623-200110000-00001.

43. Lysholm J, Gillquist J. Evaluation of knee ligament surgery results with special emphasis on use of a scoring scale. Am J Sports Med. 1982;10(3):150-154. doi:10.1177/036354658201000306.

44. Tegner Y, Lysholm J. Rating systems in the evaluation of knee ligament injuries. Clin Orthop Relat Res. 1985;198:43-49. doi:10.1097/00003086-198509000-00007.

45. Lukianov AV, Gillquist J, Grana WA, DeHaven KE. An anterior cruciate ligament (ACL) evaluation format for assessment of artificial or autologous anterior cruciate reconstruction results. Clin Orthop Relat Res. 1987;218:167-180. doi:10.1097/00003086-198705000-00024.

46. Bengtsson J, Mollborg J, Werner S. A study for testing the sensitivity and reliability of the Lysholm knee scoring scale. Knee Surg Sports Traumatol Arthrosc. 1996;4(1):27-31. doi:10.1007/BF01565994.

47. Risberg MA, Holm I, Steen J, Beynnon BD. Sensitivity to changes over time for the IKDC form, the Lysholm score, and the Cincinnati knee score. A prospective study of 120 ACL reconstructed patients with a 2-year follow-up. Knee Surg Sports Traumatol Arthrosc. 1999;7(3):152-159. doi:10.1007/s001670050140.

48. Irrgang JJ, Anderson AF, Boland AL, et al. Development and validation of the international knee documentation committee subjective knee form. Am J Sports Med. 2001;29(5):600-613. doi:10.1177/03635465010290051301.

49. Irrgang JJ, Anderson AF, Boland AL, et al. Responsiveness of the International Knee Documentation Committee Subjective Knee Form. Am J Sports Med. 2006;34(10):1567-1573. doi:10.1177/0363546506288855.

50. Logerstedt D, Di Stasi S, Grindem H, et al. Self-reported knee function can identify athletes who fail return-to-activity criteria up to 1 year after anterior cruciate ligament reconstruction: a Delaware-Oslo ACL cohort study. J Orthop Sports Phys Ther. 2014;44(2):914-923. doi:10.2519/jospt.2014.4852.

51. Lentz TA, Zeppieri G Jr, George SZ, et al. Comparison of physical impairment, functional and psychosocial measures based on fear of reinjury/lack of confidence and return-to-sport status after ACL reconstruction. Am J Sports Med. 2015;43(2):345-353. doi:10.1177/0363546514559707.

52. Greco NJ, Anderson AF, Mann BJ, et al. Responsiveness of the International Knee Documentation Committee Subjective Knee Form in comparison to the Western Ontario and McMaster Universities Osteoarthritis Index, modified Cincinnati Knee Rating System, and Short Form 36 in patients with focal articular cartilage defects. Am J Sports Med. 2010;38(5):891-902. doi:10.1177/0363546509354163.

53. Hefti F, Muller W, Jakob RP, Staubli HU. Evaluation of knee ligament injuries with the IKDC form. Knee Surg Sports Traumatol Arthrosc. 1993;1(3-4):226-234. doi:10.1007/BF01560215.

54. Schmitt LC, Paterno MV, Huang S. Validity and internal consistency of the International Knee Documentation Committee Subjective Knee Evaluation Form in children and adolescents. Am J Sports Med. 2010;38(12):2443-2447. doi:10.1177/0363546510374873.

55. Briggs KK, Lysholm J, Tegner Y, Rodkey WG, Kocher MS, Steadman JR. The reliability, validity, and responsiveness of the Lysholm and Tegner activity scale for anterior cruciate ligament injuries of the knee: 25 years later. Am J Sports Med. 2009;37(5):890-897. doi:10.1177/0363546508330143.

56. Negahban H, Mostafaee N, Sohani SM, et al. Reliability and validity of the Tegner and Marx activity rating scales in Iranian patients with anterior cruciate ligament injury. Disabil Rehabil. 2011;33(23-24):2305-2310. doi:10.3109/09638288.2011.570409.

57. Marx RG, Stump TJ, Jones EC, Wickiewicz TL, Warren RF. Development and evaluation of an activity rating scale for disorders of the knee. Am J Sports Med. 2001;29(2):213-218. doi:10.1177/03635465010290021601.

58. Garratt AM, Brealey S, Gillespie WJ, in collaboration with the DAM-ASK Trial Team. Patient-assessed health instruments for the knee: a structured review. Rheumatology. 2004;43(11):1414-1423. doi:10.1093/rheumatology/keh362.

59. American Academy of Orthopaedic Surgeons. Scoring algorithms for the lower limb: Outcomes data collection instrument. Rosemon, IL: American Academy of Orthopaedic Surgeons; 1998.

60. Johanson NA, Liang MH, Daltroy L, Rudicel S, Richmond J. American Academy of Orthopaedic Surgeons lower limb outcomes assessment instruments. Reliability, validity, and sensitivity to change. J Bone Joint Surg Am. 2004;86-A(5):902-909.

References

1. Mall NA, Chalmers PN, Moric M, et al. Incidence and trends of anterior cruciate ligament reconstruction in the United States. Am J Sports Med. 2014;42(10):2363-2370. doi:10.1177/0363546514542796.

2. Brophy RH, Schmitz L, Wright RW, et al. Return to play and future ACL injury risk after ACL reconstruction in soccer athletes from the Multicenter Orthopaedic Outcomes Network (MOON) group. Am J Sports Med. 2012;40(11):2517-2522. doi:10.1177/0363546512459476.

3. Johnson DS, Smith RB. Outcome measurement in the ACL deficient knee- what’s the score? Knee. 2001;8(1):51-57. doi:10.1016/S0968-0160(01)00068-0.

4. Graham B, Green A, James M, Katz J, Swiontkowski M. Measuring patient satisfaction in orthopaedic surgery. J Bone Joint Surg Am. 2015;97(1):80-84. doi:10.2106/JBJS.N.00811.

5. Kocher MS, Steadman JR, Briggs K, Zurakowski D, Sterett WI, Hawkins RJ. Determinants of patient satisfaction with outcome after anterior cruciate ligament reconstruction. J Bone Joint Surg Am. 2002;84(9):1560-1572. doi:10.2106/00004623-200209000-00008.

6. Streiner DL, Norman GR. Health Measurement Scales: A Practical Guide to their Development and Use. Oxford: Oxford University Press; 1989.

7. Terwee CB, Bot SD, de Boer MR, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol. 2007;60(1):34-42. doi:10.1016/j.jclinepi.2006.03.012.

8. Bartko JJ. The intraclass correlation coefficient as a measure of reliability. Psychol Rep. 1966;19(1):3-11. doi:10.2466/pr0.1966.19.1.3.

9. Scholtes VA, Terwee CB, Poolman RW. What makes a measurement instrument valid and reliable? Injury. 2011;42(3):236-240. doi:10.1016/j.injury.2010.11.042.

10. Fries J, Rose M, Krishnan E. The PROMIS of better outcome assessment: responsiveness, floor and ceiling effects, and internet administration. J Rheumatol. 2011;38(8):1759-1764. doi:10.3899/jrheum.110402.

11. Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt L. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol. 1988;15(12):1833-1840.

12. Gandek B. Measurement properties of the Western Ontario and McMaster Universities Osteoarthritis Index: a systematic review. Arthritis Care Res (Hoboken). 2015;67(2):216-229. doi:10.1002/acr.22415.

13. Angst F, Aeschlimann A, Stucki G. Smallest detectable and minimal clinically important differences of rehabilitation intervention with their implications for required sample sizes using WOMAC and SF-36 quality of life measurement instruments in patients with osteoarthritis of the lower extremities. Arthritis Rheum. 2001;45(4):384-391. doi:10.1002/1529-0131(200108)45:4<384::AID-ART352>3.0.CO;2-0.

14. Ryser L, Wright BD, Aeschlimann A, Mariacher-Gehler S, Stuckl G. A new look at the Western Ontario and McMaster Universities Osteoarthritis Index using Rasch analysis. Arthritis Care Res. 1999;12(5):331-335.

15. Wolfe F, Kong SX. Rasch analysis of the Western Ontario MacMaster questionnaire (WOMAC) in 2205 patients with osteoarthritis, rheumatoid arthritis, and fibromyalgia. Ann Rheum Dis. 1999;58(9):563-568. doi:10.1136/ard.58.9.563.

16. Roos EM, Roos HP, Lohmander LS, Ekdahl C, Beynnon BD. Knee Injury and Osteoarthritis Outcome Score (KOOS)—development of a self-administered outcome measure. J Orthop Sports Phys Ther. 1998;28(2):88-96. doi:10.2519/jospt.1998.28.2.88.

17. Salavati M, Akhbari B, Mohammadi F, Mazaheri M, Khorrami M. Knee injury and Osteoarthritis Outcome Score (KOOS): reliability and validity in competitive athletes after anterior cruciate ligament reconstruction. Osteoarthritis Cartilage. 2011;19(4):406-410. doi:10.1016/j.joca.2011.01.010.

18. Roos EM, Roos HP, Lohmander LS. WOMAC Osteoarthritis Index—additional dimensions for use in subjects with post-traumatic osteoarthritis of the knee. Western Ontario and MacMaster Universities. Osteoarthritis Cartilage. 1999;7(2):216-221. doi:10.1053/joca.1998.0153.

19. Roos EM, Toksvig-Larsen S. Knee injury and osteoarthritis outcome score (KOOS)—validation and comparison to the WOMAC in total knee replacement. Health Qual Life Outcomes. 2003;1(1):17. doi:10.1186/1477-7525-1-17.

20. Paradowski PT, Bergman S, Sunden-Lundius A, Lohmander LS, Roos EM. Knee complaints vary with age and gender in the adult population: population-based reference data for the Knee injury and Osteoarthritis Outcome Score (KOOS). BMC Musculoskeletal Disord. 2006;7(1):38. doi:10.1186/1471-2474-7-38.

21. MARS Group. Effect of graft choice on the outcome of revision anterior cruciate ligament reconstruction in the Multicenter ACL Revision Study (MARS) Cohort. Am J Sports Med. 2014;42(10):2301-2310. doi:10.1177/0363546514549005.

22. Ventura A, Legnani C, Terzaghi C, Borgo E, Albisetti W. Revision surgery after failed ACL reconstruction with artificial ligaments: clinical, histologic and radiographic evaluation. Eur J Orthop Surg Traumatol. 2014;21(1):93-98. doi:10.1007/s00590-012-1136-3.

23. Wasserstein D, Huston LJ, Nwosu S, et al. KOOS pain as a marker for significant knee pain two and six years after primary ACL reconstruction: a Multicenter Orthopaedic Outcomes Network (MOON) prospective longitudinal cohort study. Osteoarthritis Cartilage. 2015;23(10):1674-1684. doi:10.1016/j.joca.2015.05.025.

24. Zaffagnini S, Grassi A, Muccioli GM, et al. Return to sport after anterior cruciate ligament reconstruction in professional soccer players. Knee. 2014;21(3):731-735. doi:10.1016/j.knee.2014.02.005.

25. Duffee A, Magnussen RA, Pedroza AD, Flanigan DC; MOON Group, Kaeding CC. Transtibial ACL femoral tunnel preparation increases odds of repeat ipsilateral knee surgery. J Bone Joint Surg Am. 2013;95(22):2035-2042. doi:10.2106/JBJS.M.00187.

26. Bellamy N, Buchanan WW. A preliminary evaluation of the dimensionality and clinical importance of pain and disability in osteoarthritis of the hip and knee. Clin Rheumatol. 1986;5(2):231-241. doi:10.1007/BF02032362.

27. Fries J, Rose M, Krishnan E. The PROMIS of better outcome assessment: responsiveness, floor and ceiling effects, and Internet administration. J Rheumatol. 2011;38(8):1759-1764. doi:10.3899/jrheum.110402.

28. Hancock KJ, Glass NA, Anthony CA, et al. Performance of PROMIS for healthy patients undergoing meniscal surgery. J Bone Joint Surg Am. 2017;99(11):954-958. doi:10.2106/JBJS.16.00848.

29. Hung M, Clegg Do, Greene T, et al. Evaluation of the PROMIS physical function item bank in orthopedic patients. J Orthop Res. 2011;29(6):947-953. doi:10.1002/jor.21308.

30. Hung M, Baumhauer JF, Brodsky JW, et al; Orthopaedic Foot & Ankle Outcomes Research (OFAR) of the American Orthopaedic Foot & Ankle Society (AOFAS). Psychometric comparison of the PROMIS physical function CAT with the FAAM and FFI for measuring patient-reported outcomes. Foot Ankle Int. 2014;35(6):592-599. doi:10.1177/1071100714528492.

31. Hung M, Stuart AR, Higgins TF, Saltzman CL, Kubiak EN. Computerized adaptive testing using the PROMIS physical function item bank reduces test burden with less ceiling effects compared with the short musculoskeletal function assessment in orthopaedic trauma patients. J Orthop Trauma. 2014;28(8):439-443. doi:10.1097/BOT.0000000000000059.

32. Hancock, et al. PROMIS: A valid and efficient outcomes instrument for patients with ACL tears. KSSTA. In press.

33. Scott, et al. Performance of PROMIS physical function compared with KOOS, SF-36, Eq5D, and Marx activity scale in patients who undergo ACL reconstruction. In press.

34. Papuga MO, Beck CA, Kates SL, Schwarz EM, Maloney MD. Validation of GAITRite and PROMIS as high-throughput physical function outcome measures following ACL reconstruction. J Orthop Res. 2014;32(6):793-801. doi:10.1002/jor.22591.

35. Mohtadi N. Development and validation of the quality of life outcome measure (questionnaire) for chronic anterior cruciate ligament deficiency. Am J Sports Med. 1998;26(3):350-359. doi:10.1177/03635465980260030201.

36. Lafave MR, Hiemstra L, Kerslake S, Heard M, Buchko G. Validity, reliability, and responsiveness of the anterior cruciate ligament quality of life measure: a continuation of its overall validation. Clin J Sport Med. 2017;27(1):57-63. doi:10.1097/JSM.0000000000000292.

37. Noyes FR, McGinniss GH, Mooar LA. Functional disability in the anterior cruciate insufficient knee syndrome: Review of knee rating systems and projected risk factors in determining treatment. Sports Med. 1984;1(4):278-302. doi:10.2165/00007256-198401040-00004.

38. Noyes FR, Matthews DS, Mooar PA, Grood ES. The symptomatic anterior cruciate-deficient knee: Part II. The results of rehabilitation, activity modification, and counseling on functional disability. J Bone Joint Surg Am. 1983;65(2):163-174. doi:10.2106/00004623-198365020-00004.

39. Barber-Westin SD, Noyes FR, McCloskey JW. Rigorous statistical reliability, validity, and responsiveness testing of the Cincinnati knee rating system in 350 subjects with uninjured, injured, or anterior cruciate ligament-reconstructed knees. Am J Sports Med. 1999;27(4):402-416. doi:10.1177/03635465990270040201.

40. Bollen S, Seedhorn BB. A comparison of the Lysholm and Cincinnati knee scoring questionnaires. Am J Sports Med. 1991;19(2):189-190. doi:10.1177/036354659101900215.

41. Sgaglione NA, Del Pizzo W, Fox JM, Friedman MJ. Critical analysis of knee ligament rating systems. Am J Sports Med. 1995;23(6):660-667. doi:10.1177/036354659502300604.

42. Marx RG, Jones EC, Allen AA, et al. Reliability, validity, and responsiveness of four knee outcome scales for athletic patients. J Bone Joint Surg Am. 2001;83(10):1459-1469. doi:10.2106/00004623-200110000-00001.

43. Lysholm J, Gillquist J. Evaluation of knee ligament surgery results with special emphasis on use of a scoring scale. Am J Sports Med. 1982;10(3):150-154. doi:10.1177/036354658201000306.

44. Tegner Y, Lysholm J. Rating systems in the evaluation of knee ligament injuries. Clin Orthop Relat Res. 1985;198:43-49. doi:10.1097/00003086-198509000-00007.

45. Lukianov AV, Gillquist J, Grana WA, DeHaven KE. An anterior cruciate ligament (ACL) evaluation format for assessment of artificial or autologous anterior cruciate reconstruction results. Clin Orthop Relat Res. 1987;218:167-180. doi:10.1097/00003086-198705000-00024.

46. Bengtsson J, Mollborg J, Werner S. A study for testing the sensitivity and reliability of the Lysholm knee scoring scale. Knee Surg Sports Traumatol Arthrosc. 1996;4(1):27-31. doi:10.1007/BF01565994.

47. Risberg MA, Holm I, Steen J, Beynnon BD. Sensitivity to changes over time for the IKDC form, the Lysholm score, and the Cincinnati knee score. A prospective study of 120 ACL reconstructed patients with a 2-year follow-up. Knee Surg Sports Traumatol Arthrosc. 1999;7(3):152-159. doi:10.1007/s001670050140.

48. Irrgang JJ, Anderson AF, Boland AL, et al. Development and validation of the international knee documentation committee subjective knee form. Am J Sports Med. 2001;29(5):600-613. doi:10.1177/03635465010290051301.

49. Irrgang JJ, Anderson AF, Boland AL, et al. Responsiveness of the International Knee Documentation Committee Subjective Knee Form. Am J Sports Med. 2006;34(10):1567-1573. doi:10.1177/0363546506288855.

50. Logerstedt D, Di Stasi S, Grindem H, et al. Self-reported knee function can identify athletes who fail return-to-activity criteria up to 1 year after anterior cruciate ligament reconstruction: a Delaware-Oslo ACL cohort study. J Orthop Sports Phys Ther. 2014;44(2):914-923. doi:10.2519/jospt.2014.4852.

51. Lentz TA, Zeppieri G Jr, George SZ, et al. Comparison of physical impairment, functional and psychosocial measures based on fear of reinjury/lack of confidence and return-to-sport status after ACL reconstruction. Am J Sports Med. 2015;43(2):345-353. doi:10.1177/0363546514559707.

52. Greco NJ, Anderson AF, Mann BJ, et al. Responsiveness of the International Knee Documentation Committee Subjective Knee Form in comparison to the Western Ontario and McMaster Universities Osteoarthritis Index, modified Cincinnati Knee Rating System, and Short Form 36 in patients with focal articular cartilage defects. Am J Sports Med. 2010;38(5):891-902. doi:10.1177/0363546509354163.

53. Hefti F, Muller W, Jakob RP, Staubli HU. Evaluation of knee ligament injuries with the IKDC form. Knee Surg Sports Traumatol Arthrosc. 1993;1(3-4):226-234. doi:10.1007/BF01560215.

54. Schmitt LC, Paterno MV, Huang S. Validity and internal consistency of the International Knee Documentation Committee Subjective Knee Evaluation Form in children and adolescents. Am J Sports Med. 2010;38(12):2443-2447. doi:10.1177/0363546510374873.

55. Briggs KK, Lysholm J, Tegner Y, Rodkey WG, Kocher MS, Steadman JR. The reliability, validity, and responsiveness of the Lysholm and Tegner activity scale for anterior cruciate ligament injuries of the knee: 25 years later. Am J Sports Med. 2009;37(5):890-897. doi:10.1177/0363546508330143.

56. Negahban H, Mostafaee N, Sohani SM, et al. Reliability and validity of the Tegner and Marx activity rating scales in Iranian patients with anterior cruciate ligament injury. Disabil Rehabil. 2011;33(23-24):2305-2310. doi:10.3109/09638288.2011.570409.

57. Marx RG, Stump TJ, Jones EC, Wickiewicz TL, Warren RF. Development and evaluation of an activity rating scale for disorders of the knee. Am J Sports Med. 2001;29(2):213-218. doi:10.1177/03635465010290021601.

58. Garratt AM, Brealey S, Gillespie WJ, in collaboration with the DAM-ASK Trial Team. Patient-assessed health instruments for the knee: a structured review. Rheumatology. 2004;43(11):1414-1423. doi:10.1093/rheumatology/keh362.

59. American Academy of Orthopaedic Surgeons. Scoring algorithms for the lower limb: Outcomes data collection instrument. Rosemon, IL: American Academy of Orthopaedic Surgeons; 1998.

60. Johanson NA, Liang MH, Daltroy L, Rudicel S, Richmond J. American Academy of Orthopaedic Surgeons lower limb outcomes assessment instruments. Reliability, validity, and sensitivity to change. J Bone Joint Surg Am. 2004;86-A(5):902-909.

Publications
Publications
Topics
Article Type
Display Headline
Current Concepts in Clinical Research: Anterior Cruciate Ligament Outcome Instruments
Display Headline
Current Concepts in Clinical Research: Anterior Cruciate Ligament Outcome Instruments
Sections
Inside the Article

TAKE-HOME POINTS

  • PRO instruments are widely used to capture patient perception of general health, QOL, daily function, and pain, and are an essential part of evaluation after ACL reconstruction.
  • ACL outcome measures vary widely in regards to their validity, reliability, minimal clinically important difference, and applicability to specific patient populations.
  • There is currently no standardized instrument universally accepted as superior following ACL reconstruction.
  • In most cases, a general health outcome measure should be used in combination with a condition-specific rating scale.
  • Activity rating scales, such as Marx or Tegner, should be included when evaluating patients with low-activity lifestyles.
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Gate On Date
Thu, 03/21/2019 - 15:00
Un-Gate On Date
Thu, 03/21/2019 - 15:00
Use ProPublica
CFC Schedule Remove Status
Thu, 03/21/2019 - 15:00
Hide sidebar & use full width
render the right sidebar.

Spine fracture risk may be increased in IBD patients

Article Type
Changed
Fri, 01/18/2019 - 17:36

 

Although patients with inflammatory bowel disease (IBD) aren’t at greater risk for fractures overall, they may be at greater risk of fractures in the spine, results of a recent meta-analysis suggest.

Moreover, fracture risk appears to be higher among IBD patients using steroids, according to a report published in the Journal of Clinical Gastroenterology by Yuga Komaki, MD, of the Inflammatory Bowel Disease Center, University of Chicago, and coauthors.

“Further studies addressing the differential risk among Crohn’s disease and ulcerative colitis are needed, but strict surveillance and prevention of spine fractures are indicated in IBD,” wrote Dr. Komaki and associates.

PALMIHELP/Getty Images


The systematic review and meta-analysis by Dr. Komaki and colleagues was based on 10 studies comprising 470,541 patients with IBD for whom the risk of fracture was reported.

“It is of importance to identify the risk of fractures, as it will increase patient morbidity, disability, and mortality,” the authors wrote. “However, it is often overlooked in the management of IBD.”

Results of the analysis by this group of researchers showed that there was no significant difference in fracture risk overall between IBD patients and controls (odds ratio, 1.08; 95% confidence interval, 0.72-1.62; P = .70).

By contrast, the OR for spine fractures was significantly elevated (OR, 2.21; 95% CI, 1.39-3.50; P less than .0001), while risk of hip, rib, and wrist fractures were not, Dr. Komaki and coauthors said in their report.

 

 


Steroids were more often being used in the treatment of IBD patients who had fractures than in patients with no fractures, though the finding did not quite reach statistical significance (OR, 1.47; 95% CI, 0.99-2.20; P = .057).

Prior studies of fracture risk in IBD have shown “controversial results,” according to Dr. Komaki and colleagues. Some of those studies suggest an increased risk of fractures, whereas others suggest the risk is not different from what is seen in the general population.

“Individual studies may be underpowered to detect any risk,” they said in the report.

Steroids have been shown to increase risk of spine and rib fracture, but whether those earlier studies apply in IBD is unclear, they noted.
 

 


While the present meta-analysis sheds light on fracture risk in IBD patients, further meta-analyses may be needed to specifically look at cohorts of patients with Crohn’s disease and ulcerative colitis.

In this study, the investigators did find that spine fracture risk was significantly elevated in patients with Crohn’s disease, and was trending toward significance for ulcerative colitis patients. They cautioned that those results were based on a limited amount of patient data.

Dr. Komaki reported that he had no disclosures related to the reported study. One study coauthor reported disclosures related to AbbVie and Celltrion.

SOURCE: Komaki Y et al. J Clin Gastroenterol. 2018 Apr 18. 2018 Apr 18. doi: 10.1097/MCG.0000000000001031.

Publications
Topics
Sections

 

Although patients with inflammatory bowel disease (IBD) aren’t at greater risk for fractures overall, they may be at greater risk of fractures in the spine, results of a recent meta-analysis suggest.

Moreover, fracture risk appears to be higher among IBD patients using steroids, according to a report published in the Journal of Clinical Gastroenterology by Yuga Komaki, MD, of the Inflammatory Bowel Disease Center, University of Chicago, and coauthors.

“Further studies addressing the differential risk among Crohn’s disease and ulcerative colitis are needed, but strict surveillance and prevention of spine fractures are indicated in IBD,” wrote Dr. Komaki and associates.

PALMIHELP/Getty Images


The systematic review and meta-analysis by Dr. Komaki and colleagues was based on 10 studies comprising 470,541 patients with IBD for whom the risk of fracture was reported.

“It is of importance to identify the risk of fractures, as it will increase patient morbidity, disability, and mortality,” the authors wrote. “However, it is often overlooked in the management of IBD.”

Results of the analysis by this group of researchers showed that there was no significant difference in fracture risk overall between IBD patients and controls (odds ratio, 1.08; 95% confidence interval, 0.72-1.62; P = .70).

By contrast, the OR for spine fractures was significantly elevated (OR, 2.21; 95% CI, 1.39-3.50; P less than .0001), while risk of hip, rib, and wrist fractures were not, Dr. Komaki and coauthors said in their report.

 

 


Steroids were more often being used in the treatment of IBD patients who had fractures than in patients with no fractures, though the finding did not quite reach statistical significance (OR, 1.47; 95% CI, 0.99-2.20; P = .057).

Prior studies of fracture risk in IBD have shown “controversial results,” according to Dr. Komaki and colleagues. Some of those studies suggest an increased risk of fractures, whereas others suggest the risk is not different from what is seen in the general population.

“Individual studies may be underpowered to detect any risk,” they said in the report.

Steroids have been shown to increase risk of spine and rib fracture, but whether those earlier studies apply in IBD is unclear, they noted.
 

 


While the present meta-analysis sheds light on fracture risk in IBD patients, further meta-analyses may be needed to specifically look at cohorts of patients with Crohn’s disease and ulcerative colitis.

In this study, the investigators did find that spine fracture risk was significantly elevated in patients with Crohn’s disease, and was trending toward significance for ulcerative colitis patients. They cautioned that those results were based on a limited amount of patient data.

Dr. Komaki reported that he had no disclosures related to the reported study. One study coauthor reported disclosures related to AbbVie and Celltrion.

SOURCE: Komaki Y et al. J Clin Gastroenterol. 2018 Apr 18. 2018 Apr 18. doi: 10.1097/MCG.0000000000001031.

 

Although patients with inflammatory bowel disease (IBD) aren’t at greater risk for fractures overall, they may be at greater risk of fractures in the spine, results of a recent meta-analysis suggest.

Moreover, fracture risk appears to be higher among IBD patients using steroids, according to a report published in the Journal of Clinical Gastroenterology by Yuga Komaki, MD, of the Inflammatory Bowel Disease Center, University of Chicago, and coauthors.

“Further studies addressing the differential risk among Crohn’s disease and ulcerative colitis are needed, but strict surveillance and prevention of spine fractures are indicated in IBD,” wrote Dr. Komaki and associates.

PALMIHELP/Getty Images


The systematic review and meta-analysis by Dr. Komaki and colleagues was based on 10 studies comprising 470,541 patients with IBD for whom the risk of fracture was reported.

“It is of importance to identify the risk of fractures, as it will increase patient morbidity, disability, and mortality,” the authors wrote. “However, it is often overlooked in the management of IBD.”

Results of the analysis by this group of researchers showed that there was no significant difference in fracture risk overall between IBD patients and controls (odds ratio, 1.08; 95% confidence interval, 0.72-1.62; P = .70).

By contrast, the OR for spine fractures was significantly elevated (OR, 2.21; 95% CI, 1.39-3.50; P less than .0001), while risk of hip, rib, and wrist fractures were not, Dr. Komaki and coauthors said in their report.

 

 


Steroids were more often being used in the treatment of IBD patients who had fractures than in patients with no fractures, though the finding did not quite reach statistical significance (OR, 1.47; 95% CI, 0.99-2.20; P = .057).

Prior studies of fracture risk in IBD have shown “controversial results,” according to Dr. Komaki and colleagues. Some of those studies suggest an increased risk of fractures, whereas others suggest the risk is not different from what is seen in the general population.

“Individual studies may be underpowered to detect any risk,” they said in the report.

Steroids have been shown to increase risk of spine and rib fracture, but whether those earlier studies apply in IBD is unclear, they noted.
 

 


While the present meta-analysis sheds light on fracture risk in IBD patients, further meta-analyses may be needed to specifically look at cohorts of patients with Crohn’s disease and ulcerative colitis.

In this study, the investigators did find that spine fracture risk was significantly elevated in patients with Crohn’s disease, and was trending toward significance for ulcerative colitis patients. They cautioned that those results were based on a limited amount of patient data.

Dr. Komaki reported that he had no disclosures related to the reported study. One study coauthor reported disclosures related to AbbVie and Celltrion.

SOURCE: Komaki Y et al. J Clin Gastroenterol. 2018 Apr 18. 2018 Apr 18. doi: 10.1097/MCG.0000000000001031.

Publications
Publications
Topics
Article Type
Click for Credit Status
Ready
Sections
Article Source

FROM THE JOURNAL OF CLINICAL GASTROENTEROLOGY

Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Vitals

 

Key clinical point: Patients with inflammatory bowel disease may be at increased risk of fractures in the spine.

Major finding: The odds ratio for spine fractures was 2.21 (95% CI, 1.39-3.50; P less than .0001).

Study details: A systematic review and meta-analysis of 10 studies including 470,541 patients.

Disclosures: One study author reported disclosures related to AbbVie and Celltrion.

Source: Komaki Y et al. J Clin Gastroenterol. 2018 Apr 18. doi: 10.1097/MCG.0000000000001031.

Disqus Comments
Default
Use ProPublica

Drs. O'Neil, Meadows, and Patterson Earn Annual AJO Resident Writer's Awards

Article Type
Changed
Thu, 09/19/2019 - 13:18
Display Headline
Drs. O'Neil, Meadows, and Patterson Earn Annual AJO Resident Writer's Awards

Bryan Hanypsiak, MD, Editor-in-Chief of The American Journal of Orthopedics, along with Darla Conrad, Senior Director, North America, and Mindy Edgar, Manager, Academic Alliances from the Johnson & Johnson Institute presented the 2017 Resident Writer’s Award to the three winners at the American Academy of Orthopaedic Surgeons (AAOS) annual meeting in New Orleans. All articles published in 2017 with a resident as the first-listed author and accepted through the journal’s standard blinded-review process were eligible for this award. The annual Resident Writer's Award is sponsored by Johnson & Johnson. Papers published in 2018 will be judged by The American Journal of Orthopedics Editorial Board, and honoraria will be presented to the winners at the 2019 AAOS annual meeting.

The second- and third-place Resident Writer’s Award winners, Molly C. Meadows, MD, and Joseph T. Patterson, MD, at the Johnson & Johnson booth at the 2018 Annual Meeting of the AAOS in New Orleans.

First-Place Award

Joseph T. O’Neil, MD


Second-Place Award

Molly C. Meadows, MD


Third-Place Award

Joseph T. Patterson, MD

See more information about the 2018 Resident Writer's Award.


Supported by Johnson & Johnson

 

Publications
Topics

Bryan Hanypsiak, MD, Editor-in-Chief of The American Journal of Orthopedics, along with Darla Conrad, Senior Director, North America, and Mindy Edgar, Manager, Academic Alliances from the Johnson & Johnson Institute presented the 2017 Resident Writer’s Award to the three winners at the American Academy of Orthopaedic Surgeons (AAOS) annual meeting in New Orleans. All articles published in 2017 with a resident as the first-listed author and accepted through the journal’s standard blinded-review process were eligible for this award. The annual Resident Writer's Award is sponsored by Johnson & Johnson. Papers published in 2018 will be judged by The American Journal of Orthopedics Editorial Board, and honoraria will be presented to the winners at the 2019 AAOS annual meeting.

The second- and third-place Resident Writer’s Award winners, Molly C. Meadows, MD, and Joseph T. Patterson, MD, at the Johnson & Johnson booth at the 2018 Annual Meeting of the AAOS in New Orleans.

First-Place Award

Joseph T. O’Neil, MD


Second-Place Award

Molly C. Meadows, MD


Third-Place Award

Joseph T. Patterson, MD

See more information about the 2018 Resident Writer's Award.


Supported by Johnson & Johnson

 

Bryan Hanypsiak, MD, Editor-in-Chief of The American Journal of Orthopedics, along with Darla Conrad, Senior Director, North America, and Mindy Edgar, Manager, Academic Alliances from the Johnson & Johnson Institute presented the 2017 Resident Writer’s Award to the three winners at the American Academy of Orthopaedic Surgeons (AAOS) annual meeting in New Orleans. All articles published in 2017 with a resident as the first-listed author and accepted through the journal’s standard blinded-review process were eligible for this award. The annual Resident Writer's Award is sponsored by Johnson & Johnson. Papers published in 2018 will be judged by The American Journal of Orthopedics Editorial Board, and honoraria will be presented to the winners at the 2019 AAOS annual meeting.

The second- and third-place Resident Writer’s Award winners, Molly C. Meadows, MD, and Joseph T. Patterson, MD, at the Johnson & Johnson booth at the 2018 Annual Meeting of the AAOS in New Orleans.

First-Place Award

Joseph T. O’Neil, MD


Second-Place Award

Molly C. Meadows, MD


Third-Place Award

Joseph T. Patterson, MD

See more information about the 2018 Resident Writer's Award.


Supported by Johnson & Johnson

 

Publications
Publications
Topics
Article Type
Display Headline
Drs. O'Neil, Meadows, and Patterson Earn Annual AJO Resident Writer's Awards
Display Headline
Drs. O'Neil, Meadows, and Patterson Earn Annual AJO Resident Writer's Awards
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Eyebrow Default
AWARDS
Gate On Date
Thu, 04/11/2019 - 14:30
Un-Gate On Date
Thu, 04/11/2019 - 14:30
Use ProPublica
CFC Schedule Remove Status
Thu, 04/11/2019 - 14:30
Hide sidebar & use full width
render the right sidebar.

AJO Awards Molly C. Meadows, MD, Second-Place Resident Writer's Award

Article Type
Changed
Thu, 09/19/2019 - 13:18
Display Headline
AJO Awards Molly C. Meadows, MD, Second-Place Resident Writer's Award
Molly C. Meadows, MD

2017 AJO Resident Writer's Awards

Second-Place Award

An Original Study

Effects of Platelet-Rich Plasma and Indomethacin on Biomechanics of Rotator Cuff Repair

Molly C. Meadows, MD, David M. Levy, MD, Christopher M. Ferry, MS, Thomas R. Gardner, MCE, Takeshi Teratani, MD, and Christopher S. Ahmad, MD

Molly C. Meadows, MD

Dr. Meadows is currently in her chief year of orthopedic surgery residency training at Rush University Medical Center. Prior to residency, she completed undergraduate education at Brown University and medical school at Columbia University. Dr. Meadows is beginning a sports medicine fellowship at Stanford University in August 2018, and she plans to pursue a pediatric orthopedic fellowship thereafter.

Her research interests include osteochondritis dissecans lesions, patellofemoral disorders, and other sports injuries in the skeletally immature population.

Read the full version of Dr. Meadows' original study.

Publications
Topics
Molly C. Meadows, MD
Molly C. Meadows, MD

2017 AJO Resident Writer's Awards

Second-Place Award

An Original Study

Effects of Platelet-Rich Plasma and Indomethacin on Biomechanics of Rotator Cuff Repair

Molly C. Meadows, MD, David M. Levy, MD, Christopher M. Ferry, MS, Thomas R. Gardner, MCE, Takeshi Teratani, MD, and Christopher S. Ahmad, MD

Molly C. Meadows, MD

Dr. Meadows is currently in her chief year of orthopedic surgery residency training at Rush University Medical Center. Prior to residency, she completed undergraduate education at Brown University and medical school at Columbia University. Dr. Meadows is beginning a sports medicine fellowship at Stanford University in August 2018, and she plans to pursue a pediatric orthopedic fellowship thereafter.

Her research interests include osteochondritis dissecans lesions, patellofemoral disorders, and other sports injuries in the skeletally immature population.

Read the full version of Dr. Meadows' original study.

2017 AJO Resident Writer's Awards

Second-Place Award

An Original Study

Effects of Platelet-Rich Plasma and Indomethacin on Biomechanics of Rotator Cuff Repair

Molly C. Meadows, MD, David M. Levy, MD, Christopher M. Ferry, MS, Thomas R. Gardner, MCE, Takeshi Teratani, MD, and Christopher S. Ahmad, MD

Molly C. Meadows, MD

Dr. Meadows is currently in her chief year of orthopedic surgery residency training at Rush University Medical Center. Prior to residency, she completed undergraduate education at Brown University and medical school at Columbia University. Dr. Meadows is beginning a sports medicine fellowship at Stanford University in August 2018, and she plans to pursue a pediatric orthopedic fellowship thereafter.

Her research interests include osteochondritis dissecans lesions, patellofemoral disorders, and other sports injuries in the skeletally immature population.

Read the full version of Dr. Meadows' original study.

Publications
Publications
Topics
Article Type
Display Headline
AJO Awards Molly C. Meadows, MD, Second-Place Resident Writer's Award
Display Headline
AJO Awards Molly C. Meadows, MD, Second-Place Resident Writer's Award
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Eyebrow Default
AWARDS
Gate On Date
Thu, 04/11/2019 - 14:15
Un-Gate On Date
Thu, 04/11/2019 - 14:15
Use ProPublica
CFC Schedule Remove Status
Thu, 04/11/2019 - 14:15
Hide sidebar & use full width
render the right sidebar.

AJO Awards Joseph T. Patterson, MD, Third-Place Resident Writer's Award

Article Type
Changed
Thu, 09/19/2019 - 13:18
Display Headline
AJO Awards Joseph T. Patterson, MD, Third-Place Resident Writer's Award
Joseph T. Patterson, MD

2017 AJO Resident Writer's Awards

Third-Place Award

An Original Study

Does Preoperative Pneumonia Affect Complications of Geriatric Hip Fracture Surgery?

Joseph T. Patterson, MD, Daniel D. Bohl, MD, MPH, Bryce A. Basques, MD, Alexander H. Arzeno, MD, and Jonathan Grauer, MD

Joseph T. Patterson, MD

Dr. Patterson is completing his orthopedic surgery residency at the University of California San Francisco, and will continue training with a fellowship in orthopedic trauma at Harborview Medical Center. Prior to residency, he completed undergraduate education at the University of California Los Angeles and medical school at Yale University.

His research interests include geriatric hip fracture care, interdisciplinary trauma care performance improvement, and outcome assessment in orthopedic trauma.

Read the full version of Dr. Patterson's original study.

Publications
Topics
Joseph T. Patterson, MD
Joseph T. Patterson, MD

2017 AJO Resident Writer's Awards

Third-Place Award

An Original Study

Does Preoperative Pneumonia Affect Complications of Geriatric Hip Fracture Surgery?

Joseph T. Patterson, MD, Daniel D. Bohl, MD, MPH, Bryce A. Basques, MD, Alexander H. Arzeno, MD, and Jonathan Grauer, MD

Joseph T. Patterson, MD

Dr. Patterson is completing his orthopedic surgery residency at the University of California San Francisco, and will continue training with a fellowship in orthopedic trauma at Harborview Medical Center. Prior to residency, he completed undergraduate education at the University of California Los Angeles and medical school at Yale University.

His research interests include geriatric hip fracture care, interdisciplinary trauma care performance improvement, and outcome assessment in orthopedic trauma.

Read the full version of Dr. Patterson's original study.

2017 AJO Resident Writer's Awards

Third-Place Award

An Original Study

Does Preoperative Pneumonia Affect Complications of Geriatric Hip Fracture Surgery?

Joseph T. Patterson, MD, Daniel D. Bohl, MD, MPH, Bryce A. Basques, MD, Alexander H. Arzeno, MD, and Jonathan Grauer, MD

Joseph T. Patterson, MD

Dr. Patterson is completing his orthopedic surgery residency at the University of California San Francisco, and will continue training with a fellowship in orthopedic trauma at Harborview Medical Center. Prior to residency, he completed undergraduate education at the University of California Los Angeles and medical school at Yale University.

His research interests include geriatric hip fracture care, interdisciplinary trauma care performance improvement, and outcome assessment in orthopedic trauma.

Read the full version of Dr. Patterson's original study.

Publications
Publications
Topics
Article Type
Display Headline
AJO Awards Joseph T. Patterson, MD, Third-Place Resident Writer's Award
Display Headline
AJO Awards Joseph T. Patterson, MD, Third-Place Resident Writer's Award
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Eyebrow Default
AWARDS
Gate On Date
Thu, 04/11/2019 - 14:15
Un-Gate On Date
Thu, 04/11/2019 - 14:15
Use ProPublica
CFC Schedule Remove Status
Thu, 04/11/2019 - 14:15
Hide sidebar & use full width
render the right sidebar.

AJO Awards Joseph T. O'Neil, MD, First-Place Resident Writer's Award

Article Type
Changed
Thu, 09/19/2019 - 13:18
Display Headline
AJO Awards Joseph T. O'Neil, MD, First-Place Resident Writer's Award
Joseph T. O'Neil, MD

2017 AJO Resident Writer's Awards

First-Place Award

An Original Study

Prospective Evaluation of Opioid Consumption After Distal Radius Fracture Repair Surgery

Joseph T. O’Neil, MD, Mark L. Wang, MD, PhD, Nayoung Kim, BS, Mitchell Maltenfort, PhD, and Asif M. Ilyas, MD

Joseph T. O’Neil, MD

Dr. O'Neil completed his orthopedic surgery residency training at Thomas Jefferson University Hospital in Philadelphia, Pennsylvania. Prior to residency, he completed undergraduate education at the University of Notre Dame and medical school at Thomas Jefferson University. He was born and raised in the Philadelphia area.

Dr. O'Neil is currently an orthopedic foot and ankle surgery fellow at Union Memorial Hospital in Baltimore, Maryland.

His research interests include total ankle arthroplasty; the diagnosis, treatment, and prevention of periprosthetic joint infection in the ankle; as well as helping to combat the opioid epidemic in the United States by better understanding patterns of prescribing and use following common orthopedic surgical procedures.

Read the full version of Dr. O'Neil's original study.

Publications
Topics
Joseph T. O'Neil, MD
Joseph T. O'Neil, MD

2017 AJO Resident Writer's Awards

First-Place Award

An Original Study

Prospective Evaluation of Opioid Consumption After Distal Radius Fracture Repair Surgery

Joseph T. O’Neil, MD, Mark L. Wang, MD, PhD, Nayoung Kim, BS, Mitchell Maltenfort, PhD, and Asif M. Ilyas, MD

Joseph T. O’Neil, MD

Dr. O'Neil completed his orthopedic surgery residency training at Thomas Jefferson University Hospital in Philadelphia, Pennsylvania. Prior to residency, he completed undergraduate education at the University of Notre Dame and medical school at Thomas Jefferson University. He was born and raised in the Philadelphia area.

Dr. O'Neil is currently an orthopedic foot and ankle surgery fellow at Union Memorial Hospital in Baltimore, Maryland.

His research interests include total ankle arthroplasty; the diagnosis, treatment, and prevention of periprosthetic joint infection in the ankle; as well as helping to combat the opioid epidemic in the United States by better understanding patterns of prescribing and use following common orthopedic surgical procedures.

Read the full version of Dr. O'Neil's original study.

2017 AJO Resident Writer's Awards

First-Place Award

An Original Study

Prospective Evaluation of Opioid Consumption After Distal Radius Fracture Repair Surgery

Joseph T. O’Neil, MD, Mark L. Wang, MD, PhD, Nayoung Kim, BS, Mitchell Maltenfort, PhD, and Asif M. Ilyas, MD

Joseph T. O’Neil, MD

Dr. O'Neil completed his orthopedic surgery residency training at Thomas Jefferson University Hospital in Philadelphia, Pennsylvania. Prior to residency, he completed undergraduate education at the University of Notre Dame and medical school at Thomas Jefferson University. He was born and raised in the Philadelphia area.

Dr. O'Neil is currently an orthopedic foot and ankle surgery fellow at Union Memorial Hospital in Baltimore, Maryland.

His research interests include total ankle arthroplasty; the diagnosis, treatment, and prevention of periprosthetic joint infection in the ankle; as well as helping to combat the opioid epidemic in the United States by better understanding patterns of prescribing and use following common orthopedic surgical procedures.

Read the full version of Dr. O'Neil's original study.

Publications
Publications
Topics
Article Type
Display Headline
AJO Awards Joseph T. O'Neil, MD, First-Place Resident Writer's Award
Display Headline
AJO Awards Joseph T. O'Neil, MD, First-Place Resident Writer's Award
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Eyebrow Default
AWARDS
Gate On Date
Thu, 04/11/2019 - 12:30
Un-Gate On Date
Thu, 04/11/2019 - 12:30
Use ProPublica
CFC Schedule Remove Status
Thu, 04/11/2019 - 12:30
Hide sidebar & use full width
render the right sidebar.

2018 Resident Writer’s Award Information

Article Type
Changed
Thu, 09/19/2019 - 13:18
Display Headline
2018 Resident Writer’s Award Information

The 2018 Resident Writer’s Award competition is sponsored by Johnson & Johnson. Orthopedic residents are invited to submit original studies, review papers, or case reports for publication. Papers published in 2018 will be judged by The American Journal of Orthopedics Editorial Board. Honoraria will be presented to the winners at the 2019 AAOS annual meeting.

  • $1,500 for the First-Place Award
  • $1,000 for the Second-Place Award
  • $500 for the Third-Place Award

To quality for consideration, papers must have the resident as the first-listed author and must be accepted through the journal’s standard blinded-review process. Papers submitted in 2018 but not published until 2019 will automatically qualify for the 2019 competition. Manuscripts should be prepared according to our Information for the Authors and submitted via our online submission system, Editorial Manager®, at www.editorialmanager.com/AmJOrthop.

Read more about this year's RWA winners.


Supported by Johnson & Johnson

Publications
Topics

The 2018 Resident Writer’s Award competition is sponsored by Johnson & Johnson. Orthopedic residents are invited to submit original studies, review papers, or case reports for publication. Papers published in 2018 will be judged by The American Journal of Orthopedics Editorial Board. Honoraria will be presented to the winners at the 2019 AAOS annual meeting.

  • $1,500 for the First-Place Award
  • $1,000 for the Second-Place Award
  • $500 for the Third-Place Award

To quality for consideration, papers must have the resident as the first-listed author and must be accepted through the journal’s standard blinded-review process. Papers submitted in 2018 but not published until 2019 will automatically qualify for the 2019 competition. Manuscripts should be prepared according to our Information for the Authors and submitted via our online submission system, Editorial Manager®, at www.editorialmanager.com/AmJOrthop.

Read more about this year's RWA winners.


Supported by Johnson & Johnson

The 2018 Resident Writer’s Award competition is sponsored by Johnson & Johnson. Orthopedic residents are invited to submit original studies, review papers, or case reports for publication. Papers published in 2018 will be judged by The American Journal of Orthopedics Editorial Board. Honoraria will be presented to the winners at the 2019 AAOS annual meeting.

  • $1,500 for the First-Place Award
  • $1,000 for the Second-Place Award
  • $500 for the Third-Place Award

To quality for consideration, papers must have the resident as the first-listed author and must be accepted through the journal’s standard blinded-review process. Papers submitted in 2018 but not published until 2019 will automatically qualify for the 2019 competition. Manuscripts should be prepared according to our Information for the Authors and submitted via our online submission system, Editorial Manager®, at www.editorialmanager.com/AmJOrthop.

Read more about this year's RWA winners.


Supported by Johnson & Johnson

Publications
Publications
Topics
Article Type
Display Headline
2018 Resident Writer’s Award Information
Display Headline
2018 Resident Writer’s Award Information
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Eyebrow Default
AWARDS
Gate On Date
Thu, 04/11/2019 - 12:30
Un-Gate On Date
Thu, 04/11/2019 - 12:30
Use ProPublica
CFC Schedule Remove Status
Thu, 04/11/2019 - 12:30
Hide sidebar & use full width
render the right sidebar.